Document

0000934549-18-000007.txt : 20180307 0000934549-18-000007.hdr.sgml : 20180307 20180307162405 ACCESSION NUMBER: 0000934549-18-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180307 DATE AS OF CHANGE: 20180307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACACIA RESEARCH CORP CENTRAL INDEX KEY: 0000934549 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 954405754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37721 FILM NUMBER: 18673652 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 9494808300 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 10-K 1 actg2017123110-k.htm 10-K Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 10-K

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017

o TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO .

Commission File Number 0-26068

____________________

(Exact name of registrant as specified in its charter)



DELAWARE	95-4405754
(State or other jurisdiction of	(I.R.S. Employer
incorporation organization)	Identification No.)

520 NEWPORT CENTER DRIVE, 12TH FLOOR
NEWPORT BEACH, CA	92660
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 480-8300

Securities registered pursuant to Section 12(b) of the Act:



Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, $0.001 par value	The NASDAQ Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Act: None

____________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities

Act. Yes £ No R

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes £ No R

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes R No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes R No £

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. R

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:



Large accelerated filer o		Accelerated filer x
Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o
		Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes £ No R

The aggregate market value of the registrant’s voting and non-voting common stock held by non-affiliates of the registrant on June 30, 2017, the last business day of the registrant’s most recently completed second fiscal quarter, computed by reference to the last sale price of the registrant’s common stock as reported by The Nasdaq Global Select Market on such date, was approximately $202,307,000. This computation assumes that all executive officers and directors are affiliates of the registrant. Such assumption should not be deemed conclusive for any other purpose.

As of March 1, 2018, 50,637,882 shares of common stock were issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

In accordance with General Instruction G(3) to Form 10-K, portions of the registrant’s Definitive Proxy Statement on Schedule 14A for its Annual Meeting of Stockholders to be filed with the Commission within 120 days after the close of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III of this Annual Report on Form 10-K. Only those portions of the proxy statement that are specifically incorporated by reference herein shall constitute a part of this Annual Report on Form 10-K.

ACACIA RESEARCH CORPORATION

ANNUAL REPORT ON FORM 10-K

FISCAL YEAR ENDED DECEMBER 31, 2017

TABLE OF CONTENTS



		Page
PART I

Item 1.	Business	3
Item 1A.	Risk Factors	8
Item 1B.	Unresolved Staff Comments	19
Item 2.	Properties	19
Item 3.	Legal Proceedings	19
Item 4.	Mine Safety Disclosures	20


PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	21
Item 6.	Selected Financial Data	23
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	46
Item 8.	Financial Statements and Supplementary Data	46
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	47
Item 9A.	Controls and Procedures	47
Item 9B.	Other Information	47


PART III

Item 10.	Directors, Executive Officers and Corporate Governance	48
Item 11.	Executive Compensation	48
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	48
Item 13.	Certain Relationships and Related Transactions, and Director Independence	48
Item 14.	Principal Accounting Fees and Services	48


PART IV

Item 15.	Exhibits, Financial Statement Schedules	49

PART I

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

As used in this Annual Report on Form 10-K, “we,” “us” and “our” refer to Acacia Research Corporation and/or its wholly and majority-owned operating subsidiaries. All patent portfolio investments, development, licensing and enforcement activities are conducted solely by certain of our wholly owned operating subsidiaries.

This Annual Report on Form 10-K, or the annual report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which include, without limitation, statements about our future business operations and results, our strategies and competition, and other forward-looking statements included in this annual report. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms, variations of such terms or the negative of such terms. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Such statements address future events and conditions concerning earnings, capital expenditures, litigation, competition, regulatory matters, stock price volatility, liquidity and capital resources, accounting matters and investments. Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as future economic conditions, legislative, regulatory and competitive developments in markets in which we and our subsidiaries operate, and other circumstances affecting anticipated revenues and costs, as more fully disclosed in our discussion of “Risk Factors” in Item 1A of Part I of this annual report. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Additional factors that could cause such results to differ materially from those described in the forward-looking statements are set forth in connection with the forward-looking statements.

ITEM 1. BUSINESS

General

We partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and application, and facilitating efficiency in connection with the monetization of patent assets. We also identify opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by us, along with entering into intellectual property, or IP, related agreements where we provide IP and other patent related services to these companies. We leverage our experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement our primary licensing and enforcement business.

We generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that our operating subsidiaries control or own. We assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries.

We have established a proven track record of licensing and enforcement success with over 1,550 license agreements executed to date, across 193 patent portfolio licensing and enforcement programs. To date, we have generated gross licensing revenue of approximately $1.4 billion, and have returned more than $731 million to our patent partners.

Corporate Information

We were originally incorporated in California in January 1993 and reincorporated in Delaware in December 1999. Our website address is www.acaciaresearch.com. Reference in this annual report to this website address does not constitute incorporation by reference of the information contained on or accessed through our website and references to our website address in this annual report are inactive textual references only. We make our filings with the Securities and Exchange Commission, or the SEC, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form

8-K, other reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, and amendments to the foregoing reports, available free of charge on or through our website as soon as reasonably practicable after we file these reports with, or furnish such reports to, the SEC. In addition, we post the following information on our website:


•	our corporate code of conduct, our code of conduct for our board of directors and our fraud policy;


•	our insider trading policy;


•	charters for our audit committee, nominating and corporate governance committee, disclosure committee and compensation committee; and


•	applicable dividend related tax forms.

The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

Also, the SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically with the SEC. The public can obtain any documents that we file with the SEC at http://www.sec.gov.

Patent Licensing and Enforcement Business

We invest in, license and enforce patented technologies. We partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and application, and facilitating efficiency in connection with the monetization of patent assets.

Refer to the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” below for a partial summary of patent portfolios owned or controlled by certain of our operating subsidiaries.

Patents are an important asset class worldwide. Due to legislative and regulatory changes, licensing and enforcing patents has become increasingly difficult for patent holders, necessitating an experienced, well-capitalized, licensing partner. We have partnered with patent owners, including individual inventors, universities, and large multi-national corporations in a variety of technology sectors. These patent owners may have possessed limited internal resources and/or expertise to effectively address the unauthorized use of their patented technologies, or may seek to effectively and efficiently monetize their portfolio of patented technologies on an outsourced basis.

Under U.S. law, a patent owner has the right to exclude others from making, selling or using their patented invention. A third-party infringes a patent by making, offering for sale, selling, or using a patented invention without a license from the patent owner. Unfortunately, in the majority of cases, infringers are generally unwilling, at least initially, to negotiate or pay reasonable license fees for their unauthorized use of third-party patents and will typically indiscriminately challenge any allegations of patent infringement. Inventors and/or patent holders without sufficient legal, financial and/or expert technical resources to bring and continue the pursuit of costly and complex patent infringement actions are often effectively ignored.

As a result of the common reluctance of patent infringers to negotiate and ultimately take a patent license for the use of patented technologies without at least the threat of legal action, patent licensing and enforcement often begins with the filing of patent infringement litigation. However, most patent infringement litigation settles out of court at amounts that are related to the strength of the patent portfolio and the value of the invention or inventions in the infringer’s products or services. We execute agreements that grant rights in our patents to users of our patented technologies. Our agreements can be negotiated without the filing of patent litigation, or negotiated within the context of ongoing patent litigation, depending on the specific facts and circumstances.

We are a principal in the licensing and enforcement effort, with our operating subsidiaries obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Our relationship with patent owners is the cornerstone of our corporate strategy. We assume all responsibility for advancing operational expenses while pursuing a patent licensing

and enforcement program, and then, when applicable, share net licensing revenue with our patent partners as that program matures, on a pre-arranged and negotiated basis. We may also provide upfront capital to patent owners as an advance against future licensing revenue.

Patent Licensing Business Model and Strategy - Overview

We have the flexibility to structure arrangements in a number of ways to address the needs and specific sets of circumstances presented by each of our unique patent partners, examples of which include the following:

Generally, we maintain a 100% preferred rate of return until all deployed capital and advanced operational costs are recovered by us. After recovery of these costs, the net profit revenue share with patent partner commences, if applicable.

Key Elements of Business Strategy

Patent licensing and enforcement can be an effective and efficient way to maximize the profit potential of a patent, or patents, that are being practiced by third-parties without authorization. A patent license agreement grants a third-party user of an invention specific patent rights to the patented invention in exchange for patent license fees. Our patent licensing business provides patent holders with an opportunity to generate income from their patented inventions being practiced by third-parties without authorization and from third-parties that desire to practice their patented inventions with authorization. Our patent licensing and enforcement business strategy includes three fundamental elements, as follows:


•	Patent Discovery - Discover potentially valuable patents or patent portfolios.


•	Assessment of Economic Value - Work internally and with external experts to evaluate the use of the patented invention(s) in the relevant marketplace and assess a patents or patent portfolios’ expected economic value.


•	Licensing and Enforcement - License those users wanting to utilize the patented invention with authorization. For unauthorized users of the patented invention, enter into license negotiations and, if necessary, litigation to monetize the patent based on its assessed value.

Patent Discovery. The patent process breeds, encourages and sustains innovation and invention by granting a limited monopoly to the inventor in exchange for sharing the invention with the public. Certain technologies, become core technologies in the way products and services are manufactured, sold or delivered by companies across a wide array of industries. Patent discovery involves identifying core, patented technologies that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture, sale or use of products and services.

Assessment of Economic Value. Subsequent to the patent discovery process, our executives work internally and/or with external industry experts in the specific technology field, to evaluate the patented invention and its adoption and implementation in the marketplace. There are a number of factors to consider when analyzing a patent and determining a patent’s value including, (i) infringement, (ii) validity and (iii) enforceability.

To determine infringement, we must first identify third-parties that are practicing the invention(s) covered by the patent without obtaining permission from the patent owner to do so. A key tool in determining whether or not a company is infringing a patent is a claim chart, which demonstrates how the manufacture, sale, or use of an existing product compares against the claims of the patent.

The three main factors analyzed to determine validity are: (1) anticipation, which occurs when the claims of the patent are entirely revealed within a single piece of prior art, (2) obviousness which considers whether the differences between prior art and the patented invention are so slight that they would have been obvious at the time of invention to one who is skilled in the subject matter being patented, and (3) the existence of non-patentable subject matter, which considers whether the subject matter includes naturally occurring things, abstract concepts, or algorithms that perform an ordinary function.

To determine enforceability, a number of factors are analyzed, including whether or not there has been patent misuse, or whether or not there are antitrust violations associated with the patent. Due to the inherently complex nature of patent law, only a court or specific administrative body, such as the International Trade Commission, can make a decision whether a patent is infringed, valid and enforceable; however, we employ our wealth of expertise to make the best assessment possible given a specific fact pattern and set of circumstances.

We estimate a patent’s economic value by evaluating the expected value of the license revenue stream based on past, present and future revenue of infringing products or services, and the risk that a court will disagree with our infringement, validity or enforcement assessments of the patent. The processes and procedures employed in connection with the evaluation of a specific patent portfolio for future investment, licensing and enforcement are tailored and unique to each specific situation and can vary widely based on the specific facts and circumstances of a specific patent portfolio, such as the related technology, related industry and other factors.

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we may not be able to identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.

Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our licensing, enforcement and overall business. In some cases, universities and other technology sources compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

For example, we obtained control of only one, two and three new patent portfolios during fiscal years 2017, 2016 and 2015, respectively, compared to 6 new patent portfolios and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. This decrease in our patent portfolio intake reflects in part our strategic decision in 2013 to shift the focus of our operating business to serving a smaller number of customers, each having higher quality patent portfolios. As a result, our gross number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. As a result of these continuing industry trends, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

As a result of the foregoing, we continue to evaluate other business opportunities which compliment, or supplement, our primary licensing and enforcement business and leverage our intellectual property expertise, as described below, including our continued efforts to identify and partner with potentially high-growth and disruptive technology companies.

Licensing and Enforcement. The final step in the patent licensing and enforcement process is to seek to monetize the patent portfolio by securing license agreements based on the patents use in the marketplace and estimated value. While we prefer to convince unauthorized users of our patented inventions of the value of the patented invention and secure a license agreement in a non-litigious manner, many infringers refuse to take such licenses even when confronted with substantial and persuasive evidence of infringement, validity, enforceability and significant economic value. As a result, often we must resort to litigation to demonstrate and prove infringement and ultimately induce infringers to take a license from us. We have found it

effective to negotiate licenses concurrently with litigation due to the fact that litigation necessitates and facilitates an information exchange that helps both sides assess the value of a patent and make informed decisions. Also, litigation eventually leads to a court’s judgment. When a court agrees with our assessment of a patent, this judgment stops recalcitrant infringers from utilizing our patented technology indefinitely, without appropriate authorization.

We engage highly competent and experienced patent lawyers to prosecute our patent portfolio litigation. It is imperative for us to be persistent and patient throughout the litigation process as it typically takes 18-36 months from the filing date of a lawsuit to yield a license agreement from a potential licensee. Often, it takes longer to secure a final court judgment.

Patent license negotiations and litigation initiated by our operating subsidiaries usually lead to serious and thoughtful discussions with the unauthorized users of the patented inventions. The result can be quite favorable with the user being granted rights under the patents for the patented invention in its products and services in exchange for financial remuneration.

Partnership Opportunities

In this regard, we leverage our experience, expertise, data and relationships developed as a leader in the IP industry to pursue opportunities to partner with high-growth companies in potentially disruptive technology areas. Examples of some of these technology areas include Artificial Intelligence, or AI, and machine learning, machine vision, robotics and blockchain technologies. Examples of our initial execution of this strategy are our partnerships with Veritone, Inc., or Veritone (Nasdaq: VERI), and Miso Robotics, Inc., or Miso Robotics.

In June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding. In addition, in February 2018, we made an additional strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics. Miso Robotics will use the capital to expand its suite of collaborative, adaptable robotic kitchen assistants and to broaden applications for Miso AI, the company’s machine learning cloud platform. In addition, we also entered into an IP services agreement with Miso Robotics to help the company drive AI-based solutions for the restaurant industry. Our partnership with Miso Robotics represents our second partnership with companies seeking to transform the marketplace through Artificial Intelligence.

In August 2016, we announced the formation of a partnership with Veritone, a leading cloud-based Artificial Intelligence technology company that is pioneering next generation search and analytics through their proprietary Cognitive Media Platform™. Under the partnership, we have the ability to leverage our intellectual property expertise to assist Veritone with building its patent portfolio and executing upon its overall intellectual property strategy. In order to enhance Veritone’s leadership position in the field of machine learning and AI, we provided a total of $53.3 million in funding to Veritone pursuant to an investment agreement executed in August 2016, as amended. Upon Veritone’s consummation of its initial public offering on May 17, 2017, or IPO, our loans and accrued interest were automatically converted into shares of Veritone common stock, and we were issued an additional warrant to purchase additional shares of Veritone common stock as described elsewhere herein.

Subsequent to the year ended December 31, 2017, in January 2018, we entered into a Joint Venture and Services Agreement, or Joint Venture Agreement, with Bitzumi, a company developing macro opportunities in the cryptocurrency and blockchain industries, including a next generation decentralized exchange. Bitzumi recently filed a Regulation A Offering Statement with the Securities and Exchange Commission and a listing application with NASDAQ. We made an initial $1.0 million equity investment in Bitzumi in January 2018. Under the Joint Venture Agreement, we will provide various patent-related services to Bitzumi and have the option to invest up to an additional $9.0 million to acquire Bitzumi common stock. In connection with our initial investment, we received a short-term warrant to purchase $4.0 million of Bitzumi common shares. Under the Joint Venture Agreement, we have a right to acquire up to an aggregate of $10.0 million of Bitzumi common shares (inclusive of our initial $1.0 million equity investment and exercise of our short-term warrant) at a price, except as paid by us for the initial investment and the exercise price of our short-term warrant, of $2.50 per share. Upon meeting certain conditions set forth in the Joint Venture Agreement, Bitzumi will also issue us a warrant for 30,000,000 shares of Bitzumi’s common stock. Our Joint Venture Agreement with Bitzumi represents our first venture in the cryptocurrency and blockchain marketplaces.

Patented Technologies

Currently, on a consolidated basis, our operating subsidiaries own or control the rights to patent portfolios with future patent expiration dates ranging from 2018 to approximately 2033, covering technologies used in a number of industries, including: transportation and automotive, telecommunications / smartphones, communications, memory, consumer electronics, energy efficiency, wireless and imaging and diagnostics.

Refer to Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Overview” for a summary of patent portfolios generating revenues for the applicable periods presented.

Competition

We encounter competition in the area of patent portfolio investment opportunities and enforcement. This includes an increase in the number of competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. Existing non-practicing entities compete in acquiring rights to intellectual property assets, and more entities may enter the market in future periods.

We also compete with financial firms, corporate buyers and others acquiring IP and investing in other technology opportunities. Many of these competitors may have more financial and human resources than us. We may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently or in the future may rely upon to generate future revenue.

Companies or other entities may develop competing technologies that offer better or less expensive alternatives to our patented technologies or technology partnerships. Many potential competitors may have significantly greater resources than the resources that we or our operating subsidiaries possess. Such technological advances or entirely different approaches developed by one or more of our competitors could render certain of the technologies owned or controlled by us obsolete and/or uneconomical.

Employees

As of December 31, 2017, on a consolidated basis, we had 13 full-time employees. Neither we, nor any of our subsidiaries, are a party to any collective bargaining agreement. We believe we have good relations with our employees.

ITEM 1A. RISK FACTORS

An investment in our common stock involves risks. You should carefully consider the risks described below, together with all of the other information included in this annual report, as well as in our other filings with the SEC, in evaluating our business. The risks described below are not the only risks we face. Additional risks that we do not yet know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition and results of operations could be materially adversely affected, and the trading price of our common stock could decline significantly. Certain statements below may be considered forward-looking statements. For additional information, see “Cautionary Note Regarding Forward-Looking Statements.”

Risks Related to Our Business

We have a history of losses and may incur additional losses in the future.

We reported net income of $22.2 million (includes $42.2 million of unrealized equity investment gains), a net loss of $54.1 million (includes $42.3 million of noncash patent impairment charges) and a net loss of $160.0 million (includes $104.9 million of noncash goodwill and patent impairment charges) for the years ended December 31, 2017, 2016 and 2015, respectively, and on a cumulative basis, we have sustained substantial losses since our inception. As of December 31, 2017, our accumulated deficit was $320.0 million. As of December 31, 2017, we had approximately $136.6 million in cash and cash equivalents and short-term investments and working capital of $130.1 million. Although we believe that our current cash and cash equivalents and investments will be sufficient to finance our anticipated capital and operating requirements for at least the next twelve months, we expect to continue incurring significant legal, general and administrative expenses in connection with our operations. As a result, we anticipate that we may incur losses in the future. Additional increases in our expenses without commensurate increases in revenues could significantly increase our operating losses. Any additional operating losses may have a material adverse effect on our stockholders’ equity and overall financial condition.

Our ability to use net operating losses and certain other tax attributes is uncertain and may be limited.

Our ability to use our federal and state net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our generation of future taxable income before the expiration dates of the net operating losses, and we cannot predict with certainty when, or whether, we will generate sufficient taxable income to use all or any portion of our net operating losses. In addition, utilization of net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is subject to annual limitations under the “ownership change” provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and similar state provisions, which may result in the expiration of net operating losses before future utilization. In general, under the Code, if a corporation undergoes an “ownership change,” generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership, some of which may be outside of our control, could in the future result in an ownership change. Although we have completed studies to provide reasonable assurance that an ownership change limitation would not apply, we cannot be certain that a taxing authority would reach the same conclusion. If, after a review or audit, an ownership change limitation were to apply, utilization of our domestic net operating losses and tax credit carryforwards could be limited in future periods and a portion of the carryforwards could expire before being available to reduce future income tax liabilities.

On December 22, 2017, new tax legislation was signed into law. Among other things, it will reduce the maximum federal corporate income tax rate to 21% in future periods. It has also limited or eliminated certain deductions to which the Company has been entitled in past years and has reduced the value of the Company’s deferred tax assets as described elsewhere herein. Given the full valuation allowance provided for net deferred tax assets as of December 31, 2017, we do not expect the change in tax law to have a material impact on our consolidated financial statements provided herein. However, in the absence of guidance on various uncertainties and ambiguities in the application of certain provisions of the new legislation, we will use what we believe are reasonable interpretations and assumptions in applying the new legislation, but it is possible that the IRS could issue subsequent guidance or take positions on audit that differ from our prior interpretations and assumptions, which could have a material adverse effect on our cash tax liabilities, results of operations, and financial condition.

If we encounter unforeseen difficulties with our business or operations in the future that require us to obtain additional working capital, and we cannot obtain additional working capital on favorable terms, or at all, our business may suffer.

Our consolidated cash and cash equivalents and short-term investments totaled $136.6 million and $158.5 million at December 31, 2017 and 2016, respectively. To date, we have relied primarily upon net cash flows from our operations and from the public and private sale of equity securities to generate the working capital needed to finance our operations. We may encounter unforeseen difficulties with our business or operations in the future that may deplete our capital resources more rapidly than anticipated. As a result, we may be required to obtain additional working capital in the future through bank credit facilities, public or private debt or equity financings, or otherwise. If we are required to raise additional working capital in the future, such financing may be unavailable to us on favorable terms, if at all, or may be dilutive to our existing stockholders. If we fail to obtain additional working capital, as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.

Failure to effectively manage our operational changes could strain our managerial, operational and financial resources and could adversely affect our business and operating results.

Our recent operational changes have placed, and are expected to continue to place, a strain on our managerial, operational and financial resources and systems. Operational changes primarily relate to the reductions in employee headcount across our licensing, business development and engineering functions during the three year period ended December 31, 2017. Reductions in headcount in these functions may impact our ability to effectively and efficiently allocate resources in a timely manner in connection with the licensing and enforcement of our existing patent portfolios. In addition, we have increased our focus on opportunities to partner with high-growth and potentially disruptive technology companies. As our businesses evolve, we will be required to continue to manage multiple relationships. Any further change by us, or increases in the number of our strategic relationships, may place additional strain on our managerial, operational and financial resources and systems. If we fail to manage our operational changes effectively or to develop, expand or otherwise modify our managerial, operational and financial resources and systems, our business and financial results will be materially harmed.

Patent portfolio investments may present risks, and we may be unable to achieve the financial or other goals intended at the time of any potential investment.

Our licensing and enforcement business has depended, in part, on our ability to invest in patented technologies, patent portfolios, or companies holding such patented technologies and patent portfolios. Accordingly, historically we have engaged in patent portfolio investments in an effort to expand our patent portfolio assets. Such investments and potential investments are subject to numerous risks, including the following:


•	our inability to enter into a definitive agreement with respect to any potential patent portfolio investment, or if we are able to enter into such agreement, our inability to consummate the potential investment transaction;


•	difficulty integrating the operations, technology and personnel of the acquired entity;


•	our inability to achieve the anticipated financial and other benefits of the specific patent portfolio investment;


•	our inability to retain key personnel from the acquired company, if necessary;


•	difficulty in maintaining controls, procedures and policies during the transition and integration process;


•	diversion of our management’s attention from other business concerns; and


•	failure of our due diligence process to identify significant issues, including issues with respect to patented technologies and patent portfolios, and other legal and financial contingencies.

If we are unable to manage these risks effectively as part of any patent portfolio investment, our business could be adversely affected.

Our revenues are unpredictable, and this may harm our financial condition.

Due to the nature of our licensing business and uncertainties regarding the amount and timing of the receipt of license and other fees from potential infringers, stemming primarily from uncertainties regarding the outcome of enforcement actions, rates of adoption of our patented technologies, the growth rates of our existing licensees and certain other factors, our revenues may vary significantly from quarter to quarter and period to period, which could make our business difficult to manage, adversely affect our business and operating results, cause our quarterly and periodic results to fall below market expectations and adversely affect the market price of our common stock.

Our operating subsidiaries depend upon relationships with others to provide technology-based opportunities that can develop into profitable royalty-bearing licenses, and if they are unable to maintain and generate new relationships, then they may not be able to sustain existing levels of revenue or increase revenue.

number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. As a result of these continuing industry trends, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

The success of our operating subsidiaries depends in part upon their ability to retain the best legal counsel to represent them in patent enforcement litigation in order to achieve favorable outcomes from such litigation. The outcome of such litigation is uncertain.

The success of our licensing business depends upon our operating subsidiaries’ ability to retain the best legal counsel to prosecute patent infringement litigation. As our operations evolve and industry conditions increase in complexity, it will become more difficult to find the best legal counsel to handle all of our cases. This is due in part to many of the best law firms having conflicts of interest that prevents their representation of our subsidiaries.

We spend a significant amount of our financial and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources. The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us. We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. The inability to retain the best legal counsel to represent our operating subsidiaries in infringement actions may result in unfavorable or adverse outcomes, which may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to effectively operate our business or execute our business strategy.

Our operating subsidiaries, in certain circumstances, rely on representations, warranties and opinions made by third-parties that, if determined to be false or inaccurate, may expose us and our operating subsidiaries to certain material liabilities.

From time to time, our operating subsidiaries may rely upon representations and warranties made by third-parties from whom our operating subsidiaries acquired patents or the exclusive rights to license and enforce patents. We also may rely upon the opinions of purported experts. In certain instances, we may not have the opportunity to independently investigate and verify the facts upon which such representations, warranties, and opinions are made. By relying on these representations, warranties and opinions, our operating subsidiaries may be exposed to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material adverse effect on our operating results and financial condition.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may rule that we or our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards, which may expose us and our operating subsidiaries to certain material liabilities.

In connection with any of our patent enforcement actions, it is possible that a defendant may request and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if we or our operating subsidiaries are required to pay such monetary sanctions, attorneys’ fees and/or expenses, such payment could materially harm our operating results and our financial position.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may find the patents invalid, not infringed or unenforceable and/or the U.S. Patent and Trademark Office, or the USPTO, or other relevant patent office, may either invalidate the patents or materially narrow the scope of their claims during the course of a reexamination, opposition or other such proceeding.

Patent litigation is inherently risky and the outcome is uncertain. Some of the parties that we believe infringe on our patents are large and well-financed companies with substantially greater resources than ours. We believe that these parties

would devote a substantial amount of resources in an attempt to avoid or limit a finding that they are liable for infringing on our patents or, in the event liability is found, to avoid or limit the amount of associated damages. In addition, there is a risk that these parties may file reexaminations or other proceedings with the USPTO or other government agencies in the United States or abroad in an attempt to invalidate, narrow the scope or render unenforceable the patents we own or control. If this were to occur, it may have a material adverse effect on our operations.

In addition, it is difficult to predict the outcome of patent enforcement litigation at any level. In the United States, there is a higher rate of appeals in patent enforcement litigation than standard business litigation. The defendant to any case we bring, may file as many appeals as allowed by right, including to the first, second and/or final courts of appeal (in the United States those courts would be the Federal Circuit and Supreme Court, respectively). Such appeals are expensive and time-consuming, and the outcomes of such appeals are sometimes unpredictable, resulting in increased costs and reduced or delayed revenue which could have a material adverse effect on our operating results and financial condition.

Our licensing cycle is lengthy and costly, and our legal and sales efforts may be unsuccessful.

We expect our operating subsidiaries to incur significant general and administrative and legal expenses prior to entering into license agreements and generating license revenues. We also spend considerable resources educating prospective licensees on the benefits of a license arrangement with us. As such, we may incur significant losses in any particular period before any associated revenue stream begins.

If our efforts to educate prospective licensees on the benefits of a license arrangement are unsuccessful, we may need to pursue litigation or other enforcement action to protect our patent rights. We may also need to litigate to enforce the terms of our existing license agreements, protect our trade secrets, or determine the validity and scope of the proprietary rights of others. Enforcement proceedings are typically protracted and complex. The costs are typically substantial, and the outcomes are unpredictable. Enforcement actions will divert our managerial, technical, legal and financial resources from business operations and there are no assurances that such enforcement actions will result in favorable results for us.

Failure to maintain effective internal control over our financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could cause our financial reports to be inaccurate.

We are required pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, to maintain internal control over financial reporting and to assess and report on the effectiveness of those controls. This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting.

Our management concluded that our internal control over financial reporting was effective as of December 31, 2017. However, there are inherent limitations on effectiveness of controls. Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

If we are not able to maintain effective internal control over financial reporting, our financial statements, including related disclosures, may be inaccurate, which could have a material adverse effect on our business. Refer to Item 9A. “Controls and Procedures” for additional information related to the current period.

Our partnerships are subject to risks and we may experience significant financial losses on our related existing equity investments.

As described herein, in August 2016, we formed a partnership with Veritone pursuant to which we have the ability to leverage our expertise in intellectual property licensing and enforcement to assist Veritone with building its patent portfolio and execute upon its overall intellectual property strategy. As a part of this partnership, we entered into an investment agreement and bridge financing with Veritone, investing approximately $53.3 million in Veritone, comprised of common stock and warrants as of December 31, 2017.

In addition, in June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding. In addition, in February 2018, we made an additional strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics. Miso Robotics will use the new capital to expand its suite of collaborative, adaptable robotic kitchen assistants and to broaden applications for Miso AI, the company’s machine learning cloud platform. In addition, we also entered into an intellectual property services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the restaurant industry.

Our current partnerships and related equity investments are subject to a high degree of risk and could diminish our financial condition. Currently, none of our investees are profitable and have limited financial resources. The overall sustained economic uncertainty, as well as financial, operational and other difficulties encountered by certain companies in which we have equity investments increases the risk that the actual amounts realized in the future on our debt and equity investments will differ significantly from the fair values currently assigned to them. In addition, the companies in which we have equity investments or with whom we partner may not be able to compete effectively or there may be insufficient demand for the services and products offered by these companies. These partnerships could also expose us to significant financial losses and may restrict our ability to execute other partnerships or limit alternative uses of our capital resources. If our partnerships suffer losses, our financial condition could be materially adversely affected. In addition, applicable securities law restrictions and other factors may result in an inability to liquidate any equity components of our equity investments. Our Veritone common shares are subject to a lock-up agreement that expired on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.

Our initiative to identify partnerships may not be successfully implemented.

We intend to continue to selectively explore opportunities to partner with potentially high-growth and disruptive technology companies that we believe will allow us to leverage our experience, expertise, data and relationships to increase shareholder value. We may allocate significant resources for long-term initiatives that may not have a short or medium-term or any positive impact on our revenue, results of operations, or cash flow.

The successful implementation of our initiative to identify partnerships requires an investment of time, talent and money and is dependent upon a number of factors, some of which are not within our control. Those factors include the ability to effectively execute such initiatives in new and existing markets and market conditions in the various technology industries we pursue. We may allocate significant resources for long-term initiatives that may not have a short or medium-term or any positive impact on our revenue, results of operations, or cash flow. If we fail to properly identify successful companies to partner with and invest in, it may have an adverse effect on our financial condition. There can be no assurance that we will successfully implement this strategic initiative or that, if successfully pursued, this initiative will have the desired effect on our business or results of operations. Additionally, these new partnerships could expose us to significant financial losses and may restrict our ability to enter future partnerships or limit alternative uses of our capital resources. If our partnership related equity investments suffer losses, our financial condition could be materially adversely affected.

Recent U.S. tax legislation may materially adversely affect our financial condition, results of operations and cash flows.

Recently-enacted U.S. tax legislation has significantly changed the U.S. federal income taxation of U.S. corporations, including the reduction of the U.S. corporate income tax rate, the limiting of interest deductions, adopting elements of a territorial tax system, imposing a one-time transition tax (or “repatriation tax”) on all undistributed earnings and profits of certain U.S.-owned foreign corporations, revising the rules governing net operating losses and the rules governing foreign tax credits, and introducing new anti-base erosion provisions. Many of these changes are effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service, or IRS, any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.

fully valued. This amount may be subject to further adjustment in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified.

While some of the changes made by the tax legislation may adversely affect the Company in one or more reporting periods and prospectively, other changes may be beneficial on a going forward basis. We continue to work with our tax advisors to determine the full impact that the recent tax legislation as a whole will have on us. We urge our investors to consult with their legal and tax advisors with respect to such legislation.

Risks Related to Our Industry

Our exposure to uncontrollable outside influences, including new legislation, court rulings or actions by the USPTO, could adversely affect our licensing and enforcement business and results of operations.

Our licensing and enforcement business is subject to numerous risks from outside influences, including the following:

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.

Our operating subsidiaries invest in patents with enforcement opportunities and spend a significant amount of resources to enforce those patents. If new legislation, regulations or rules are implemented by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement process or the rights of patent holders, such changes could negatively affect our business. United States patent laws were amended with the enactment of the Leahy-Smith America Invents Act, or the America Invents Act, which took effect on March 16, 2013. The America Invents Act includes a number of significant changes to U.S. patent law. In general, the legislation attempts to address issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new procedures for patent litigation. For example, the America Invents Act changes the way that parties may be joined in patent infringement actions, increasing the likelihood that such actions will need to be brought against individual allegedly-infringing parties by their respective individual actions or activities. In addition, the America Invents Act enacted a new inter-partes review process, or IPR process, at the USPTO which can be, and often is, used by defendants, and other individuals and entities, to separately challenge the validity of any patent. The IPR process of the America Invents Act has in many instances increased costs for licensing and litigation and has resulted in the loss of certain portfolio patents which, in some cases, may have negatively impacted the value of those portfolios. The America Invents Act and its implementation has increased the uncertainties and costs surrounding the enforcement of our patented technologies, which in certain circumstances could have a material adverse effect on our business and financial condition.

The U.S. Department of Justice, or the DOJ, has conducted reviews of the patent system to evaluate the impact of patent assertion entities on industries in which those patents relate. It is possible that the findings and recommendations of the DOJ could impact the ability to effectively license and enforce standards-essential patents and could increase the uncertainties and costs surrounding the enforcement of any such patented technologies. Also, in 2014, the Federal Trade Commission, or FTC, initiated a study under Section 6(b) of the Federal Trade Commission Act to evaluate the patent assertion practice and market impact of Patent Assertion Entities, or PAEs. The FTC’s initial notice and request for public comment relating to the PAE study appeared in the Federal Register on October 3, 2013. We received and responded to a request for information as part of this FTC study. The FTC study entitled, “Patent Assertion Entity Activity” was released in October 2016.

Finally, new rules regarding the burden of proof in patent enforcement actions could significantly increase the cost of our enforcement actions, and new standards or limitations on liability for patent infringement could negatively impact our revenue derived from such enforcement actions. In addition, recent federal court decisions have lowered the threshold for obtaining attorneys’ fees in patent infringement cases and increased the level of deference given to a district court’s fee-shifting determination. These decisions may make it easier for district courts to shift a prevailing party’s attorneys’ fees to a non-prevailing party if the district court believes that the case was weak or conducted in an abusive manner. As a result, defendants in patent infringement actions brought by non-practicing entities may elect not to settle because these decisions make it much easier for defendants to get attorneys’ fees.

Changes in patent law could adversely impact our business.

Patent laws may continue to change, and may alter the historically consistent protections afforded to owners of patent rights. Such changes may not be advantageous for us and may make it more difficult to obtain adequate patent protection to

enforce our patents against infringing parties. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States Congress has considered a bill that would require, among other things, non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met.

Trial judges and juries often find it difficult to understand complex patent enforcement litigation, and as a result, we may need to appeal adverse decisions by lower courts in order to successfully enforce our patents.

It is difficult to predict the outcome of patent enforcement litigation at the trial level. It is often difficult for juries and trial judges to understand complex, patented technologies, and as a result, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and delayed revenue. Although we diligently pursue enforcement litigation, we cannot predict with significant reliability the decisions made by juries and trial courts.

More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.

Certain of our operating subsidiaries hold and continue to invest in pending patents. We have identified a trend of increasing patent applications each year, which we believe is resulting in longer delays in obtaining approval of pending patent applications. The application delays could cause delays in recognizing revenue from these patents and could cause us to miss opportunities to license patents before other competing technologies are developed or introduced into the market.

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.

Our patent enforcement actions are almost exclusively prosecuted in federal court. Federal trial courts that hear our patent enforcement actions also hear criminal cases. Criminal cases always take priority over our actions. As a result, it is difficult to predict the length of time it will take to complete an enforcement action. Moreover, we believe there is a trend in increasing numbers of civil lawsuits and criminal proceedings before federal judges and, as a result, we believe that the risk of delays in our patent enforcement actions will have a greater negative effect on our business in the future unless this trend changes.

Any reductions in the funding of the USPTO could have an adverse impact on the cost of processing pending patent applications and the value of those pending patent applications.

The assets of our operating subsidiaries consist of patent portfolios, including pending patent applications before the USPTO. The value of our patent portfolios is dependent upon the issuance of patents in a timely manner, and any reductions in the funding of the USPTO could negatively impact the value of our assets. Further, reductions in funding from Congress could result in higher patent application filing and maintenance fees charged by the USPTO, causing an increase in our expenses.

Competition is intense in the industries in which our subsidiaries do business and as a result, we may not be able to grow or maintain our market share for our technologies and patents.

We expect to encounter competition in the area of patent portfolio investments and enforcement. This includes competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. As new technological advances occur, many of our patented technologies may become obsolete before they are completely monetized. If we are unable to replace obsolete technologies with more technologically advanced patented technologies, then this obsolescence could have a negative effect on our ability to generate future revenues.

Our licensing business also competes with venture capital firms and various industry leaders for patent licensing opportunities. Many of these competitors may have more financial and human resources than we do. As we become more successful, we may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to generate future revenue.

Our patented technologies face uncertain market value.

Our operating subsidiaries have invested in patents and technologies that may be in the early stages of adoption in the commercial and consumer markets. Demand for some of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents and technologies in their products and services.

Further, significant judgment is required in connection with estimates of the recoverability of the carrying value of our intangible patent assets, including estimates of market values, estimates of the amount and timing of future cash flows, and estimates of other factors that are used to determine the fair value and recoverability of the respective patent asset values. Developments with respect to ongoing patent litigation, patent challenges and re-exams, legislative and judicial decisions and other factors outside of our control, may unfavorably impact the validity, applicability, and enforceability of our patent assets, and therefore, negatively impact the future value of our patent portfolios. If certain of these unfavorable events occur, our estimates or related projections may change materially in future periods, and future intangible asset impairment tests may result in material charges to earnings.

As patent enforcement litigation becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

We believe that the more prevalent patent enforcement actions become, the more difficult it will be for us to voluntarily license our patents. As a result, we may need to increase the number of our patent enforcement actions to cause infringing companies to license the patent or pay damages for lost royalties. This may increase the risks associated with an investment in our company.

Patent litigation trials and scheduled trial dates are subject to routine delay, and any such delays could adversely impact our business, results of operations and financial condition.

Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to the existence of possible future revenue opportunities for us. Patent litigation schedules in general, and in particular trial dates, are subject to routine adjustment, and in most cases delay, as courts adjust their calendars or respond to requests from one or more parties. Trial dates often are rescheduled by the court for various reasons that are often unrelated to the underlying patent assets and typically for reasons that are beyond our control. As a result, to the extent such events are an indicator of possible future revenue opportunities for us, or other outcome determinative events, they may and often do change which can result in delay of the expected scheduled event. Any such delay could be significant and could affect the corresponding future revenue opportunities, thus adversely impacting our business, results of operations and financial condition.

The markets served by our operating subsidiaries are subject to rapid technological change, and if our operating subsidiaries are unable to develop and invest in new technologies and patents, our ability to generate revenues could be substantially impaired.

The markets served by our operating subsidiaries and their licensees frequently undergo transitions in which products rapidly incorporate new features and performance standards on an industry-wide basis. Products for communications applications and high-speed computing applications, as well as other applications covered by our operating subsidiaries’ intellectual property, are based on continually evolving industry standards. In addition, the communications industry is intensely competitive and has been impacted by price erosion, rapid technological change, short product life cycles, cyclical market patterns and increasing foreign and domestic competition. Our ability to compete in the future will depend on our ability to identify and ensure compliance with evolving industry standards. This will require our continued efforts and success in acquiring new patent portfolios with licensing and enforcement opportunities. If we are unable to invest in new patented technologies and patent portfolios, or to identify and ensure compliance with evolving industry standards, our ability to generate revenues could be substantially impaired and our business and financial condition could be materially harmed.

Uncertainty in global economic conditions could negatively affect our business, results of operations and financial condition.

Our revenue-generating opportunities depend on the use of our patented technologies by existing and prospective licensees, the overall demand for the products and services of our licensees, and on the overall economic and financial health of our licensees. If economic conditions do not continue to improve, or if they deteriorate, many of our licensees’ customers, which may rely on credit financing, may delay or reduce their purchases of our licensees’ products and services. In addition, the use or adoption of our patented technologies is often based on current and forecasted demand for our licensees’ products and services in the marketplace and may require companies to make significant initial commitments of capital and other resources. If negative conditions in the global credit markets delay or prevent our licensees’ and their customers’ access to credit, overall consumer spending on the products and services of our licensees may decrease and the adoption or use of our patented technologies may slow, respectively. Further, if the markets in which our licensees’ participate do not continue to improve, or deteriorate further, this could negatively impact our licensees’ long-term sales and revenue generation, margins and operating expenses, which could in turn have an adverse effect on our business, results of operations and financial condition.

In addition, we have significant patent-related intangible assets recorded on our consolidated balance sheets. We will continue to evaluate the recoverability of the carrying amount of our patent-related intangible assets on an ongoing basis, and we may incur substantial impairment charges, which would adversely affect our consolidated financial results. There can be no assurance that the outcome of such reviews in the future will not result in substantial impairment charges. Impairment assessment inherently involves judgment as to assumptions about expected future cash flows and the impact of market conditions on those assumptions. Reductions in internal resources may result in decisions to no longer allocate resources to certain licensing and enforcement programs which may result in significant impairment charges. Future events and changing market conditions may impact our assumptions as to prices, costs, holding periods or other factors that may result in changes in our estimates of future cash flows. Although we believe the assumptions we used in testing for impairment are reasonable, significant changes in any one of our assumptions could produce a significantly different result.

Risks Related to Our Common Stock

The availability of shares for sale in the future could reduce the market price of our common stock.

In the future, we may issue securities to raise cash for operations and patent portfolio investments. We may also pay for interests in additional subsidiary companies by using shares of our common stock or a combination of cash and shares of our common stock. We may also issue securities convertible into our common stock. Any of these events may dilute stockholders’ ownership interests in our company and have an adverse impact on the price of our common stock.

In addition, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common stock. This could also impair our ability to raise additional capital through the sale of our securities.

Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving a premium over the market price of their shares.

Provisions of Delaware law and our certificate of incorporation and bylaws could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and the removal of incumbent officers and directors, more difficult. These provisions include:


•	Section 203 of the Delaware General Corporation Law, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder;


•	amendment of our bylaws by the stockholders requires a two-thirds approval of the outstanding shares;


•	the authorization in our certificate of incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover;


•	provisions in our bylaws eliminating stockholders’ rights to call a special meeting of stockholders, which could make it more difficult for stockholders to wage a proxy contest for control of our board of directors or to vote to repeal any of the anti-takeover provisions contained in our certificate of incorporation and bylaws; and


•	the division of our board of directors into three classes with staggered terms for each class, which could make it more difficult for an outsider to gain control of our board of directors.

Together, these provisions may make the removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing market prices for our common stock.

We may fail to meet market expectations because of fluctuations in quarterly operating results, which could cause the price of our common stock to decline.

Our reported revenues and operating results have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future. It is possible that in future periods, revenues could fall below the expectations of securities analysts or investors, which could cause the market price of our common stock to decline. The following are among the factors that could cause our operating results to fluctuate significantly from period to period:


•	the dollar amount of agreements executed in each period, which is primarily driven by the nature and characteristics of the technology being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed in each period and the periods of infringement contemplated by the respective payments;


•	fluctuations in the total number of agreements executed;


•	fluctuations in the sales results or other royalty-per-unit activities of our licensees that impact the calculation of license fees due;


•	the timing of the receipt of periodic license fee payments and/or reports from licensees;


•	fluctuations in the net number of active licensees period to period;


•	costs related to investments, alliances, licenses and other efforts to expand our operations;


•	the timing of payments under the terms of any customer or license agreements into which our operating subsidiaries may enter;

•

we may elect to account for equity investments in companies where our investment gives us the ability to exercise significant influence over the operating and financial policies of the investee at fair value, which may result in significant fluctuations in operating results (unrealized gains and losses) each period based on fluctuations in the stock price of our investments and the requirement to mark such investments to market at each balance sheet date;


•	expenses related to, and the timing and results of, patent filings and other enforcement proceedings relating to intellectual property rights, as more fully described in this section; and


•	new litigation or developments in current litigation and the unpredictability of litigation results or settlements or appeals.

Technology company stock prices are especially volatile, and this volatility may depress the price of our common stock.

The stock market has experienced significant price and volume fluctuations, and the market prices of technology companies have been highly volatile. We believe that various factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:


•	announcements of developments in our patent enforcement actions;


•	developments or disputes concerning our patents;


•	our or our competitors’ technological innovations;


•	developments in relationships with licensees;


•	variations in our quarterly operating results;


•	our failure to meet or exceed securities analysts’ expectations of our financial results;


•	a change in financial estimates or securities analysts’ recommendations;


•	changes in management’s or securities analysts’ estimates of our financial performance;


•	changes in market valuations of similar companies;


•	concerns about sovereign debt of the United States and the European Union;


•	announcements by us or our competitors of significant contracts, investments, partnerships, joint ventures, capital commitments, new technologies, or patents; and


•	failure to complete significant transactions.

For example, the NASDAQ-100 Technology Sector Index (NDXT) had a range of $2,873.11 - $4,095.06 during the 52-weeks ended December 31, 2017 and the NASDAQ Composite Index (IXIC) had a range of $5,397.99 - $7,003.89 over the same period. Over the same period, our common stock fluctuated within a range of $2.90 - $7.20.

As noted above, our stock price, like many others, has fluctuated significantly in recent periods and if investors have concerns that our business, operating results and financial condition will be negatively impacted by industry, global economic or other negative conditions, our stock price could continue to fluctuate significantly in future periods.

In addition, we believe that fluctuations in our stock price during applicable periods can also be impacted by court rulings and/or other developments in our patent licensing and enforcement actions. Court rulings in patent enforcement actions are often difficult to understand, even when favorable or neutral to the value of our patents and our overall business, and we believe that investors in the market may overreact, causing fluctuations in our stock prices that may not accurately reflect the impact of court rulings on our business operations and assets.

In the past, companies that have experienced volatility in the market price of their stock have been the objects of securities class action litigation. If our common stock was the object of securities class action litigation, it could result in substantial costs and a diversion of management’s attention and resources, which could materially harm our business and financial results.

We do not currently intend to pay dividends on our common stock in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

On February 23, 2016, our board of directors eliminated our dividend policy that provided for the discretionary payment of a total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter, effective as of February 23, 2016. As a result, we do not anticipate paying any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which our stockholders have purchased their shares.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our principal executive, corporate and administrative offices are located in Newport Beach, California, where we lease approximately 17,758 square feet of office space, under a lease agreement that expires in December 2019, a portion of which is currently subleased. Our primary operating subsidiary, Acacia Research Group, LLC, and its subsidiaries, are headquartered in Frisco, Texas, where we lease office space under a lease agreement that expires in April 2019. Certain of our operating subsidiaries also maintain additional leased office space in Munich, Germany. We believe that our facilities are adequate, suitable and of sufficient capacity to support our immediate needs.

ITEM 3. LEGAL PROCEEDINGS

In the ordinary course of business, we are the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our patent enforcement activities. We believe that any liability arising from these actions will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. Certain of our operating subsidiaries are parties to ongoing patent enforcement related litigation, alleging infringement by third-parties of certain of the patented technologies owned or controlled by our operating subsidiaries.

In connection with any of our patent enforcement actions, it is possible that a defendant may claim and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and our financial position.

We spend a significant amount of our financial and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources. The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us. We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to effectively and efficiently monetize our assets.

ITEM 4. MINE SAFETY DISCLOSURES

None.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

General

Our common stock trades on The NASDAQ Global Select Market under the symbol “ACTG.”

Price Range of Common Stock

The high and low sales prices for our common stock as reported by The NASDAQ Global Select Market for the periods indicated are shown in the table below. Such prices are inter-dealer prices without retail markups, markdowns or commissions and may not necessarily represent actual transactions.



	2017				2016
	Fourth Quarter	Third Quarter	Second Quarter	First Quarter	Fourth Quarter	Third Quarter	Second Quarter	First Quarter

High	$4.75	$5.50	$5.75	$7.20	$7.68	$7.25	$5.64	$4.30
Low	$3.80	$2.90	$3.70	$5.00	$5.55	$4.20	$3.75	$2.82

Dividend Policy

On April 23, 2013, we announced that our Board of Directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, we paid quarterly cash dividends totaling $25.4 million during 2015. On February 23, 2016, our Board of Directors terminated the company’s dividend policy. Our Board of Directors terminated the dividend policy due to a number of factors, including our financial performance, our available cash resources, our cash requirements and alternative uses of capital that our Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

The current policy of our Board of Directors is to retain earnings, if any, to provide for our growth. Consequently, we do not expect to pay any cash dividends in the foreseeable future. Further, there can be no assurance that our proposed operations will generate revenues and cash flow needed to declare any future cash dividends or that we will have legally available funds to pay future dividends.

Stock Repurchase Program

In February 2018, our Board of Directors authorized a stock repurchase program, or the Program, to repurchase up to $20 million of our outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion. In determining whether or not to repurchase any shares of our common stock, our Board of Directors will consider such factors as the impact of the repurchase on our cash position, as well as our capital needs and whether there is a better alternative use of our capital. We have no obligation to repurchase any amount of our common stock under the Program. The Program is set to expire on February 28, 2019.

Holders of Common Stock

On March 1, 2018, there were approximately 49 owners of record of our common stock. The majority of the outstanding shares of our common stock are held by a nominee holder on behalf of an indeterminable number of ultimate beneficial owners.

Stock Price Performance Graph

The following stock price performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act.

The Stock Performance Graph depicted below compares the yearly change in our cumulative total stockholder return for the last five fiscal years with the cumulative total return of The NASDAQ Stock Market (U.S.) Composite Index and the NASDAQ-100 Technology Sector Index.



	2013	2014	2015	2016	2017

Acacia Research Corporation common stock	$57	$66	$17	$25	$16
Nasdaq Composite Index (IXIC)	$138	$157	$166	$178	$229
NASDAQ-100 Technology Sector Index (NDXT)	$137	$170	$166	$206	$281

The graph covers the period from December 31, 2012 to December 31, 2017. Cumulative total returns are calculated assuming that $100 was invested on December 31, 2012, in our common stock, in the NASDAQ Composite Index, and in the NASDAQ-100 Technology Sector Index, and that all dividends, if any, were reinvested. Stockholder returns over the indicated period should not be considered indicative of future stock prices or stockholder returns.

ITEM 6. SELECTED FINANCIAL DATA

The consolidated selected balance sheet data as of December 31, 2017 and 2016 and the consolidated selected statements of operations data for the years ended December 31, 2017, 2016 and 2015 set forth below have been derived from our audited consolidated financial statements included elsewhere herein, and should be read in conjunction with those financial statements (including notes thereto). The consolidated selected balance sheet data as of December 31, 2015, 2014 and 2013 and the consolidated selected statements of operations data for the years ended December 31, 2014 and 2013 have been derived from audited consolidated financial statements not included herein, but which were previously filed with the SEC.

Consolidated Statements of Operations Data

(In thousands, except share and per share data)



	For the Years Ended December 31,
	2017			2016			2015			2014			2013

Revenues	$	65,402		$	152,699		$	125,037		$	130,876		$	130,556
Inventor royalties and contingent legal fees expense	21,634			49,204			34,631			44,233			54,508
Litigation and licensing expenses - patents	18,219			27,858			39,373			37,614			39,335
Amortization of patents	22,154			34,208			53,067			53,745			49,039
General and administrative expenses (excluding non-cash stock compensation expense)	17,145			23,857			27,128			30,439			31,335
Non-cash stock compensation expense (included in G&A in the statements of operations)	8,885			9,062			11,048			18,115			27,894
Other expenses - business development	1,189			3,079			3,391			3,840			3,251
Impairment of patent-related intangible assets	2,248			42,340			74,731			3,497			4,619
Impairment of goodwill	—			—			30,149			—			—
Other	1,200			500			4,141			1,548			3,506
Operating loss	(27,272		)	(37,409		)	(152,622		)	(62,155		)	(82,931		)
Other income (expense)	51,911			798			(56		)	(595		)	2,131
Income (loss) before (provision for) benefit from income taxes	24,639			(36,611		)	(152,678		)	(62,750		)	(80,800		)
(Provision for) benefit from income taxes	(2,955		)	(18,188		)	(4,800		)	(3,912		)	21,958
Net income (loss) including noncontrolling interests in subsidiaries	$	21,684		$	(54,799	)	$	(157,478	)	$	(66,662	)	$	(58,842	)

Net income (loss) attributable to Acacia Research Corporation	$	22,180		$	(54,067	)	$	(160,036	)	$	(66,029	)	$	(56,434	)

Diluted income (loss) per common share	$	0.44		$	(1.08	)	$	(3.25	)	$	(1.37	)	$	(1.18	)

Cash dividends declared per common share	$	—		$	—		$	0.50		$	0.50		$	0.375

Consolidated Balance Sheet Data (In thousands)



	At December 31,
	2017		2016		2015		2014		2013

Cash and cash equivalents, restricted cash and investments	$	136,604	$	158,495	$	145,948	$	193,024	$	256,702
Investment at fair value	104,754		—		—		—		—
Patents, net of accumulated amortization	61,917		86,319		162,642		286,636		288,432
Goodwill	—		—		—		30,149		30,149
Total assets	308,768		296,003		347,901		536,348		593,393
Total liabilities	13,109		28,560		33,746		47,300		31,195
Noncontrolling interests in operating subsidiaries	1,358		1,854		3,944		5,491		6,488
Acacia Research Corporation stockholders’ equity	294,301		265,589		310,211		483,557		555,710

Factors Affecting Comparability:

•

Investments at fair value. Our equity investment in Veritone is recorded at fair value at each balance sheet date, with changes in fair value reflected in the statements of operations. Results for the year ended December 31, 2017 included a net unrealized gain (included in other income (expense) in our consolidated statements of operations and in the table above) on our equity investment in Veritone totaling $49.5 million, comprised of an unrealized gain on conversion of our Veritone loans to equity of $2.7 million and an unrealized gain on the exercise of our Primary Warrant of $4.6 million, both as of May 2017, and an unrealized gain related to the change in fair value of our equity investment in Veritone through December 31, 2017 of $42.2 million. Refer to Note 7 to the consolidated financial statements elsewhere herein for additional information regarding the impact of our equity investment in Veritone.

•

Litigation and licensing expenses - patents. Litigation and licensing expenses-patents fluctuate from period to period based on patent enforcement and prosecution activity associated with ongoing licensing and enforcement programs and the timing of the commencement of new licensing and enforcement programs in each period. The trend of declining litigation and licensing expenses-patents reflects an overall decrease in portfolio related enforcement activities over the applicable periods. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.

•

Non-cash stock compensation expense. In February 2017, AIP Operation LLC, or AIP, an indirect subsidiary of ours, adopted a Profits Interests Plan, or the Profits Interests Plan, that provides for the grant of AIP membership interests to certain members of management and the Board of Directors of Acacia Research Corporation as compensation for services rendered. The membership interests are represented by units, or the Units, reserved for the issuance of awards under the Profits Interests Plan. As of December 31, 2017, AIP holds the Veritone 10% Warrant described at Note 10. The fair value of the Units totaled $3.0 million as of December 31, 2017 and is classified as a liability in our consolidated balance sheet, with the corresponding compensation charge included in non-cash general and administrative expenses in the statement of operations for the year ended December 31, 2017.

•

Impairment of patent related intangible assets. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse legal outcomes, conclusion of the related licensing and enforcement programs and /or certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

•

Goodwill. We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company’s stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million. Refer to “Critical Accounting Policies” below for additional information.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors including the risks we discuss in Item 1A, “Risk Factors,” and elsewhere herein.

General

We invest in, license and enforce patented technologies. We partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We generate revenues and related cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries control or own. We assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. We are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

We have a proven track record of licensing and enforcement success with over 1,550 license agreements executed to date, across 193 patent portfolio licensing and enforcement programs. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries. To date, we have generated gross licensing revenue of approximately $1.4 billion, and have returned more than $731 million to our patent partners.

We also identify opportunities to partner with high-growth and potentially disruptive technology companies. We leverage our experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement our primary licensing and enforcement business.

Our business is described more fully in Item 1. “Business,” of this annual report.

Executive Overview

For the years ended December 31, 2017, 2016 and 2015 we reported revenues of $65.4 million, $152.7 million and $125.0 million, respectively. Cash and short-term investments totaled $136.6 million as of December 31, 2017, as compared to $158.5 million as of December 31, 2016. Our operating activities during the periods presented were focused on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent licensing and enforcement programs. During 2017 and 2016, we also focused on cost reduction and optimization efforts, including reductions in headcount, renegotiation of certain existing arrangements, termination of certain patent licensing programs to maximize resource allocation, and reducing facilities costs.

We continue to experience challenges in the existing patent and licensing environment, including challenges in identifying and acquiring new high-quality patent assets as discussed below. Despite these challenges, we will continue to invest in and monetize our existing quality patent assets.

Our team’s expertise in identifying and evaluating complex IP, and in developing and cultivating long-term business relationships, provides us a unique window into innovation and technological advancement. We are increasing our efforts to leverage our expertise and experience to create new avenues which we believe will lead to increased shareholder value. In this regard, and in addition to monetizing our existing IP assets, we will increase our focus on opportunities to partner with high-growth and potentially disruptive technology companies. We will leverage our experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. Examples of some of these technology areas include Artificial Intelligence, or AI, and machine learning, machine vision, robotics and blockchain technologies. Examples of our initial execution of this strategy are our partnerships with Veritone, Inc., or Veritone (Nasdaq: VERI), and Miso Robotics, Inc., or Miso Robotics, described below.

Enforcement Activities. In March 2017, our subsidiary, Saint Lawrence Communications, LLC, or Saint Lawrence, received a jury verdict in its case against Motorola, Inc. in the United States District Court for the Eastern District of Texas, or District Court. The jury returned a verdict that five U.S. patents were valid and infringed. The jury found that the infringement

was willful and returned a damages award of nearly $9.2 million for past infringement. The District Court is currently considering Saint Lawrence’s post-trial motion for and attorneys’ fees as well as post-trial motions from Motorola. We are awaiting issue of the final judgment by the District Court in this matter, after which appeals may be filed. In addition, our German subsidiary, Saint Lawrence Communications GmbH, was granted injunctions by the German court in enforcement proceedings against Motorola, Inc., which injunctions have been appealed by Motorola. The Motorola actions have not yet concluded, and hence, no revenues have been recognized in the statements of operations related to these specific Motorola actions.

During the second quarter of 2017, Saint Lawrence resolved its enforcement actions against ZTE including the U.S. lawsuit. In February 2018, Saint Lawrence and Saint Lawrence Communications GmbH entered into an agreement with Apple Inc. to resolve all outstanding litigation.

As previously reported, in September 2016, our subsidiary Cellular Communications Equipment LLC, or CCE, received a jury verdict of infringement by Apple, Inc. In the third quarter of 2017, CCE entered into an agreement with Apple Inc. to resolve the patent litigation.

Partnerships. We may from time to time evaluate other business opportunities which complement, or supplement, our primary licensing and enforcement business and leverage our intellectual property expertise. For example, in June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding. In addition, in February 2018, we made an additional strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics. Miso Robotics will use the capital to expand its suite of collaborative, adaptable robotic kitchen assistants and to broaden applications for Miso AI, the company’s machine learning cloud platform. In addition, we also entered into an IP services agreement with Miso Robotics to help the company drive AI-based solutions for the entire restaurant industry. Our partnership with Miso Robotics represents our second partnership with companies seeking to transform the marketplace through Artificial Intelligence.

Upon Veritone’s consummation of its IPO, our loans and accrued interest were automatically converted into 1,969,186 shares of Veritone common stock. In addition, Acacia exercised its Primary Warrant, acquiring 2,150,335 shares of Veritone common stock. Following the automatic exercise of our Primary Warrant, Veritone issued to us an additional warrant, or the 10% Warrant, that provides for the issuance of additional shares of common stock of Veritone at an exercise price per share of $13.6088 per share, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date and the remaining 50% of the shares vesting on the first anniversary of the issuance date. Results for the year ended December 31, 2017 included a net unrealized investment gain on our equity investment in Veritone totaling $49.5 million, primarily related to the increase in Veritone’s stock price since the IPO and our related requirement to mark our Veritone investment to market at each balance sheet date. Our Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. Refer to Note 7 to the consolidated financial statements elsewhere herein for additional information regarding our partnership with Veritone.

We believe these partnerships will be synergistic with our overall business strategies.

Patent Portfolio Intake. One of the significant challenges in our industry continues to be quality patent intake due to the challenges and complexity of the current patent environment. We acquired one portfolio during fiscal year 2017 from our partnership with Renesas Electronics of Japan.

With respect to our licensing, enforcement and overall business, neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we may not be able to identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.

Operating activities during the periods presented included the following:



	2017		2016		2015

Revenues (in thousands)	$	65,402	$	152,699	$	125,037
New agreements executed	20		39		63
Licensing and enforcement programs generating revenues - during the respective period	13		28		30
Licensing and enforcement programs with initial revenues	1		7		4
New patent portfolios	1		2		3
Year end cash, cash equivalents and short-term investments*	$	136,604	$	158,495	$	145,948

___________________________________

* Includes restricted cash (2016 and 2015 balances only)

Our revenues historically have fluctuated period to period, and can vary significantly, based on a number of factors including the following:


•	the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments;


•	fluctuations in the total number of agreements executed each period;


•	the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;


•	the relative maturity of licensing programs during the applicable periods;


•	other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors;


•	historically, based on the merits and strength of our operating subsidiary’s patent infringement claims and other factors, many prospective licensees have elected to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as those patent infringement cases approached a court determined trial date; and


•	fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above.

Our management does not attempt to manage for smooth sequential periodic growth in revenues period to period, and therefore, periodic results can be uneven. Unlike most operating businesses and industries, licensing revenues not generated in a current period are not necessarily foregone but, depending on whether negotiations, litigation or both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be pushed into subsequent fiscal periods.

Summary of Results of Operations - For Fiscal Years 2017, 2016 and 2015

(In thousands, except percentage change values)



	Fiscal Year									% Change
	2017			2016			2015			2017 vs. 2016		2016 vs. 2015

Revenues	$	65,402		$	152,699		$	125,037		(57	)%	22	%
Inventor royalties and contingent legal fees	21,634			49,204			34,631			(56	)%	42	%
Litigation and licensing expenses - patents	18,219			27,858			39,373			(35	)%	(29	)%
Amortization expense	22,154			34,208			53,067			(35	)%	(36	)%
Impairment of patent-related intangible assets	2,248			42,340			74,731			(95	)%	(43	)%
Impairment of goodwill	—			—			30,149			—	%	(100	)%
Other operating costs and expenses⁽¹⁾	28,419			36,498			45,708			(22	)%	(20	)%
Operating loss	(27,272		)	(37,409		)	(152,622		)	(27	)%	(75	)%
Total other income (expense)	51,911			798			(56		)	*		*
Provision for income taxes	(2,955		)	(18,188		)	(4,800		)	(84	)%	279	%
Net (income) loss attributable to noncontrolling interests in subsidiaries	496			732			(2,558		)	(32	)%	(129	)%
Net income (loss) attributable to Acacia Research Corporation	22,180			(54,067		)	(160,036		)	(141	)%	(66	)%

____________________________________

* Percentage change in excess of 300%

⁽¹⁾ Includes non-cash stock compensation charges of $8.9 million, $9.1 million and $11.0 million in fiscal years 2017, 2016 and 2015, respectively, included in General and administrative expense in the consolidated statements of operations.

Overview - Fiscal Year 2017 compared with Fiscal Year 2016


•	Revenues decreased $87.3 million, or 57% to $65.4 million, due primarily to a decrease in the number of agreements executed and a decrease in average revenue per agreement. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues.

•

Income before provision for income taxes was $24.6 million for fiscal year 2017, as compared to a loss before provision for income taxes of $36.6 million for fiscal year 2016. The net change was primarily comprised of the change in revenues described above, a net $49.5 million unrealized gain on our equity investment in Veritone, a $3.0 million non-cash stock compensation charge for our Veritone related profits interest units and a net decrease in operating expenses, as follows:

•

Inventor royalties and contingent legal fees, on a combined basis, decreased $27.6 million, or 56%, relatively consistent with the 57% decrease in revenues in fiscal year 2017. Contingent legal fees decreased $9.8 million, or 37%, due to an increase in average contingent legal fee rates for the portfolios generating revenues in fiscal year 2017. Inventor royalties decreased $17.8 million, or 78%, primarily due to lower average inventor royalty rates for the portfolios generating revenues during fiscal year 2017.


•	Litigation and licensing expenses-patents decreased $9.6 million, or 35%, to $18.2 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing licensing and enforcement programs and an overall decrease in portfolio related enforcement activities. Refer to “Investments in

Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.


•	Amortization expense decreased $12.1 million, or 35%, to $22.2 million, due to a decrease in scheduled amortization resulting from patent portfolio impairment charges previously recorded in the second and fourth quarters of 2016, and no new patent portfolio acquisition costs incurred during fiscal year 2017.


•	Impairment of patent-related intangible asset charges decreased $40.1 million, or 95%, to $2.2 million. Impairment charges reflect the impact of reductions in expected estimated future net cash flows for certain patent portfolios and/or the impairment of certain portfolios that management determined it would no longer allocate resources to in future periods.


•	General and administrative expenses decreased $6.9 million, or 21%, to $26.0 million, due primarily to a reduction in personnel costs in connection with headcount reductions in 2016 and 2017, a decrease in variable performance based compensation costs consistent with the decrease in revenues for the periods and a decrease in corporate, general and administrative costs.

Excluding profits interests related non-cash stock compensation, non-cash stock compensation expense decreased $3.2 million, or 36% due primarily to the reduction in head count. Profits interests related non-cash stock compensation expense totaled $3.0 million, reflecting the December 31, 2017 fair value of our Veritone related profits interest units granted in February 2017.

•

Results for fiscal year 2017 included a net unrealized gain on our investment in Veritone totaling $49.5 million (included in other income (expense)), comprised of an unrealized gain on conversion of our Veritone loans to equity of $2.7 million and an unrealized gain on the exercise of our Primary Warrant of $4.6 million, both as of May 2017, and an unrealized gain related to the change in fair value of our equity investment in Veritone through December 31, 2017 of $42.2 million.

•

Tax expense for fiscal years 2017 and 2016 primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. Results for fiscal year 2017 included a significant unrealized gain on our investment in Veritone, which created a related deferred tax liability. The future anticipated reversal of this deferred tax liability provides for a source of taxable income that allows for the realizability of existing deferred tax assets that have been reduced by a valuation allowance for the periods presented. The effective tax rate reflects both the recognition of the deferred tax liability and the reversal of valuation allowance. See below for additional information.

Overview - Fiscal Year 2016 compared with Fiscal Year 2015


•	Revenues increased $27.7 million, or 22% to $152.7 million for fiscal year 2016, due to an increase in average revenue per agreement, which was partially offset by a decrease in the number of agreements executed.


•	Inventor royalties and contingent legal fees, on a combined basis, increased $14.6 million, or 42%, due primarily to the 22% increase in revenues in fiscal year 2016, and a 4% increase in average contingent legal fee rates for the portfolios generating revenues in fiscal year 2016, as compared to the portfolios generating revenues in fiscal year 2015.


•	Litigation and licensing expenses-patents decreased $11.5 million, or 29%, to $27.9 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with patent trials and ongoing licensing and enforcement programs.


•	Amortization expense decreased $18.9 million, or 36%, to $34.2 million, due to a decrease in scheduled amortization on existing patent portfolios resulting from various patent portfolio impairment charges previously recorded in the fourth quarter of 2015 and second quarter of 2016.

•

Impairment of patent-related intangible asset charges decreased $32.4 million, or 43%, to $42.3 million. Impairment charges reflect the impact of reductions in expected estimated future net cash flows for certain patent portfolios and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

•

In the fourth quarter of fiscal 2015, we performed an impairment analysis of goodwill. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company’s stock price and adverse litigation outcomes occurring in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.


•	General and administrative expenses decreased $5.3 million, or 14%, to $32.9 million, due primarily to a net decrease in personnel costs in connection with the net reduction in headcount during 2016 and 2015 and a net decrease in non-cash stock compensation expense.


•	Fiscal year 2016 and 2015 operating expenses included expenses for court ordered attorney fees totaling $500,000 and $4.1 million, respectively.

•

Tax expense for the periods presented reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss (2015 only) and foreign tax credit related tax assets generated during the periods. As such, no tax benefit was recognized for net operating loss and foreign tax credit related tax benefits generated during the applicable periods presented.

Revenues for the periods presented included fees from the following licensing and enforcement programs:



•	360 Degree View Technology⁽³⁾	•	Oil and Gas Drilling technology⁽²⁾
•	3G & 4G Cellular Air Interface and Infrastructure technology⁽³⁾	•	Oil and Gas Production technology⁽³⁾
•	4G Wireless technology⁽²⁾⁽³⁾	•	Online Auction Guarantee technology^(1)(2)(3)
•	Audio Communications Fraud Detection technology⁽²⁾⁽³⁾	•	Optical Networking technology^(1)(2)(3)
•	Automotive Safety, Navigation and Diagnostics technology⁽³⁾	•	Optimized Microprocessor Operation technology⁽³⁾
•	Bone Wedge technology^(1)(2)(3)	•	Reflective and Radiant Barrier Insulation technology⁽²⁾⁽³⁾
•	Broadband Communications technology⁽²⁾⁽³⁾	•	Semiconductor 3D Die Stacking technology⁽²⁾
•	Cardiology and Vascular Device technology^(1)(2)(3)	•	Semiconductor Memory Circuit and Manufacturing Processes technology⁽²⁾
•	Diamond and Gemstone Grading technology⁽²⁾	•	Semiconductor and Memory-Related technology⁽¹⁾
•	DisplayPort and MIPI DSI technology^(1)(2)(3)	•	Semiconductor Testing technology⁽³⁾
•	DRAM and Flash Memory technology⁽²⁾	•	Shared Memory for Multimedia Processing^(1)(2)(3)
•	Electronic Access Control technology⁽¹⁾⁽³⁾	•	Speech codes used in wireless and wireline systems technology^(1)(2)(3)
•	Electronic spreadsheet, data analysis and software development technology⁽²⁾	•	Spinning and Jousting Toy Game technology⁽³⁾
•	Enhanced Mobile Communications technology⁽³⁾	•	Super Resolutions Microscopy technology^(1)(2)(3)
•	Flash Memory technology⁽²⁾	•	Surgical Access technology⁽³⁾
•	Gas Modulation Control Systems technology⁽²⁾⁽³⁾	•	Suture Anchors technology⁽³⁾
•	High Speed Circuit Interconnect and Display Control technology^{(2) (3)}	•	Telematics technology⁽²⁾⁽³⁾
•	Improved Lighting technology⁽³⁾	•	Unicondylar Knee Replacement technology⁽³⁾
•	Innovative Display technology⁽¹⁾⁽³⁾	•	Variable Data Printing technology⁽²⁾
•	Intercarrier SMS technology⁽³⁾	•	Video Analytics for Security technology⁽³⁾
•	Interstitial and Pop-Up Internet Advertising technology⁽²⁾⁽³⁾	•	Video Conferencing technology⁽¹⁾
•	Knee Replacement technology⁽²⁾	•	Voice-Over-IP technology⁽³⁾
•	Lighting Ballast technology⁽²⁾	•	Wireless Data Synchronization & Data Transfer technology⁽³⁾
•	Location Based Services technology⁽³⁾	•	Wireless Infrastructure and User Equipment technology^(1)(2)(3)
•	Messaging technology⁽³⁾	•	Wireless Location Based Services technology⁽³⁾
•	Microprocessor and Memory technology⁽²⁾⁽³⁾	•	Wireless Monitoring technology⁽³⁾
•	Mobile Computer Synchronization technology⁽³⁾

______________________________________



⁽¹⁾	Licensing and enforcement program generating revenue in 2017.
⁽²⁾	Licensing and enforcement program generating revenue in 2016.
⁽³⁾	Licensing and enforcement program generating revenue in 2015.

Revenues from one or more of our patents or patent portfolios may be significant in a specific reporting period, and may be significant to our licensing and enforcement business as a whole.

Patent Licensing and Enforcement

Patent Litigation Trial Dates and Related Trials. As of the date of this report, our operating subsidiaries have approximately seven pending patent infringement cases with a scheduled trial date in the next twelve months. Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us. Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the trials may occur according to the court’s scheduling calendar at a specific point in time. A court may change previously scheduled trial dates. In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent assets and typically for reasons that are beyond our control. While scheduled trial dates provide an indication of the timing of possible future revenue generating opportunities for us, the trials themselves and the immediately preceding periods represent the possible future revenue generating opportunities. These future opportunities can result in varying outcomes. In fact, it is difficult to predict the outcome of patent enforcement litigation at the trial level and outcomes can be unfavorable. It can be difficult to understand complex patented technologies, and as a result, this may lead to a higher rate of unfavorable litigation outcomes. Moreover, in the event of a favorable outcome, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and a potential for delayed or foregone revenue opportunities in the event of modification or reversal of favorable outcomes. Although we diligently pursue enforcement litigation, we cannot predict with reliability the decisions made by juries and trial courts. Please refer to Item 1A. “Risk Factors” for additional information regarding trials, patent litigation and related risks.

Litigation and Licensing Expense. We expect patent-related legal expenses to continue to fluctuate from period to period based on the factors summarized herein, in connection with future trial dates, international enforcement, strategic patent portfolio prosecution and our current and future patent portfolio investment, prosecution, licensing and enforcement activities. The pursuit of enforcement actions in connection with our licensing and enforcement programs can involve certain risks and uncertainties, including the following:

•

Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs could increase our operating costs and decrease our profit generating opportunities;


•	Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;

•

New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States House of Representatives passed a bill that would require non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met;


•	Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position;


•	The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e. markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios; and


•	Fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above could harm our operating results and our financial position.

Investments in Patent Portfolios

One of the significant challenges in our industry continues to be quality patent intake due to the challenges and complexity associated with the current patent environment. We acquired one portfolio during fiscal year 2017 from our

partnership with Renesas Electronics of Japan, compared to two new patent portfolios and three new patent portfolios in fiscal years 2016 and 2015, respectively. There were no patent portfolio investment costs paid in fiscal year 2017, compared to $1.2 million and $19.5 million in fiscal years 2016 and 2015, respectively.

Critical Accounting Policies

Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.

We believe that, of the significant accounting policies discussed in Note 2 to our notes to consolidated financial statements, the following accounting policies require our most difficult, subjective or complex judgments:


•	revenue recognition;


•	stock-based compensation expense, including valuation of profits interests;


•	valuation of long-lived and intangible assets including goodwill;


•	valuation of investments; and


•	accounting for income taxes.

We discuss below the critical accounting assumptions, judgments and estimates associated with these policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. For further information on our critical accounting policies, refer to Note 2 to the notes to consolidated financial statements included herein.

Revenue Recognition

As described below, significant management judgment must be made and used in connection with the revenue recognized in any accounting period. Material differences may result in the amount and timing of revenue recognized or deferred for any period, if management made different judgments.

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been performed pursuant to the terms of the agreement, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.

We make estimates and judgments when determining whether the collectibility of fees receivable from licensees is reasonably assured. We assess the collectibility of fees receivable based on a number of factors, including past transaction history and the credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash for transactions where collectibility may have been an issue. Management’s estimates regarding collectibility impact the actual revenues recognized each period and the timing of the recognition of revenues. Our assumptions and judgments regarding future collectibility could differ from actual events and thus materially impact our financial position and results of operations.

Generally, our agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

Depending on the complexity of the underlying revenue arrangement and related terms and conditions, significant judgments, assumptions and estimates may be required to determine when substantial delivery of contract elements has occurred, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period or periods in which, or during which, the completion of the earnings process occurs. Depending on the magnitude of specific revenue arrangements, if different judgments, assumptions and estimates are made regarding contracts executed in any specific period, our periodic financial results may be materially affected.

Our operating subsidiaries are responsible for the licensing and enforcement of their respective patented technologies and pursue third-parties that are utilizing their intellectual property without a license or who have under-reported the amount of royalties owed under a license agreement. As a result of these activities, from time to time, our operating subsidiaries may recognize revenues in a current period that relate to infringements by licensees that occurred in prior periods. These recoveries may cause revenues to be higher than expected during a particular reporting period and may not occur in subsequent periods. Differences between amounts initially recognized and amounts subsequently audited or reported as an adjustment to those amounts, are recognized in the period such adjustment is determined as a change in accounting estimate.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by our operating subsidiaries. Inventor royalties, noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, noncontrolling interests and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

For fiscal years 2017, 2016 and 2015, the majority of our revenue agreements provided for the payment to us of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents. Pursuant to the terms of these agreements, our operating subsidiaries have no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on our operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. The agreements provided for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process was determined to be complete and revenue was recognized upon the execution of the agreements, when all other revenue recognition criteria were met. Historically, term

license agreements have not been a material component of our operating revenues, with the majority of license agreements being paid-up, perpetual license agreements.

Stock-based Compensation Expense

Equity Based Awards. Stock-based compensation payments to employees and non-employee directors are recognized as expense in the statements of operations. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award (determined using a Black-Scholes option pricing model for stock options and intrinsic value on the date of grant for nonvested restricted stock), and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity award). Determining the fair value of stock-based awards at the grant date requires significant estimates and judgments, including estimating the market price volatility of our common stock, future employee stock option exercise behavior and requisite service periods.

The FASB issued a new standard, effective January 1, 2017, that changes the accounting for certain aspects of share-based payments to employees, including allowing an employer to make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest (current GAAP) or account for forfeitures when they occur. Effective January 1, 2017, we elected to account for forfeitures of awards as they occur. The prior standard required us to estimate the number of awards for which the requisite service period is expected to be rendered and base the accruals of compensation cost on the estimated number of awards that will vest. The adoption of this standard did not have a material impact on our consolidated financial statements.

During the year ended December 31, 2016, the Company granted stock options with market-based vesting conditions. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market-based vesting condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate of .92%; expected volatility of 55%; and expected dividend yield of 0%. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Profits Interests Units. The fair value of the Units issued under our Veritone related Profits Interests Plan is estimated utilizing a Geometric Brownian Motion model, or GBM, which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note 7) underlying or associated with the Units. At the estimated end of the term of the underlying warrant, the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a discount for lack of marketability, or DLOM, using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the year ended December 31, 2017, assumptions utilized in the GBM included a term of 4.4 years, stock price of $23.20, volatility of 50%, and risk free interest rates ranging from 1.76% to 2.40% for terms ranging from one to 10 years. The estimated DLOM utilized was 30%, based on assumptions including a term of approximately 4.4 years and a volatility of 85% for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately 4.4 years. A hypothetical 5% change in the estimated DLOM would result in a $217,000 change in the estimated fair value of the profits interest liability.

Valuation of Long-lived and Intangible Assets Including Goodwill

Patent Portfolio Impairment Testing. We review long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If

quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows.

For the fiscal year ended December 31, 2017, we recorded $2.2 million of patent portfolio impairment charges. For the fiscal year ended December 31, 2016, we recorded $42.3 million of patent portfolio impairment charges, primarily comprised of the write-off of the remaining carrying value of our Adaptix portfolio. The impairment charges were recorded in the periods due to adverse litigation outcomes, a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date. Estimated fair value was determined based on estimates of future cash flows and estimates of probabilities of realization given adverse litigation outcomes and resource allocation decisions.

We performed an impairment analysis for our patents as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in $74.7 million of patent portfolio impairment charges, for the following reasons:

•

In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the applicable patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015.

•

Management considered the impact of the fourth quarter 2015 adverse trial outcomes on our estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for certain portfolios were reduced in part, in connection with our assessment of probabilities of realization given the recent adverse trial outcomes.

•

Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, we experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios we intend to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off of any remaining carrying value in the fourth quarter of 2015.

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at our single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the our stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for our overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

We consider our market capitalization and other valuation techniques, as applicable, when estimating fair value for goodwill impairment testing purposes. When conducting annual and interim goodwill impairment assessments, we initially perform a qualitative evaluation (considering factors described above as applicable) of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, we apply a two-step impairment. The two-step impairment test first compares the estimated fair value of our single reporting unit to its carrying or book value. If the estimated fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and there is no requirement to perform further testing. If the carrying value of the reporting unit exceeds its estimated fair value, we are required to perform step-two of the impairment analysis to determine the estimated implied fair value of the reporting unit’s goodwill, and if the carrying value of the reporting unit’s goodwill exceeds its estimated implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statements of operations.

In connection with our annual goodwill impairment testing for 2015, we identified several qualitative factors triggering an impairment test at December 31, 2015, as follows;

•

Adverse legal outcomes and changes in legal factors. In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patent in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Consistent gradual decline in the Company’s stock price: Historically, our stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, our stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in our stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of our company, as reflected in our lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization due to changes in our management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios we intend to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to our decision to no longer allocate resources to those programs. In addition, we made changes in estimates regarding the best and highest use of certain patent portfolios, resulting in reductions in estimated future cash flows.

At December 31, 2015, we utilized the following methods and assumptions in our annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:

•

At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in our stock price was sustained. We also considered the impact of the December 2015 adverse trial outcomes on our stock price and related estimates of fair value for remaining portfolio opportunities. Based on our assessment of these factors, we determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

We conducted the first step of the goodwill impairment test for our single reporting unit as of December 31, 2015. We utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying our stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for our single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of our reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of our reporting unit did not exceed the amounts assigned to our reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

Valuation of Investments

Equity investments without readily determinable fair values, in companies over which we have the ability to exercise significant influence, are accounted for using the equity method of accounting and classified within “Investments - equity method” in the consolidated balance sheet. We include our proportionate share of earnings and/or losses of our equity method investees in “Equity in earnings (losses) of investee” in our consolidated statements of operations.

We may elect to account for equity investments in companies with readily determinable fair values, where our investment gives us the ability to exercise significant influence over the operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants). Refer to Note 7 for information regarding our investment in Veritone.

Determination of whether we possess the ability to exercise significant influence requires significant judgment, including consideration of the extent to which our voting interests, board representation, financial arrangements and other factors provide us with the ability to exercise significant influence with respect to an investee. A change in facts or judgments resulting in the determination that control exists would result in consolidation of the investment and recognition of related revenues and expenses with a corresponding non-controlling interest.

U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value includes: Level 1 - Observable Inputs; Level 2 - Pricing Models with Significant Observable Inputs; and Level 3 - Unobservable Inputs. Refer to Note 2 to the consolidated financial statements elsewhere herein for additional information.

Whenever possible, we are required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Our Veritone common stock is reported at fair value, based on the applicable NASDAQ Global Select Market stock price as of the applicable valuation date, as adjusted for an estimated DLOM associated with the restricted nature of the common shares acquired (Level 3 input). Our Veritone warrants are recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions: risk-free interest rates ranging from 1.94% to 2.37%; expected terms ranging from 3 to 9 years; volatilities ranging from 45% to 55%; and a dividend yield of zero.

The DLOM for our Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:



	Veritone Common Stock		Veritone Warrants
	IPO Date	December 31, 2017	IPO Date	December 31, 2017
Estimated DLOM applied	5.7%	5%	5.7%	10%
Volatility assumptions	35%	37%	35%	72% - 87%
Term assumptions	6 months	2 months	6 months	5 months

A one percent increase in the DLOM assumptions utilized at all applicable valuation dates would result in a $1.1million decrease in the fair value of our investment in Veritone at December 31, 2017, and a corresponding decrease in the net unrealized investment gain reflected in the consolidated statements of operations for the year ended December 31, 2017.

We review investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, we consider available quantitative and qualitative evidence in evaluating potential impairment of our investments. If the cost of an investment exceeds its fair value, we evaluate, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. We also consider specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments.

Accounting for Income Taxes

As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves the estimating of our actual current tax exposure together with assessing temporary differences resulting from differing treatment of items. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not likely, we must establish a valuation allowance. To the extent we establish a valuation allowance or increase this allowance in a period, we must include an expense within the tax provision in the consolidated statements of operations.

Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and our valuation allowance. Due to uncertainties related to our ability to utilize certain deferred tax assets in future periods, we have recorded a full valuation allowance against our net deferred tax assets as of December 31, 2017, 2016 and 2015. These assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.

In assessing the need for a valuation allowance, management has considered both the positive and negative evidence available, including but not limited to, estimates of future taxable income and related probabilities, estimates surrounding the character of future income and the timing of realization, consideration of the period over which our deferred tax assets may be recoverable, our recent history of net income and prior history of losses, projected future outcomes, industry and market trends and the nature of existing deferred tax assets. In management’s estimate, any positive indicators, including forecasts of potential future profitability of our businesses, are outweighed by the uncertainties surrounding our estimates and judgments of potential future taxable income, primarily due to uncertainties surrounding the timing of realization of future taxable income and the character of such income in particular future periods (i.e. foreign or domestic). In the event that actual results differ from these estimates or we adjust these estimates should we believe we would be able to realize these deferred tax assets in the future, an adjustment to the valuation allowance would increase income in the period such determination was made.

In 2017, 2016 and 2015, based on management’s assessment, a full valuation allowance was recorded against the company’s net deferred tax assets generated during the periods and the balances as of the end of each of the periods, due to uncertainty regarding future realization of such tax assets pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if we determine that the company will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statements of operations in the period the determination is recorded.

Any changes in the judgments, assumptions and estimates associated with our analysis of the need for a valuation allowance in any future periods could materially impact our financial position and results of operations in the periods in which those determinations are made.

Consolidated Results of Operations

Comparison of the Results of Operations for Fiscal Years 2017, 2016 and 2015

Revenues



							2017 vs. 2016					2016 vs. 2015
	2017		2016		2015		$ Change			% Change		$ Change		% Change
	(in thousands, except percentage change values and number of agreements)
Revenues	$	65,402	$	152,699	$	125,037	$	(87,297	)	(57	)%	$	27,662	22	%
New revenue agreements executed	20		39		63
Average revenue per agreement	$	3,270	$	3,915	$	1,985

A reconciliation of the change in revenues (based on average revenue per agreement) for the periods presented, in relation to the revenues reported for the comparable prior year period, is as follows:



	2017 vs. 2016			2016 vs. 2015
	(in thousands)
Decrease in number of agreements executed	$	(74,392	)	$	(47,633	)
Increase (decrease) in average revenue per agreement executed	(12,905		)	75,295
Total	$	(87,297	)	$	27,662

For the periods presented herein, the majority of the revenue agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents. Refer to “Investments in Patent Portfolios” above for information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

Net Income (Loss)



									2017 vs. 2016				2016 vs. 2015
	2017		2016			2015			$ Change		% Change		$ Change		% Change
	(in thousands, except percentages)
Net income (loss) attributable to Acacia Research Corporation	$	22,180	$	(54,067	)	$	(160,036	)	$	76,247	(141	)%	$	105,969	(66	)%

A reconciliation of the change in net income (loss) for the periods presented is as follows:



	2017 vs. 2016			%		2016 vs. 2015			%
	(in thousands, except percentage values)
Increase (decrease) in revenues	$	(87,297	)	(114	)%	$	27,662		26	%
(Increase) decrease in inventor royalties and contingent legal fees combined	27,570			36	%	(14,573		)	(14	)%
Decrease in general and administrative expenses	6,889			9	%	5,257			5	%
Decrease in litigation and licensing expenses	9,639			13	%	11,515			11	%
Decrease in patent amortization expenses	12,054			16	%	18,859			18	%
Decrease in impairment of patent-related intangible assets	40,092			53	%	32,391			31	%
Decrease in impairment for goodwill	—			—	%	30,149			28	%
Change in provision for income taxes	15,233			20	%	(13,388		)	(13	)%
Unrealized gain and change in fair value of investment	49,526			65	%	—			—	%
Other	2,541			2	%	8,097			8	%
Net change in net income (loss)	$	76,247		100	%	$	105,969		100	%

Cost of Revenues



							2017 vs. 2016					2016 vs. 2015
	2017		2016		2015		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Inventor royalties	$	4,952	$	22,730	$	18,462	$	(17,778	)	(78	)%	$	4,268		23	%
Contingent legal fees	16,682		26,474		16,169		(9,792		)	(37	)%	10,305			64	%
Litigation and licensing expenses - patents	18,219		27,858		39,373		(9,639		)	(35	)%	(11,515		)	(29	)%
Amortization of patents	22,154		34,208		53,067		(12,054		)	(35	)%	(18,859		)	(36	)%

Inventor Royalties and Contingent Legal Fees Expense. The economic terms of patent portfolio related partnering agreements and contingent legal fee arrangements, if any, including royalty obligations, if any, royalty rates, contingent fee rates and other terms and conditions, vary across the patent portfolios owned or controlled by our operating subsidiaries. In certain instances, we have invested in certain patent portfolios without future inventor royalty obligations. These costs fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms, conditions and obligations generating revenues each period.

A summary of the main drivers of the change in inventor royalties expense and contingent legal fees expense, in relation to the change in total revenues, for the comparable periods presented, is as follows:



	2017 vs. 2016			% of Prior Period Balance		2016 vs. 2015			% of Prior Period Balance
Inventor Royalties:	(in thousands, except percentage change values)
Increase (decrease) in inventor royalty rates	$	(4,345	)	(19	)%	$	11,518		62	%
Increase (decrease) in total revenues	(30,254		)	(133	)%	4,729			26	%
Decrease (increase) in revenues without inventor royalty obligations	16,821			74	%	(11,979		)	(65	)%
Total change - inventor royalties expense	$	(17,778	)	(78	)%	$	4,268		23	%



	2017 vs. 2016			% of Prior Period Balance		2016 vs. 2015			% of Prior Period Balance
Contingent Legal Fees:	(in thousands, except percentage change values)
Increase in contingent legal fee rates	$	5,359		20	%	$	6,850		43	%
Increase (decrease) in total revenues	(15,832		)	(60	)%	3,719			23	%
Decrease (increase) in revenues without contingent legal fee obligations	681			3	%	(264		)	(2	)%
Total change - contingent legal fees	$	(9,792	)	(37	)%	$	10,305		64	%

Litigation and Licensing Expenses - Patents. Litigation and licensing expenses-patents include patent-related litigation, enforcement and prosecution costs incurred by external patent attorneys engaged on an hourly basis and the out-of-pocket expenses incurred by law firms engaged on a contingent fee basis. Litigation and licensing expenses-patents also includes third-party patent research, development, prosecution, re-exam and inter partes reviews, consulting, and other costs incurred in connection with the licensing and enforcement of patent portfolios.

Litigation and licensing expenses-patents decreased for the periods presented due to a net decrease in litigation support, patent prosecution and litigation expenses associated with ongoing licensing and enforcement programs and an overall decrease in portfolio related enforcement activities. We expect patent-related legal expenses to continue to decrease based upon the overall decrease in portfolio related enforcement activities as we continue monetizing our existing patent assets. Refer to “Investments in Patent Portfolios” above for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.

Amortization of Patents. The change in amortization expense for the comparable periods presented was due to the following:



	2017 vs. 2016			2016 vs. 2015
	(in thousands)
Scheduled amortization related to patent portfolios owned or controlled as of the end of the prior year	$	(11,829	)	$	(18,704	)
Accelerated amortization related to recovery of upfront advances	(225		)	225
Patent portfolio dispositions	—			(380		)
Total change in patent amortization expense	$	(12,054	)	$	(18,859	)

Impairment Charges



							2017 vs. 2016					2016 vs. 2015
	2017		2016		2015		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Impairment of patent-related intangible assets	$	2,248	$	42,340	$	74,731	$	(40,092	)	(95	)%	$	(32,391	)	(43	)%
Impairment of goodwill	—		—		30,149		—			—	%	(30,149		)	(100	)%

Patent Impairment Charges

Impairment charges for fiscal year 2017 primarily reflect reductions in expected estimated future net cash flows for certain patent portfolios that management determined it would no longer allocate resources to in future periods. Impairment charges for 2016 and 2015 reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse litigation outcomes and certain patent portfolios that management determined it would no longer allocate licensing and enforcement resources to in future periods. Impairment charges for 2016 were primarily comprised of the write-off of the remaining carrying value of our Adaptix portfolio. Impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

Impairment of Goodwill

We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in our stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015. Refer to “Critical Accounting Policies” elsewhere herein for additional information.

Operating Expenses



							2017 vs. 2016					2016 vs. 2015
	2017		2016		2015		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
General and administrative	$	17,145	$	23,857	$	27,128	$	(6,712	)	(28	)%	$	(3,271	)	(12	)%
Non-cash stock compensation expense - G&A	5,844		9,062		11,048		(3,218		)	(36	)%	(1,986		)	(18	)%
Non-cash stock compensation expense - Veritone Profits Interests	3,041		—		—		3,041			100	%	—			—	%
Total general and administrative expenses	$	26,030	$	32,919	$	38,176	$	(6,889	)	(21	)%	$	(5,257	)	(14	)%

Other expenses - business development	$	1,189	$	3,079	$	3,391	$	(1,890	)	(61	)%	$	(312	)	(9	)%

General and Administrative Expenses. General and administrative expenses include employee compensation and related personnel costs, including variable performance based compensation and non-cash stock compensation expenses, office and facilities costs, legal and accounting professional fees, public relations, marketing, stock administration, state taxes based on gross receipts and other corporate costs. A summary of the main drivers of the change in general and administrative expenses for the periods presented is as follows (in thousands):



	2017 vs. 2016			2016 vs. 2015
	(in thousands)
Net change in personnel costs due to reductions in headcount	$	(3,162	)	$	(5,841	)
Variable performance-based compensation costs	(2,580		)	1,839
Corporate, general and administrative costs	(1,821		)	1,594
Non-cash stock compensation expense - general and administrative⁽¹⁾	(3,218		)	(1,986		)
Non-cash stock compensation expense - Veritone related profits interests ⁽¹⁾	3,041			—
Employee severance costs	851			(863		)
Total change in general and administrative expenses	$	(6,889	)	$	(5,257	)

_________________________________________________________________

(1) - Refer to Note 10 in the accompany consolidated financial statements

General and administrative non-cash stock compensation expense for fiscal year 2017, excluding profits interests related non-cash compensation, decreased due to reductions in headcount and a reduction in scheduled non-cash stock compensation expense related to options with market-based performance conditions with graded vesting features that resulted in higher non-cash stock compensation expense in 2016, as compared to 2017.

Profits interests are classified as liability awards, which are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense (included in “non-cash stock compensation expense - Veritone related profits interests” above) is adjusted each reporting period for increases or decreases in the estimated fair value, which is primarily impacted by changes in the fair value of the underlying Veritone common stock and warrants related to the liability. Upon vesting of the units, which occurred in September 2017, any previously unrecognized compensation expense was immediately recognized for any changes in fair value. The fair value of the Veritone related profits interests Units totaled $3.0 million as of December 31, 2017. Refer to Note 10 in the condensed consolidated financial statements elsewhere herein for additional information.

General and administrative non-cash stock compensation expense for fiscal year 2016 decreased due primarily to a decrease in the average grant date fair value for the shares expensed in the respective periods. The decrease was partially offset by an increase in fiscal year 2016 for non-cash stock compensation expense related to the grant of options with market-based vesting conditions with graded vesting features, resulting in higher non-cash stock compensation expense during the earlier stages of the applicable service period.

Research, Consulting and Other Expenses - Business Development. Research, consulting and other expenses include third-party business development related research, consulting, and other costs incurred in connection with business development activities. These costs fluctuate period to period based on business development related activities in each period.

Other Operating Income (Expense)

Change in Fair Value of Investment, net. Our equity investment in Veritone is recorded at fair value, and therefore, is marked to market at each balance sheet date. Results for fiscal year 2017 included a net unrealized gain on our equity investment in Veritone totaling $49.5 million, comprised of an unrealized gain on conversion of our Veritone loans to equity of $2.7 million and an unrealized gain on the exercise of our Primary Warrant of $4.6 million, both as of May 2017, and an unrealized gain related to the change in fair value of our equity investment in Veritone through December 31, 2017 of $42.2 million.

Other. Fiscal year 2017, 2016 and 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $1.2 million, $500,000 and $4.1 million, respectively.

Income Taxes



	2017			2016			2015
Provision for income taxes (in thousands)	$	(2,955	)	$	(18,188	)	$	(4,800	)
Effective tax rate	(12		)%	50		%	3		%

Our effective tax rates for fiscal year 2017, 2016 and 2015, were primarily comprised of foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, state taxes, and the impact of full valuation allowances recorded for net operating loss (2017 and 2015) and foreign tax credit related tax assets generated in those periods due to uncertainty regarding future realization. Foreign taxes withheld related to revenue agreements executed with third-party licensees domiciled in certain foreign jurisdictions for fiscal year 2017, 2016 and 2015 totaled $2.9 million, $17.9 million, and $4.4 million, respectively. Results for fiscal year 2017 included an unrealized gain on our equity investment in Veritone which created a deferred tax liability totaling approximately $10.6 million. The future anticipated reversal of this deferred tax liability provides for a source of taxable income that allows for the realizability of existing deferred tax assets that have been reduced by a valuation allowance for the periods presented. The effective tax rate reflects both the recognition of the deferred tax liability and the reversal of valuation allowance.

Inflation

Inflation has not had a significant impact on us or any of our subsidiaries in the current or prior periods.

Liquidity and Capital Resources

General

Our primary sources of liquidity are cash and cash equivalents on hand generated from our operating activities. Our management believes that our cash and cash equivalent balances and anticipated cash flows from operations will be sufficient

to meet our cash requirements through at least March 2019 and for the foreseeable future. We may, however, encounter unforeseen difficulties that may deplete our capital resources more rapidly than anticipated, including those set forth under Item 1A, “Risk Factors”, above. Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing. However, additional funding may not be available on favorable terms, or at all. The capital and credit markets have experienced extreme volatility and disruption in recent years, and the volatility and impact of the disruption may continue. At times during this period, the volatility and disruption has reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, and the commercial paper markets may not be a reliable source of short-term financing for us. If we fail to obtain additional financing when needed, we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.

Certain of our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.

Cash, Cash Equivalents and Investments

Our consolidated cash and cash equivalents and short-term investments, excluding restricted cash balances, if any, totaled $136.6 million at December 31, 2017, compared to $147.0 million at December 31, 2016. The net change in cash and cash equivalents for the periods presented was comprised of the following (in thousands):



	2017			2016			2015

Net cash provided by (used in):
Operating activities	$	24,478		$	34,061		$	(9,949	)
Investing activities	(16,114		)	(40,630		)	39,307
Financing activities	700			(1,114		)	(28,601		)
	$	9,064		$	(7,683	)	$	757

Cash Flows from Operating Activities. Cash receipts from licensees totaled $91.2 million, $160.2 million and $111.0 million in fiscal years 2017, 2016 and 2015, respectively. The fluctuations in cash receipts for the periods presented primarily reflects the corresponding fluctuations in revenues recognized during the same periods, as described above, and the related timing of payments received from licensees. Cash outflows from operations totaled $66.8 million, $126.1 million and $120.9 million in fiscal years 2017, 2016 and 2015, respectively. The fluctuations in cash outflows for the periods presented reflects the fluctuations in revenue-related inventor royalties and contingent legal fees and other operating costs and expenses during the same periods, as discussed above, and the impact of the timing of payments to inventors, attorneys and other vendors.

Restricted Cash. In March 2015, an operating subsidiary of ours entered into a Guarantee with a bank in connection with enforcing a ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. The Guarantee was secured by a cash deposit (classified as restricted cash in the accompanying balances sheets) totaling $11.5 million at December 31, 2016. Upon resolution of all related matters in June 2017, the Guarantee was extinguished resulting in release of the cash collateral (and related restrictions on the cash balance) by the contracting bank. As of December 31, 2017, no amounts of Acacia’s cash and investments are restricted as to use.

Cash Flows from Investing Activities. Cash flows from investing activities and related changes were comprised of the following for the periods presented (in thousands):



	2017			2016			2015

Investment in Investees⁽¹⁾	$	(31,514	)	$	—		$	—
Advances to Investee⁽¹⁾	(4,000		)	(20,000		)	—
Purchases of property and equipment	(2		)	(4		)	(8		)
Net sale (purchase) of available-for-sale investments	19,402			(19,401		)	58,819
Patent portfolio investment costs	—			(1,225		)	(19,504		)
Net cash provided by (used in) investing activities	$	(16,114	)	$	(40,630	)	$	39,307
(1) - Refer to Note 7 in the accompany consolidated financial statements

Equity Investment in Veritone, Inc. On August 15, 2016, we entered into an Investment Agreement with Veritone, which provided for us to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, we entered into a secured convertible promissory note with Veritone, or the Veritone Loans, which permitted Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the consolidated statements of operations). On August 15, 2016, we funded the initial $10 million loan, or the First Loan. On November 25, 2016, we funded the second $10 million loan, or the Second Loan. The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued us a total of three four-year $700,000 warrants to purchase shares of Veritone’s common stock at an exercise price of $13.6088 per share. Veritone’s initial public offering date was May 12, 2017. Upon Veritone’s consummation of its IPO, all outstanding principal and accrued interest under the Veritone Loans, totaling $20.7 million, automatically converted into 1,523,746 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.

In addition, in August 2016, Veritone issued us a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of $13.6088 per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon Veritone’s consummation of its IPO, resulting in the purchase by us of an additional 2,150,335 shares of Veritone common stock, with an aggregate purchase price totaling $29.3 million. Immediately following our exercise of the Primary Warrant in full, Veritone issued us an additional 10% Warrant that provides for the issuance of an additional 809,400 shares of Veritone common stock at an exercise price of $13.6088 per share, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of shares vesting on the anniversary of the issuance date of the 10% Warrant.

On March 14, 2017, we entered into an additional secured convertible promissory note with Veritone, or the Veritone Bridge Loan, which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, we funded the initial $1.0 million advance, or the First Bridge Loan. On April 14, 2017, we funded the second $1.0 million advance, or the Second Bridge Loan. All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, we elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal balance and accrued interest under the Veritone Bridge Loan, totaling $4.0 million, automatically converted into 295,440 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.

In conjunction with the Veritone Bridge Loan, Veritone issued us (i) 60,000 shares of Veritone common stock, (ii) 90,000 shares of Veritone common stock and (iii) 10-year warrants to purchase up to 157,000 shares of Veritone common stock, with other terms and conditions similar to the warrants described above.

Our Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017.

Partnership with Miso Robotics, Inc. In June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding.

Cash Flows from Financing Activities. Cash flows from financing activities and related changes included the following for the periods presented (in thousands):



	2017			2016			2015

Dividends paid to stockholders	$	—		$	—		$	(25,434	)
Distributions to noncontrolling interests - Acacia IP Fund	—			(1,358		)	(4,105		)
Proceeds from the exercise of stock options	745			326			938
Repurchases of common stock	(45		)	(82		)	—
Net cash provided by financing activities	$	700		$	(1,114	)	$	(28,601	)

Dividends to Stockholders. In April 2013, our Board of Directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125

per share per quarter. On February 23, 2016, we announced that our Board of Directors terminated the dividend policy. Our Board of Directors terminated the dividend policy due to a number of factors, including our financial performance, our available cash resources, our cash requirements and alternative uses of capital that our Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

Stock Repurchase Program. In February 2018, our Board of Directors authorized the Program to repurchase up to $20 million of our outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion. In determining whether or not to repurchase any shares of our common stock, our Board of Directors will consider such factors as the impact of the repurchase on our cash position, as well as our capital needs and whether there is a better alternative use of our capital. We have no obligation to repurchase any amount of our common stock under the Program. The Program is set to expire on February 28, 2019.

Working Capital

The primary components of working capital are cash and cash equivalents, restricted cash, short-term investments, accounts receivable, prepaid expenses, accounts payable, accrued expenses, and royalties and contingent legal fees payable. Working capital at December 31, 2017 was $130.1 million, compared to $160.3 million at December 31, 2016.

Consolidated accounts receivable from licensees decreased to $153,000 at December 31, 2017, compared to $26.8 million at December 31, 2016. Accounts receivable balances fluctuate based on the timing, magnitude and payment terms associated with revenue agreements executed during the year, and the timing of cash receipts on accounts receivable balances recorded in previous periods. One licensee accounted for 100% of accounts receivable at December 31, 2017. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016.

Accounts payable and accrued expenses decreased to $8.0 million at December 31, 2017, from $14.3 million at December 31, 2016, due primarily to a decrease in payroll and other employee benefits and a decrease in foreign taxes payable.

Consolidated royalties and contingent legal fees payable decreased to $1.6 million at December 31, 2017, compared to $13.9 million at December 31, 2016. Royalties and contingent legal fees payable balances fluctuate based on the magnitude and timing of the execution of related license agreements, the timing of cash receipts for the related license agreements, and the timing of payment of current and prior period royalties and contingent legal fees payable to inventor and outside attorneys, respectively.

All of accounts receivable from licensees at December 31, 2017 were collected in the first quarter of 2018, in accordance with the terms of the related underlying license agreements. The majority of royalties and contingent legal fees payable are scheduled to be paid in the first and second quarter of 2018 in accordance with the underlying contractual arrangements.

Off-Balance Sheet Arrangements

We have not entered into off-balance sheet financing arrangements, other than operating leases.

Contractual Obligations

We have no significant commitments for capital expenditures in 2018. We have no committed lines of credit or other committed funding or long-term debt. The following table lists our material known future cash commitments as of December 31, 2017, and any material known commitments arising from events subsequent to year end:



	Payments Due by Period (In thousands)
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years

Operating leases, net of guaranteed sublease income	$	2,598	$	1,213	$	1,385	$	—	$	—
Total contractual obligations	$	2,598	$	1,213	$	1,385	$	—	$	—

Uncertain Tax Positions. At December 31, 2017, we had total unrecognized tax benefits of approximately $1.4 million, including a recorded noncurrent liability of $85,000 related to unrecognized tax benefits primarily associated with state

taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2017. If recognized, approximately $1.4 million would impact our effective tax rate. We do not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months.

Recent Accounting Pronouncements

Refer to Note 2 to our notes to consolidated financial statements included elsewhere herein.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The primary objective of our short-term investment activities is to preserve principal while concurrently maximizing the income we receive from our short-term investments without significantly increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity markets, with respect to market risk, may cause the principal amount or market value of the short-term investments to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.

Short-term investment balances were zero at December 31, 2017. At December 31, 2016, our short-term investments were comprised of AAA rated money market funds that invest in first-tier only securities, which primarily include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying consolidated balance sheets), and direct investments in highly liquid, AAA, U.S. government securities (included in short-term investments in the accompanying consolidated balance sheets).

In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100 basis point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected to have a material impact on the value of such money market funds. Investments in U.S. government fixed income securities are subject to interest rate risk and will decline in value if interest rates increase. However, due to the relatively short duration of our short-term investment portfolio, an immediate 10% change in interest rates would have no material impact on our financial condition, results of operations or cash flows. Declines in interest rates over time will, however, reduce our interest income.

Investment Risk. We are exposed to investment risks related to changes in the underlying financial condition of certain of our partnerships with high-growth and potentially disruptive technology companies, and our related equity investments in these companies. The fair value of these investments can be significantly impacted by the risk of adverse changes in securities markets generally, as well as risks related to the performance of the companies whose securities we have invested in, risks associated with specific industries, and other factors. These investments are subject to significant fluctuations in fair value due to the volatility of the securities markets and of the underlying businesses. As of December 31, 2017, the carrying value of our common stock and warrants in public and private companies was $107.0 million. We record our common stock and warrant investments in publicly traded companies at fair value, which is subject to market price volatility, and represents $104.8 million of our non-current investments as of December 31, 2017. A hypothetical 10% adverse change in the market price of Veritone's publicly traded common stock would have resulted in a decrease of approximately $11.1 million in the fair value of our equity and equity warrant investments in Veritone. We evaluate our equity and equity warrant investments in private companies for impairment when events and circumstances indicate that the decline in fair value of such assets below the carrying value is other-than temporary. Our analysis includes a review of recent operating results and trends, recent sales/acquisitions of the investee securities, and other publicly available data. The current global economic climate provides additional uncertainty. Valuations of private companies are inherently more complex due to the lack of readily available market data. As such, we believe that market sensitivities are not practicable for our private company equity investments.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and related financial information required to be filed hereunder are indexed under Item 15 of this report and are incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

(a) Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2017, our disclosure controls and procedures were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time periods prescribed by the SEC.

(b) Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the 2013 framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control - Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2017.

Grant Thornton LLP, the independent registered public accounting firm who audited our consolidated financial statements included in this Annual Report on Form 10-K, has issued an attestation report on the effectiveness of our internal control over financial reporting as of December 31, 2017, which is included herein.

Changes in Internal Controls. There were no changes in our internal control over financial reporting during the fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls. Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

ITEM 9B. OTHER INFORMATION

None

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Except as provided below, in accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2018 annual meeting of stockholders to be filed with the SEC no later than April 30, 2018.

Code of Conduct.

We have adopted a Code of Conduct that applies to all employees, including our chief executive officer, chief financial and accounting officer, president and any persons performing similar functions. Our Code of Conduct is provided on our internet website at www.acaciaresearch.com.

ITEM 11. EXECUTIVE COMPENSATION

In accordance with General Instruction G(3) to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2018 annual meeting of stockholders to be filed with the SEC no later than April 30, 2018.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

In accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2018 annual meeting of stockholders to be filed with the SEC no later than April 30, 2018.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES



(a)	The following documents are filed as part of this report.



(1) Financial Statements		Page

Acacia Research Corporation Consolidated Financial Statements
Reports of Independent Registered Public Accounting Firm		F- 1
Consolidated Balance Sheets as of December 31, 2017 and 2016		F- 3
Consolidated Statements of Operations for the Years Ended December 31, 2017, 2016 and 2015		F- 4
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2017, 2016 and 2015		F- 5
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2017, 2016 and 2015		F- 6
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015		F- 7
Notes to Consolidated Financial Statements		F- 8

(2) Financial Statement Schedules

Financial statement schedules are omitted because they are not applicable or the required information is shown in the Financial Statements or the Notes thereto.

(3) Exhibits

Refer to Item 15(b) below.



(b)	Exhibits. The following exhibits are either filed herewith or incorporated herein by reference:



Exhibit Number	Description

2.1	Agreement and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.(15)
3.1	Amended and Restated Certificate of Incorporation (1)
3.2	Amended and Restated Bylaws (20)
4.1	Tax Benefits Preservation Plan, dated as of March 16, 2016, by and between Acacia Research Corporation and Computershare Inc., as Rights Agent, which includes the form of Certificate of Designation of Series A Cumulative Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Terms as Exhibit C (23)
10.1*	Acacia Research Corporation 1996 Stock Option Plan, as amended (2)
10.2*	Form of Option Agreement constituting the Acacia Research Corporation 1996 Executive Stock Bonus Plan (3)
10.3*	2002 Acacia Technologies Stock Incentive Plan (4)
10.4*	2007 Acacia Technologies Stock Incentive Plan (5)
10.5*	Form of Acacia Technologies Stock Option Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.6*	Form of Acacia Technologies Stock Issuance Agreement under the 2002 Acacia Technologies Stock Incentive Plan (6)
10.7*	Form of Acacia Technologies Stock Issuance Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)



10.8	Office Space Lease dated January 28, 2002, between Acacia Research Corporation and The Irvine Company (7)
10.9	Form of Indemnification Agreement (8)
10.10	Third Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (9)
10.11*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Edward Treska (19)
10.12	Fourth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.13	Fifth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.15*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Robert L. Harris (19)
10.16*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Clayton J. Haynes (19)
10.17*	Acacia Research Corporation Amended and Restated Executive Severance Policy (12)
10.18	Sixth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (14)
10.19	Form of Purchase Agreement (16)
10.20*	2013 Acacia Research Corporation Stock Incentive Plan (17)
10.21*	Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan (18)
10.22*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Matthew Vella (19)
10.23*	2016 Acacia Research Corporation Stock Incentive Plan (21)
10.24*	Form of Stock Option Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan (24)
10.25*	Form of Stock Issuance Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan (24)
10.26*	Director Service Agreement, dated February 29, 2016, by and between Acacia Research Corporation and Robert L. Harris (22)
10.27*	Employment Agreement, dated September 18, 2017, by and between Acacia Research Group LLC and Robert Stewart (25)
10.28*	Form of Profits Interest Agreement Under AIP Operation LLC Profits Interest Plan (26)
10.29	Investment Agreement dated August 15, 2016, by and between Acacia Research Corporation and Veritone, Inc. (27)
10.30	Secured Promissory Note dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation (27)
10.31	Primary Common Stock Purchase Warrant dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation, together with form of 10% Warrant to Purchase Common Stock (27)
10.32	Common Stock Purchase Warrant dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation (27)
10.33	Common Stock Purchase Warrant dated November 25, 2016, issued by Veritone, Inc. to Acacia Research Corporation (27)
10.34	Common Stock Purchase Warrant dated November 25, 2016, issued by Veritone, Inc. to Acacia Research Corporation (27)
21.1	List of Subsidiaries
23.1	Consent of Independent Registered Public Accounting Firm
24.1	Power of Attorney (included in the signature page hereto).
31.1†	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2†	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

___________________________


*	The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.

†

The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Acacia Research Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language contained in any filing.


(1)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on June 5, 2008 (File No. 000-26068).


(2)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 20, 2000 (File No. 000-26068).


(3)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 26, 1996 (File No. 000-26068).


(4)	Incorporated by reference to Annex E to the Proxy Statement/Prospectus which formed part of Acacia Research Corporation’s Registration Statement on Form S-4 (File No. 333-87654) which became effective on November 8, 2002.


(5)	Incorporated by reference to Acacia Research Corporation’s Registration Statement on Form S-8 (File No. 333-144754) which became effective on July 20, 2007.


(6)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2007, filed on November 2, 2007 (File No. 000-26068).


(7)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10‑K for the year ended December 31, 2001, filed on March 27, 2002 (File No. 000‑26068).


(8)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed on July 30, 2012 (File No. 000-26068).


(9)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed on May 10, 2006 (File No. 000‑26068).


(10)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, filed on March 14, 2008 (File No. 000-26068).


(11)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on April 2, 2008 (File No. 000-26068).


(12)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No. 000-26068).


(13)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2009, filed on February 26, 2010, as amended on March 1, 2010 (File No. 000-26068).


(14)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 28, 2011, as amended on March 24, 2011 (File No. 000-26068).


(15)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material has been separately filed with the Securities and Exchange Commission.


(16)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).


(17)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).


(18)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on May 22, 2013 (File No. 000-26068).


(19)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2015, filed on November 9, 2015 (File No. 000-26068).


(20)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 28, 2016 (File No. 001-37721).


(21)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2016, filed on August 9, 2016 (File No. 001-37721).


(22)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 4, 2016 (File No. 000-26068).


(23)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 21, 2016 (File No. 000-26068).


(24)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2016, filed on March 10, 2017 (File No. 001-37721).


(25)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2017, filed on November 7, 2017 (File No. 001-37721).


(26)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2017, filed on May 10, 2017 (File No. 001-37721).


(27)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 16, 2017 (File No. 001-37721).

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



			ACACIA RESEARCH CORPORATION

Dated:	March 7, 2018	By:	/s/ Robert Stewart
			Robert Stewart
			President (Authorized Signatory)

POWER OF ATTORNEY

We, the undersigned directors and officers of Acacia Research Corporation, do hereby constitute and appoint Robert Stewart and Clayton J. Haynes, and each of them, as our true and lawful attorneys-in-fact and agents with power of substitution, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorney-in-fact and agent may deem necessary or advisable to enable said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with this Annual Report on Form 10-K, including specifically but without limitation, power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments hereto; and we do hereby ratify and confirm all that said attorney-in-fact and agent, shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and the capacities and on the dates indicated.



Signature		Title	Date

/s/	Robert Stewart	President	March 7, 2018
	Robert Stewart	(Principal Executive Officer)

/s/	Clayton J. Haynes	Chief Financial Officer and Treasurer	March 7, 2018
	Clayton J. Haynes	(Principal Financial and Accounting Officer)

/s/	Fred A. de Boom	Director	March 7, 2018
	Fred A. de Boom

/s/	Edward W. Frykman	Director	March 7, 2018
	Edward W. Frykman

/s/	G. Louis Graziadio, III	Executive Chairman and Director	March 7, 2018
	G. Louis Graziadio, III

/s/	William S. Anderson	Director	March 7, 2018
	William S. Anderson

/s/	Frank E. Walsh, III	Director	March 7, 2018
	Frank E. Walsh, III

/s/	James F. Sanders	Director	March 7, 2018
	James F. Sanders

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

Opinion on the financial statements

We have audited the accompanying consolidated balance sheets of Acacia Research Corporation (the “Company”) as of December 31, 2017 and 2016, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2017, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2017, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated March 7, 2018 expressed an unqualified opinion.

Basis for opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ GRANT THORNTON LLP

We have served as the Company’s auditor since 2007.

Newport Beach, California

March 7, 2018

F- 1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

Opinion on internal control over financial reporting

We have audited the internal control over financial reporting of Acacia Research Corporation (the “Company”) as of December 31, 2017, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in the 2013 Internal Control-Integrated Framework issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated financial statements of the Company as of and for the year ended December 31, 2017, and our report dated March 7, 2018 expressed an unqualified opinion on those financial statements.

Basis for opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting (“Management’s Report”). Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and limitations of internal control over financial reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ GRANT THORNTON LLP

Newport Beach, California

March 7, 2018

F- 2

ACACIA RESEARCH CORPORATION

CONSOLIDATED BALANCE SHEETS

As of December 31, 2017 and 2016

(In thousands, except share and per share information)



	2017			2016
ASSETS
Current assets:
Cash and cash equivalents	$	136,604		$	127,540
Restricted cash	—			11,512
Short-term investments	—			19,443
Accounts receivable	153			26,750
Prepaid expenses and other current assets	2,938			3,245
Total current assets	139,695			188,490
Investment at fair value⁽¹⁾	104,754			—
Investment - equity method⁽¹⁾	2,195			—
Loan receivable and accrued interest⁽¹⁾	—			18,616
Investment in warrants and shares⁽¹⁾	—			1,960
Patents, net of accumulated amortization	61,917			86,319
Other non-current assets	207			618
	$	308,768		$	296,003
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	7,956		$	14,283
Royalties and contingent legal fees payable	1,601			13,908
Total current liabilities	9,557			28,191
Other liabilities	3,552			369
Total liabilities	13,109			28,560
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	—			—
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,639,926 shares issued and outstanding as of December 31, 2017 and 50,476,042 shares issued and outstanding as of December 31, 2016	51			50
Treasury stock, at cost, 1,729,408 shares as of December 31, 2017 and 2016	(34,640		)	(34,640		)
Additional paid-in capital	648,996			642,453
Accumulated comprehensive loss	(88		)	(76		)
Accumulated deficit	(320,018		)	(342,198		)
Total Acacia Research Corporation stockholders’ equity	294,301			265,589
Noncontrolling interests in operating subsidiaries	1,358			1,854
Total stockholders’ equity	295,659			267,443
	$	308,768		$	296,003

⁽¹⁾Refer to Note 7 for additional information.

The accompanying notes are an integral part of these consolidated financial statements.

F- 3

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2017, 2016 and 2015

(In thousands, except share and per share information)



	2017			2016			2015

Revenues	$	65,402		$	152,699		$	125,037
Operating costs and expenses:
Cost of revenues:
Inventor royalties	4,952			22,730			18,462
Contingent legal fees	16,682			26,474			16,169
Litigation and licensing expenses - patents	18,219			27,858			39,373
Amortization of patents	22,154			34,208			53,067
General and administrative expenses (including non-cash stock compensation expense of $8,885 in 2017, $9,062 in 2016 and $11,048 in 2015)	26,030			32,919			38,176
Other expenses - business development	1,189			3,079			3,391
Impairment of patent-related intangible assets	2,248			42,340			74,731
Impairment of goodwill	—			—			30,149
Other	1,200			500			4,141
Total operating costs and expenses	92,674			190,108			277,659
Operating loss	(27,272		)	(37,409		)	(152,622		)
Other income (expense):
Gain on conversion of loans and accrued interest⁽¹⁾	2,671			—			—
Gain on exercise of Primary Warrant⁽¹⁾	4,616			—			—
Change in fair value of investment, net⁽¹⁾	42,239			—			—
Equity in losses of investee⁽¹⁾	(220		)	—			—
Other income	1,000			—			—
Interest income	1,605			798			(56		)
Total other income (expense)	51,911			798			(56		)
Income (loss) from operations before provision for income taxes	24,639			(36,611		)	(152,678		)
Provision for income taxes	(2,955		)	(18,188		)	(4,800		)
Net income (loss) including noncontrolling interests in subsidiaries	21,684			(54,799		)	(157,478		)
Net (income) loss attributable to noncontrolling interests in subsidiaries	496			732			(2,558		)
Net income (loss) attributable to Acacia Research Corporation	$	22,180		$	(54,067	)	$	(160,036	)
Net income (loss) attributable to common stockholders - basic and diluted	$	22,147		$	(54,067	)	$	(160,730	)
Basic and diluted income (loss) per common share	$	0.44		$	(1.08	)	$	(3.25	)
Weighted-average number of shares outstanding, basic	50,495,119			50,075,847			49,505,817
Weighted-average number of shares outstanding, diluted	50,692,012			50,075,847			49,505,817
Cash dividends declared per common share	$	—		$	—		$	0.50

⁽¹⁾Refer to Note 7 for additional information.

The accompanying notes are an integral part of these consolidated financial statements.

F- 4

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

For the Years Ended December 31, 2017, 2016 and 2015

(In thousands)



	2017			2016			2015
Net income (loss) including noncontrolling interests in subsidiaries	$	21,684		$	(54,799	)	$	(157,478	)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term investments, net of tax of $0	(40		)	40			(356		)
Unrealized gain (loss) on foreign currency translation, net of tax of $0	58			77			(123		)
Add: reclassification adjustment for (gains) losses included in net income (loss)	(30		)	22			617
Total other comprehensive income (loss)	21,672			(54,660		)	(157,340		)
Comprehensive income (loss) attributable to noncontrolling interests	496			732			(2,558		)
Comprehensive income (loss) attributable to Acacia Research Corporation	$	22,168		$	(53,928	)	$	(159,898	)

The accompanying notes are an integral part of these consolidated financial statements.

F- 5

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Years Ended December 31, 2017, 2016 and 2015

(In thousands, except share information)



	Common Shares		Common Stock			Treasury Stock			Additional Paid-in Capital			Accumulated Comprehensive Income (Loss)			Accumulated Deficit			Noncontrolling Interests in Operating Subsidiaries			Total

Balance at December 31, 2014	50,065,382		$	50		$	(34,640	)	$	646,595		$	(353	)	$	(128,095	)	$	5,491		$	489,048
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(160,036		)	—			(160,036		)
Dividends paid to stockholders	—		—			—			(25,434		)	—			—			—			(25,434		)
Stock options exercised	135,000		—			—			938			—			—			—			938
Compensation expense for share-based awards, net of forfeitures	450,857		1			—			11,047			—			—			—			11,048
Net income attributable to noncontrolling interests in subsidiaries	—		—			—			—			—			—			2,558			2,558
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(4,105		)	(4,105		)
Unrealized loss on foreign currency translation	—		—			—			—			(123		)	—			—			(123		)
Unrealized gain on short-term investments	—		—			—			—			261			—			—			261
Balance at December 31, 2015	50,651,239		51			(34,640		)	633,146			(215		)	(288,131		)	3,944			314,155
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(54,067		)	—			(54,067		)
Stock options exercised	100,992		—			—			326			—			—			—			326
Compensation expense for share-based awards, net of forfeitures	(262,660	)	(1		)	—			9,063			—			—			—			9,062
Repurchase of restricted common stock	(13,529	)	—			—			(82		)	—			—			—			(82		)
Net loss attributable to noncontrolling interests in subsidiaries	—		—			—			—			—			—			(732		)	(732		)
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(1,358		)	(1,358		)
Unrealized gain on short-term investments	—		—			—			—			40			—			—			40
Unrealized gain on foreign currency translation	—		—			—			—			99			—			—			99
Balance at December 31, 2016	50,476,042		50			(34,640		)	642,453			(76		)	(342,198		)	1,854			267,443
Net income attributable to Acacia Research Corporation	—		—			—			—			—			22,180			—			22,180
Stock options exercised	207,863		1			—			744			—			—			—			745
Compensation expense for share-based awards, net of forfeitures	(35,310	)	—			—			5,844			—			—			—			5,844
Repurchase of restricted common stock	(8,669	)	—			—			(45		)	—			—			—			(45		)
Net loss attributable to noncontrolling interests in subsidiaries	—		—			—			—			—			—			(496		)	(496		)
Unrealized gain on foreign currency translation	—		—			—			—			28			—			—			28
Unrealized loss on short-term investments	—		—			—			—			(40		)	—			—			(40		)
Balance at December 31, 2017	50,639,926		$	51		$	(34,640	)	$	648,996		$	(88	)	$	(320,018	)	$	1,358		$	295,659

The accompanying notes are an integral part of these consolidated financial statements.

F- 6

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2017, 2016 and 2015

(In thousands)



	2017			2016			2015

Cash flows from operating activities:
Net income (loss) including noncontrolling interests in subsidiaries	$	21,684		$	(54,799	)	$	(157,478	)
Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:
Gain on conversion of loans and accrued interest	(2,671		)	—			—
Gain on exercise of Primary Warrant	(4,616		)	—			—
Change in fair value of investment, net	(42,239		)	—			—
Depreciation and amortization	22,243			34,355			53,289
Non-cash stock compensation	8,885			9,062			11,048
Impairment of patent-related intangible assets	2,248			42,340			74,731
Impairment of goodwill	—			—			30,149
Other	(374		)	(477		)	(109		)
Changes in assets and liabilities:
Restricted cash	11,512			(787		)	(10,725		)
Accounts receivable	26,597			6,750			(13,332		)
Prepaid expenses and other assets	(135		)	1,593			(619		)
Accounts payable and accrued expenses / patent costs	(6,349		)	(3,006		)	2,570
Royalties and contingent legal fees payable	(12,307		)	(970		)	527
Net cash provided by (used in) operating activities	24,478			34,061			(9,949		)
Cash flows from investing activities:
Investment in Investees	(31,514		)	—			—
Advances to Investee (Note 7)	(4,000		)	(20,000		)	—
Purchases of property and equipment	(2		)	(4		)	(8		)
Purchases of short-term investments	(448,388		)	(62,633		)	(23,296		)
Sales and maturities of short-term investments	467,790			43,232			82,115
Patent portfolio investment costs	—			(1,225		)	(19,504		)
Net cash provided by (used in) investing activities	(16,114		)	(40,630		)	39,307
Cash flows from financing activities:
Dividends paid to stockholders	—			—			(25,434		)
Distributions to noncontrolling interests in operating subsidiary	—			(1,358		)	(4,105		)
Proceeds from the exercise of stock options	745			326			938
Repurchases of restricted common stock	(45		)	(82		)	—
Net cash provided by (used in) financing activities	700			(1,114		)	(28,601		)
Increase (decrease) in cash and cash equivalents	9,064			(7,683		)	757
Cash and cash equivalents, beginning	127,540			135,223			134,466
Cash and cash equivalents, ending	$	136,604		$	127,540		$	135,223
Supplemental schedule of noncash investing activities:
Patent portfolio investment costs included in accrued expenses / costs	$	—		$	—		$	1,000

The accompanying notes are an integral part of these consolidated financial statements.

F- 7

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into IP related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the intellectual property (“IP”) industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia’s primary licensing and enforcement business.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia’s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.

During fiscal year 2017 Acacia obtained control of one new patent portfolio. In fiscal year 2016, Acacia obtained control of two new patent portfolios, compared to three new patent portfolios, and six new patent portfolios in fiscal years 2015 and 2014, respectively.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End. The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP).

Principles of Consolidation. The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund.

F- 8

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology owned by Acacia’s operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues. Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of

F- 9

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:


(i)	Level 1 - Observable Inputs: Quoted prices in active markets for identical investments;


(ii)	Level 2 - Pricing Models with Significant Observable Inputs: Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and


(iii)	Level 3 - Unobservable Inputs: Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. At December 31, 2017, all of the Company’s investments recorded at fair value were valued utilizing Level 3 - unobservable inputs. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):



	Level 1		Level 2		Level 3
Assets as of December 31, 2017:
Investment at fair value (Note 7)⁽¹⁾	$	—	$	—	$	104,754

Assets as of December 31, 2016:
Short-term investments⁽¹⁾	$	19,443	$	—	$	—

____________________

⁽¹⁾There were no transfers between fair value hierarchy categories for the period presented.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended December 31, 2017 is as follows (in thousands):



	Investment at Fair Value
	Common Stock		Warrants		Total
Opening balance as of January 1, 2017	$	—	$	—	$	—
Total gains and losses included in earnings for the period⁽¹⁾
Gain on conversion of loans and accrued interest	2,671		—		2,671
Gain on exercise of Primary Warrant	—		4,616		4,616
Change in fair value of investment, net	33,922		8,317		42,239
Purchases, issues, sales and settlements
Purchases and issues⁽²⁾	54,202		1,026		55,228
Total recurring fair value measurements⁽¹⁾	$	90,795	$	13,959	$	104,754

____________________

⁽¹⁾All gains and losses included in earnings for the period presented relate to assets and liabilities held as of December 31, 2017.

⁽²⁾ Refer to Note 7 for information regarding purchase and issues activity for the years ended December 31, 2017 and 2016.

Cash and Cash Equivalents. Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised

F- 10

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Short-term Investments. Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Impairment of Short-term Investments. Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks. Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 54%, 21% and 10%, respectively, of revenues recognized during the year ended December 31, 2017. Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. One licensee individually represented 100% of accounts receivable at December 31, 2017. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016.

For 2017, 2016 and 2015, 39%, 79% and 49%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Fair Value of Financial Instruments. The carrying value of cash and cash equivalents, accounts receivables, and current liabilities approximates their fair values due to their short-term maturities.

F- 11

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Property and Equipment. Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:



Furniture and fixtures	3 to 5 years
Computer hardware and software	3 to 5 years
Leasehold improvements	2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents. Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).

Equity Method Investments. Equity investments without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting, and classified within “Equity Method Investments” in the consolidated balance sheet. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the consolidated statements of operations.

Impairment of Investments. Acacia reviews its equity method investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of

F- 12

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.

Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position.

Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate.

The FASB issued a new standard, effective January 1, 2017, that allows entities to make a policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. Effective January 1, 2017, the Company elected to account for forfeitures of awards as they occur. The prior standard required the Company to estimate the number of awards for which the requisite service period is expected to be rendered and base the accruals of compensation cost on the estimated number of awards that will vest.

The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:



	For the Years Ended
	December 31, 2017	December 31, 2016

Risk-free interest rate	1.77%	1.1%
Term	4.37	3.06
Volatility	51%	53%
Dividend yield	—%	—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the periods presented. Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the

F- 13

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 10, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying consolidated statements of operations.

Income Taxes. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

Segment Reporting. Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates. The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note 7, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share. The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of

F- 14

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:



	2017			2016			2015
Numerator (in thousands):
Basic and Diluted
Net income (loss) attributable to Acacia Research Corporation	$	22,180		$	(54,067	)	$	(160,036	)
Undistributed earnings allocated to participating securities	(33		)	—			—
Total dividends declared / paid	—			—			(25,434		)
Dividends attributable to common stockholders	—			—			24,740
Net income (loss) attributable to common stockholders – basic and diluted	$	22,147		$	(54,067	)	$	(160,730	)

Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders – basic	50,495,119			50,075,847			49,505,817
Effect of potentially dilutive securities:
Common stock options and restricted stock units	196,893			—			—
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted	50,692,012			50,075,847			49,505,817
Basic and diluted net loss per common share	$	0.44		$	(1.08	)	$	(3.25	)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share	4,425,187			3,682,532			71,468

Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company may be required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under existing guidance. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales or usage based royalties. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its intellectual property is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The amendments for this new accounting standard update are effective for interim and annual reporting periods beginning after December 15, 2017, and are to be applied retrospectively or via the cumulative effect as of the date of adoption,

F- 15

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

with early application not permitted. The Company expects to use the modified retrospective method of adoption and will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings in the period of initial application (first quarter of 2018 for Acacia). Comparative prior year periods would not be adjusted. The preliminary estimate of the cumulative effect of initially applying the new revenue standard is an decrease to beginning accumulated deficit of $3.0 million, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods. Management continues to assess the impact of this new standard on the Company’s consolidated financial statements and related disclosures, including ongoing contract reviews. Preliminary estimates of the adjustment upon initial adoption may change in connection with completion of the Company’s adoption procedures in the first quarter of 2018.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017, with early adoption

permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Recently Adopted.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

3. SHORT-TERM INVESTMENTS

Short-term investments for the periods presented were comprised of the following (in thousands):



	December 31, 2016
Security Type	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
U.S. government fixed income securities	$	19,403	$	40	$	—	$	19,443

There were no short-term investments at December 31, 2017. Short-term investments at December 31, 2016 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2017.

For the years ended December 31, 2017 and 2016, proceeds from the sale of short-term investments classified as available-for-sale were $467,790,000 and $43,232,000, respectively. Gross unrealized gains and losses were not material for the years ended December 31, 2017 and 2016. For the year ended December 31, 2015, proceeds from the sale of short-term investments were $82,115,000 and gross realized losses were $617,000.

F- 16

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

4. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2017 and 2016 (in thousands):



	2017		2016

Payroll and other employee benefits	$	465	$	1,593
Accrued vacation	294		533
Accrued legal expenses - patent	5,479		6,564
Foreign taxes payable	15		3,150
Accrued consulting and other professional fees	1,364		1,967
Other accrued liabilities	339		476
	$	7,956	$	14,283

5. PATENTS

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to six years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2017 and 2016 are as follows (in thousands):



	2017			2016

Gross carrying amount - patents	$	444,137		$	444,362
Accumulated amortization - patents⁽¹⁾	(382,220		)	(358,043		)
Patents, net	$	61,917		$	86,319

⁽¹⁾ Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 4 years. Scheduled annual aggregate amortization expense is estimated to be $20,542,000 in 2018, $18,527,000 in 2019, $6,134,000 in 2020, $5,261,000 in 2021, $5,256,000 in 2022 and $6,197,000 thereafter.

For the years ended December 31, 2017, 2016 and 2015, Acacia paid patent investment costs totaling $0, $1,225,000 and $19,504,000, respectively. The patents have initial estimated economic useful lives ranging from two to seven years.

Acacia recorded impairment of patent-related intangible asset charges totaling $2,248,000, $42,340,000 and $74,731,000 for the years ended December 31, 2017, 2016 and 2015, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment charges for the periods presented consisted of the excess of the asset’s carrying value over its estimated fair value.

In December 2015, Acacia’s subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to partial impairment charges on the portfolio in the fourth quarter of 2015. Fiscal year 2016 patent impairment charges included the impairment of the remaining carrying value for the Adapitx portfolio. In addition, for the year ended December 31, 2015 analysis, management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company’s assessment of probabilities of realization given the recent adverse trial outcomes. Additionally, patent impairment charges include the carrying value of other patent portfolios for which, in 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate

F- 17

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.

6. GOODWILL IMPAIRMENT CHARGE (Fiscal Year 2015)

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company’s single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the Company’s stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for the Company’s overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

In connection with Acacia’s annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:

•

Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Significant consistent gradual decline in the Company’s stock price. Historically, the Company’s stock price had been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company’s stock price volatility has continued, trending downward. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company’s stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.

At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:

•

At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company’s stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company’s assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company’s stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its

F- 18

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

estimate of fair value for the Company’s single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company’s reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company’s single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

7. INVESTMENTS

Investment at Fair Value

Veritone Investment Agreement. On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provided for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permitted Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the consolidated statements of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”). On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year $700,000 warrants to purchase shares of Veritone’s common stock at an exercise price of $13.6088 per share. Veritone’s initial public offering date was May 12, 2017. Upon Veritone’s consummation of its public offering of its common stock on May 17, 2017 (“IPO”), all outstanding principal and accrued interest under the Veritone Loans, totaling $20.7 million, automatically converted into 1,523,746 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.

In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of $13.6088 per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone’s IPO, resulting in the purchase by Acacia of an additional 2,150,335 shares of Veritone common stock, at an aggregate purchase price of $29.3 million. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional 809,400 shares of Veritone common stock at an exercise price of $13.6088 per share, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.

Veritone Bridge Loan. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the “Veritone Bridge Loan”), which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, Acacia funded the initial $1.0 million advance (the “First Bridge Loan”). On April 14, 2017, Acacia funded the second $1.0 million advance (the “Second Bridge Loan”). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of $4.0 million and $21,000, respectively, automatically converted into 295,440 shares of Veritone’s common stock at a conversion price of $13.6088 per share.

In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) 60,000 shares of Veritone common stock (“Upfront Shares”), (ii) 90,000 shares of Veritone common stock (the “Bridge Installment Shares”), and (iii) 10-year warrants to purchase up to 157,000 shares of Veritone common stock with other terms and conditions similar to the warrants described above.

F- 19

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017. The Veritone common shares are subject to a lock-up agreement that expires on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of December 31, 2017.

Accounting Prior to Veritone IPO. Prior to conversion, Acacia’s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the “Loans”) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (“Veritone Shares”) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO.

Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone’s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from 40% to 50%, (2) financing probabilities ranging from 25% to 75%, (3) marketability discount of 7% and (4) 100% investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the consolidated statements of operations. As of May 2017, the unamortized loan discount totaled $1.7 million. Interest income for the year ended December 31, 2017 was $1.1 million, including accretion of the loan discount of $630,000. The effective yield on the Loans for the year ended December 31, 2017 ranged from 9% to 53%.

Accounting Subsequent to Veritone IPO. Upon Veritone’s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a 20% ownership interest in Veritone (excluding warrants). Based on Acacia’s representation on the Veritone board of directors and Acacia’s 20% ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of December 31, 2017, Acacia’s ownership interest in Veritone, on a fully-diluted basis, was approximately 23%.

Acacia’s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone’s common stock on The NASDAQ Global Market (the “NASDAQ”) on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (“DLOM”) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia’s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at December 31, 2017: risk-free interest rates ranging from 1.94% to 2.37%; expected terms ranging from three to nine years; volatilities ranging from 45% to 55%; and a dividend yield of zero. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:



	Veritone Common Stock		Veritone Warrants
	IPO Date	December 31, 2017	IPO Date	December 31, 2017
Estimated DLOM applied	5.7%	5%	5.7%	10%
Volatility assumptions	35%	37%	35%	72	%	-	87%
Term assumptions	6 months	2 months	6 months	5 months

At December 31, 2017, the fair value of the 4,119,521 shares of Veritone common stock owned by Acacia totaled $90,795,000. At December 31, 2017, the fair value of the 1,120,432 common stock purchase warrants held by Acacia totaled $13,959,000. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 10% decrease in the fair value of our investment in Veritone at December 31, 2017, and a corresponding decrease in the net investment gain reflected in the consolidated statements of operations for the year ended December 31, 2017.

F- 20

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Changes in the fair value of Acacia’s investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the period from the IPO on May 17, 2017 to December 31, 2017, the accompanying consolidated statements of operations reflected the following (in thousands):



	2017
Gain on conversion of loans and accrued interest⁽¹⁾	$	2,671
Gain on exercise of warrant⁽²⁾	4,616
Change in fair value of investment, warrants	8,317
Change in fair value of investment, common stock	33,922
Net unrealized gain on investment at fair value	$	49,526

__________________________

⁽¹⁾ Pre-conversion difference between carrying value of Loan and accrued interest and the estimated fair value of common stock discounted for lack of marketability.

⁽²⁾Pre-conversion difference between carrying value of Primary Warrant and the estimated fair value of common stock and 10% Warrant discounted for lack of marketability.

Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):



	Nine Months Ended September 30, 2017
	(Unaudited)
Revenues	$	10,914
Gross profit	10,090
Operating expenses	44,024
Other income (expense), net	(12,872		)
Net loss attributable to common stockholders	(51,281		)
Net loss per share attributable to common stockholders - basic and diluted	$	(5.94	)



	September 30, 2017
Current assets	$	78,509
Noncurrent assets	1,173
Total Assets	$	79,682

Current liabilities	$	31,836
Noncurrent liabilities	14
Total liabilities	31,850
Preferred stock	—
Total stockholders’ equity (deficit)	47,832
Total liabilities, preferred stock and stockholders’ equity	$	79,682

Equity Method Investment

In June 2017, Acacia made an investment in Miso Robotics, Inc. (“Miso Robotics”), an innovative leader in robotics and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Miso Robotics, and one board seat. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry. In addition, Acacia also entered into an intellectual property services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the entire restaurant industry. Based on Acacia’s representation on the Miso Robotics board of directors, and greater than 20% ownership interest in Miso Robotics, the equity method of accounting was applied. The fair value option was not elected for Acacia’s investment in

F- 21

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Miso Robotics due to the lack of a readily determinable fair market value. For the year ended December 31, 2017, equity in losses of investee related to Miso Robotics totaled $220,000.

8. STOCKHOLDERS’ EQUITY

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 in 2015. On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

Tax Benefits Preservation Plan. On March 15, 2016, Acacia’s Board of Directors announced that it unanimously approved the adoption of a Tax Benefits Preservation Plan (the “Plan”). The purpose of the Plan is to protect the Company’s ability to utilize potential tax assets, such as net operating loss carryforwards (“NOLs”) and tax credits to offset potential future taxable income.

The Plan is designed to reduce the likelihood that the Company will experience an ownership change by discouraging any (i) person or group from acquiring beneficial ownership of 4.9% or more of the Company’s outstanding common stock and (ii) any existing shareholders who, as of the time of the first public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company’s then-outstanding shares of the Company’s common stock from acquiring additional shares of the Company’s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.

In connection with the adoption of the Plan, Acacia’s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company’s common stock to shareholders of record at the close of business on March 16, 2016. On or after the distribution date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company’s Series A Junior Participating Preferred Stock, $0.001 par value for a purchase price of $15.00.

9. INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):



	2017		2016		2015

Current:
Federal	$	—	$	—	$	—
State	90		262		379
Foreign	2,865		17,926		4,421
Total current	2,955		18,188		4,800
Deferred:
Federal	—		—		—
State	—		—		—
Total deferred	—		—		—
Provision for income taxes	$	2,955	$	18,188	$	4,800

F- 22

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2017 and 2016 (in thousands):



	2017			2016

Deferred tax assets:
Net operating loss and capital loss carryforwards and credits	$	90,871		$	83,323
Stock compensation	2,635			2,416
Fixed assets and intangibles	6,197			14,343
Basis of investments in affiliates	984			2,195
Accrued liabilities and other	167			422
State taxes	35			90
Total deferred tax assets	100,889			102,789
Valuation allowance	(90,278		)	(102,627		)
Total deferred tax assets, net of valuation allowance	10,611			162
Deferred tax liabilities:
Unrealized gain on investments held at fair value	(10,587		)	—
Other	(24		)	(162		)
Total deferred tax liabilities	(10,611		)	(162		)
Net deferred tax assets (liabilities)	$	—		$	—

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:



	2017		2016		2015

Statutory federal tax rate - (benefit) expense	35	%	(35	)%	(35	)%
State income and foreign taxes, net of federal tax effect	8	%	50	%	3	%
Foreign tax credit	—	%	(49	)%	(3	)%
Noncontrolling interests in operating subsidiaries	1	%	1	%	(1	)%
Goodwill	—	%	—	%	7	%
Nondeductible permanent items	3	%	—	%	—	%
Expired capital loss carryforwards	—	%	—	%	1	%
Change in tax rate	102	%	—	%	—	%
Valuation allowance	(137	)%	83	%	31	%
	12	%	50	%	3	%

For the periods presented, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statements of operations in the period the determination is made.

At December 31, 2017, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $180,621,000 and $17,850,000, expiring between 2026 and 2037, and 2028 and 2037, respectively. Capital loss carryovers totaled $2,804,000 at December 31, 2017, expiring in 2019 and 2020.

At December 31, 2017, approximately $26,326,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2017, Acacia had approximately $51,126,000 of foreign tax credits, expiring between 2018 and 2026. In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

F- 23

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Tax expense for the periods presented primarily reflects foreign taxes withheld on revenue agreements executed with licensees in foreign jurisdictions and other state taxes. Excluding the impact of the change in valuation allowance and the impact of the federal tax rate change under the change in tax law described below, annual effective tax rates were 47%, (33)% and (28)%, for fiscal years 2017, 2016 and 2015, respectively. Results for fiscal year 2017 included an unrealized gain on Acacia’s investment in Veritone which created a deferred tax liability totaling approximately $10,587,000. The future anticipated reversal of this deferred tax liability provides for a source of taxable income that allows for the realizability of existing deferred tax assets that have been reduced by a valuation allowance for the periods presented. The effective tax rate reflects both the recognition of the deferred tax liability and the reversal of valuation allowance

Effective January 1, 2017, the Company adopted a new standard that requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. The adoption of this standard resulted in the Company recognizing gross federal and state deferred tax assets of $21,350,000 and $1,559,000, respectively, related to the impact of share-based payments to employees in prior periods. These deferred tax assets are fully offset by a valuation allowance and were impacted by the change in tax rate described below.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2011. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2017 and 2016, the Company had total unrecognized tax benefits of approximately $808,000. No interest and penalties have been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2017, if recognized, approximately $808,000 of tax benefits, net of valuation allowance, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2017 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to 21%, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of these changes are effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.

While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we have reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately $25,261,000 in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets as of December 31, 2017, the change in tax law did not have a material impact on our consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.

F- 24

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

10. EQUITY-BASED INCENTIVE PLANS

Stock-Based Incentive Plans

The 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•

Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•

Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•

Automatic Option Grant Program. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan. At December 31, 2017, there were 660,000 shares available for grant under the 2013 Plan.

F- 25

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At December 31, 2017, there were 727,000 shares available for grant under the 2016 Plan.

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval. As of December 31, 2017, there are 7,279,000 shares of common stock reserved for issuance under the Plans.

Stock-based award grant activity for the periods presented was as follows:



	2017			2016
	Shares	Aggregate fair value (in thousands)		Shares	Aggregate fair value (in thousands)
Restricted stock awards with performance-based vesting conditions	—	$	—	138,000	$	431
Stock options with time-based service vesting conditions	1,368,000	2,930		3,434,000	5,704
Stock options with market-based vesting conditions	—	—		2,250,000	5,530
Stock options with performance-based vesting conditions	—	—		200,000	487
Total incentive awards granted	1,368,000	$	2,930	6,022,000	$	12,152

During the year ended December 31, 2016 the Company granted restricted stock awards and stock options (with weighted-average exercise price of $5.75 per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of December 31, 2017, 102,000 (net of forfeitures) shares of restricted stock with performance-based vesting conditions were outstanding and unvested. During the year ended December 31, 2017, all stock options with performance-based vesting conditions expired unvested. As of December 31, 2017, there was no unrecognized expense for awards with performance-based vesting conditions.

During the year ended December 31, 2016, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of $5.75 per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of 25% upon the Company’s achievement of 30-day average share prices ranging from $7.00 to $10.00. As of December 31, 2017, 1,687,500 options with market-based vesting conditions remain unvested. As of December 31, 2017, there was no unrecognized expense for options with market-based vesting conditions.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2017:



			Weighted-Average
	Options		Exercise Price		Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2016	5,596,000		$	4.93
Granted	1,368,000		$	5.52
Exercised	(208,000	)	$	3.57
Expired/forfeited	(926,000	)	$	4.90
Outstanding at December 31, 2017	5,830,000		$	5.13	5.8 years	$	856,000
Vested	1,959,000		$	4.84	5.8 years	$	434,000
Exercisable at December 31, 2017	1,959,000		$	4.84	5.8 years	$	434,000

F- 26

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The aggregate intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 was $296,000, $344,000, and $751,000, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2017 was $351,000. The aggregate fair value of options granted during the year ended December 31, 2017 was $2,930,000. The aggregate fair value of options vested during the year ended December 31, 2017 and 2016 was $2,009,000 and $2,342,000, respectively. No options were granted or vested during the year ended December 31, 2015. As of December 31, 2017, the total unrecognized compensation expense related to nonvested stock option awards was $3,654,000, which is expected to be recognized over a weighted-average term of approximately 2 years.

The following table summarizes nonvested restricted share activity for the year ended December 31, 2017:



	Nonvested Restricted Shares		Weighted Average Grant Date Fair Value
Nonvested restricted stock at December 31, 2016	333,000		$	8.9
Granted	—		$	—
Vested	(120,000	)	$	12.95
Canceled	(90,000	)	$	9.10
Nonvested restricted stock at December 31, 2017	123,000		$	4.77

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2016 and 2015 was $3.12 and $12.83, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2017, 2016 and 2015 was $1,560,000, $5,243,000 and $11,494,000, respectively. As of December 31, 2017, the total unrecognized compensation expense related to nonvested restricted stock awards was $53,000, which is expected to be recognized over a weighted-average period of approximately 2 months.

The following table summarizes restricted stock unit activity for the year ended December 31, 2017:



	Restricted Stock Units		Weighted Average Grant Date Fair Value
Nonvested restricted stock units outstanding at December 31, 2016	14,000		$	16.27
Vested	(12,000	)	$	16.18
Nonvested restricted stock units outstanding at December 31, 2017	2,000		$	16.72
Vested restricted stock units outstanding at December 31, 2017	60,000		$	15.38

The weighted-average grant date fair value of restricted stock units granted during the year ended December 31, 2015 was $16.72. There were no restricted units granted during the years ended December 31, 2017 and 2016. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2017, 2016 and 2015 was $200,000, $324,000 and $480,000, respectively. As of December 31, 2017, the total unrecognized compensation expense related to restricted stock unit awards was $1,000, which is expected to be recognized over a weighted-average period of approximately 1 month.

Profits Interest Plan

On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia’s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of December 31, 2017.

F- 27

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Acacia owns 60% of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As of December 31, 2017, AIP holds the Veritone 10% Warrant described at Note 7.

Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of $722,000. The fair value of the Units totaled $3,041,000 as of December 31, 2017. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.

The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (“GBM”) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note 7) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the year ended December 31, 2017, assumptions utilized in the GBM included a term of 4.4 years, stock price of $23.20, volatility of 50%, and risk free interest rates ranging from 1.76% to 2.40% for terms ranging from one to 10 years. The estimated DLOM utilized was 30%, based on assumptions including a term of approximately 4.4 years and a volatility of 85% for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately 4.4 years.

Compensation expense for the periods presented was comprised of the following:



	2017		2016		2015

Restricted stock awards with time-based service conditions	$	1,025	$	4,071	$	10,575
Restricted stock unit awards with time-based service conditions	161		320		473
Restricted stock awards with performance-based vesting conditions	121		197		—
Stock options with time-based service vesting conditions	2,165		1,316		—
Stock options with market-based vesting conditions	2,372		3,158		—
Stock options with performance-based vesting conditions	—		—		—
Profits interests units	3,041		—		—
Total compensation expense	$	8,885	$	9,062	$	11,048

11. COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2019 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):



Years ending December 31,
2018	$	1,213
2019	1,369
2020	16
Total minimum lease payments	$	2,598

Rent expense for the years ended December 31, 2017, 2016 and 2015 approximated $1,392,000, $1,795,000 and $1,926,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

F- 28

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows. Fiscal year 2017 includes estimated contingency accruals totaling $1,200,000. The estimated range of potential expenses related to these matters is $1,200,000 to $3,000,000. Fiscal year 2016 and 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $500,000 and $4,141,000, respectively.

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2017.

Bank Guarantee

In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. The Guarantee was secured by a cash deposit at the contracting bank, which was classified as restricted cash in the accompanying December 31, 2016 consolidated balance sheets, totaling $11,512,000. Upon resolution of all related matters in June 2017, the Guarantee was extinguished resulting in release of the cash collateral (and related restrictions on the cash balance) by the contracting bank. As a result, currently no amounts of Acacia’s cash and investments are restricted as to use.

Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. The Acacia IP Fund was terminated as of December 31, 2017. At December 31, 2017 and 2016, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):

F- 29

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



	2017		2016
Cash and other assets	$	986	$	1,118
Investments - noncurrent	1,905		2,933
Total assets	$	2,891	$	4,051

Accrued expenses and contributions	$	2,567	$	2,394
Net assets	$	324	$	1,657



	2017			2016
Revenues	$	—		$	16
Operating expenses	390			572
Loss from operations	(390		)	(556		)
Net loss in equity method investments	(943		)	(1,013		)
Net loss	$	(1,333	)	$	(1,569	)

12. RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

13. SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for state income taxes totaled $181,000, $223,000 and $211,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Foreign taxes withheld totaled $2,865,000, $14,776,000 and $4,421,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Refer to Note 4 for accrued foreign taxes payable.

Refer to Note 5 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 7 for information regarding noncash investing activity related to the investment in Veritone for the periods presented.

F- 30

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

14. QUARTERLY FINANCIAL DATA (unaudited)

The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2017. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.



	Quarter Ended
	Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,			Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,
	2017			2017			2017			2017			2016			2016			2016			2016
	(Unaudited, in thousands, except share and per share information)
Revenues	$	8,854		$	16,457		$	36,633		$	3,458		$	24,721		$	41,351		$	64,658		$	21,969
Operating costs and expenses:
Cost of revenues:
Inventor royalties	666			4,273			—			13			1,573			—			17,844			3,313
Contingent legal fees	627			3,236			12,173			646			4,109			10,418			7,709			4,238
Litigation and licensing expenses - patents	6,386			4,134			4,073			3,626			7,723			7,324			7,348			5,463
Amortization of patents	5,515			5,571			5,625			5,443			10,760			10,759			6,467			6,222
General and administrative expenses (including non-cash stock compensation expense)	6,916			6,734			12,715			(335		)	7,994			7,535			8,334			9,056
Other expenses - business development	320			433			241			195			522			1,334			666			557
Impairment of patent-related intangible assets	—			—			2,248			—			—			40,165			—			2,175
Other	—			—			—			1,200			1,742			(1,242		)	—			—
Total operating costs and expenses	20,430			24,381			37,075			10,788			34,423			76,293			48,368			31,024
Operating income (loss)	(11,576		)	(7,924		)	(442		)	(7,330		)	(9,702		)	(34,942		)	16,290			(9,055		)
Total other income (expense)	696			(4,862		)	159,027			(102,950		)	(3		)	(52		)	261			592
Income (loss) before (provision for) benefit from income taxes	(10,880		)	(12,786		)	158,585			(110,280		)	(9,705		)	(34,994		)	16,551			(8,463		)
Provision for income taxes	(1,241		)	(1,478		)	(216		)	(20		)	(192		)	(5,927		)	(9,655		)	(2,414		)
Net income (loss) including noncontrolling interests	(12,121		)	(14,264		)	158,369			(110,300		)	(9,897		)	(40,921		)	6,896			(10,877		)
Net (income) loss attributable to noncontrolling interests in subsidiaries	291			12			96			97			(68		)	348			186			266
Net income (loss) attributable to Acacia Research Corporation	$	(11,830	)	$	(14,252	)	$	158,465		$	(110,203	)	$	(9,965	)	$	(40,573	)	$	7,082		$	(10,611	)
Net income (loss) per common share attributable to Acacia Research Corporation:
Basic and diluted income (loss) per share	$	(0.24	)	$	(0.28	)	$	3.13		$	(2.18	)	$	(0.20	)	$	(0.81	)	$	0.14		$	(0.21	)
Weighted-average number of shares outstanding, basic	50,333,056			50,499,948			50,554,234			50,590,460			49,925,550			50,015,869			50,124,302			50,237,784
Weighted-average number of shares outstanding, diluted	50,333,056			50,499,948			50,599,974			50,590,460			49,925,550			50,015,869			50,618,757			50,237,784

F- 31

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

15. SUBSEQUENT EVENTS

Investments

In January 2018, Acacia entered into a Joint Venture and Services Agreement (“Joint Venture Agreement”) with Bitzumi, Inc., a company developing macro opportunities in the cryptocurrency and blockchain industries, including a next generation decentralized exchange. Bitzumi recently filed a Regulation A Offering Statement with the Securities and Exchange Commission and a listing application with NASDAQ. Acacia made an initial $1,000,000 equity investment in Bitzumi in January 2018. Under the Joint Venture Agreement, Acacia will provide various patent-related services to Bitzumi and has the option to invest up to an additional $9,000,000 to acquire Bitzumi common stock. In connection with Acacia’s initial investment, Acacia received a short-term warrant to purchase $4,000,000 of Bitzumi common shares. Under the Joint Venture Agreement, Acacia has a right to acquire up to an aggregate of $10.0 million of Bitzumi common shares (inclusive of Acacia’s initial $1,000,000 equity investment and exercise of Acacia’s short-term warrant) at a price, except as paid by Acacia for the initial investment and the exercise price of Acacia’s short-term warrant, of $2.50 per share. Upon meeting certain conditions set forth in the Joint Venture Agreement, Bitzumi will also issue Acacia a warrant for 30,000,000 shares of Bitzumi’s common stock. Acacia’s investment in Bitzumi represents its first venture in the cryptocurrency and blockchain marketplaces.

In February 2018, Acacia made an additional equity investment in Miso Robotics totaling $6,000,000, increasing its ownership interest in Miso Robotics to approximately 30%. In addition, Acacia acquired an additional board seat.

Stock Repurchase Program.

In February 2018, Acacia’s Board of Directors authorized the repurchase of up to $20,000,000 of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors will consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. The Stock Repurchase Program is set to expire on February 28, 2019.

F- 32

EX-21.1 2 actgex211123117.htm EXHIBIT 21.1 Exhibit

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT

The following is a listing of the significant subsidiaries of Acacia Research Corporation:



	Jurisdiction of Incorporation

Acacia Global Acquisition LLC and subsidiaries	Delaware

Acacia Research Group, LLC, formerly Acacia Patent Acquisition, LLC and subsidiaries	Delaware

Acacia Global Acquisition LLC and Acacia Research Group, LLC, wholly own multiple consolidated operating subsidiaries, that are included in Acacia Research Corporation's consolidated financial statements included elsewhere herein, each of which are separate and distinct legal entities, and all of which are in the patent acquisition, development, licensing and enforcement business. All of the operating subsidiaries wholly owned by Acacia Global Acquisition LLC and Acacia Research Group, LLC operate in the United States.

EX-23.1 3 actgex231123117.htm EXHIBIT 23.1 Exhibit

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 7, 2018, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Acacia Research Corporation on Form 10-K for the year ended December 31, 2017. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Acacia Research Corporation on Forms S-8 (File No. 333-102181, File No. 333-109352, File No. 333-119811, File No. 333-127583, File No. 333-131463, File No. 333-140280, File No. 333-144754, File No. 333-149849, File No. 333-157626, File No. 333-165110, File No. 333-172538, File No. 333-179010, File No. 333-189135, File No. 333-217878).

/s/ GRANT THORNTON LLP

Newport Beach, California

March 7, 2018

EX-31.1 4 actgex311123117.htm EXHIBIT 31.1 Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Robert Stewart, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 7, 2018	/s/ Robert Stewart
		Robert Stewart President (Principal Executive Officer)

EX-31.2 5 actgex312123117.htm EXHIBIT 31.2 Exhibit

EXHIBIT 31.2

CERTIFICATION

I, Clayton J. Haynes, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 7, 2018	/s/ Clayton J. Haynes
		Clayton J. Haynes Chief Financial Officer (Principal Financial Officer)

EX-32.1 6 actgex321123117.htm EXHIBIT 32.1 Exhibit

EXHIBIT 32.1

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission on March 7, 2018 (the “Report”), I, Robert Stewart, President of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Robert Stewart
		Robert Stewart
		President
		March 7, 2018

This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

EX-32.2 7 actgex322123117.htm EXHIBIT 32.2 Exhibit

EXHIBIT 32.2

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission on March 7, 2018 (the “Report”), I, Clayton J. Haynes, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Clayton J. Haynes
		Clayton J. Haynes
		Chief Financial Officer
		March 7, 2018

EX-101.INS 8 actg-20171231.xml XBRL INSTANCE DOCUMENT 0000934549 2017-01-01 2017-12-31 0000934549 2018-03-01 0000934549 2017-06-30 0000934549 2016-01-01 2016-12-31 0000934549 2015-01-01 2015-12-31 0000934549 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2017-01-01 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2017-01-01 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2016-01-01 2016-12-31 0000934549 2017-12-31 0000934549 2016-12-31 0000934549 us-gaap:CommonStockMember 2017-12-31 0000934549 us-gaap:CommonStockMember 2014-12-31 0000934549 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0000934549 us-gaap:TreasuryStockMember 2017-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000934549 us-gaap:TreasuryStockMember 2015-12-31 0000934549 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000934549 us-gaap:RetainedEarningsMember 2017-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000934549 us-gaap:TreasuryStockMember 2016-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-12-31 0000934549 us-gaap:CommonStockMember 2015-12-31 0000934549 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000934549 us-gaap:RetainedEarningsMember 2016-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000934549 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2017-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2016-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000934549 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0000934549 us-gaap:TreasuryStockMember 2014-12-31 0000934549 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000934549 us-gaap:CommonStockMember 2016-12-31 0000934549 us-gaap:RetainedEarningsMember 2014-12-31 0000934549 2014-01-01 2014-12-31 0000934549 us-gaap:WarrantMember 2017-12-31 0000934549 us-gaap:WarrantMember 2017-01-01 2017-12-31 0000934549 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0000934549 us-gaap:CommonStockMember 2017-12-31 0000934549 us-gaap:WarrantMember 2016-12-31 0000934549 us-gaap:CommonStockMember 2016-12-31 0000934549 us-gaap:FairValueInputsLevel3Member 2017-12-31 0000934549 us-gaap:FairValueInputsLevel2Member 2017-12-31 0000934549 us-gaap:FairValueInputsLevel1Member 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2017-01-01 2017-12-31 0000934549 us-gaap:MaximumMember 2017-01-01 2017-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2017-01-01 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee3Member 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2016-01-01 2016-12-31 0000934549 2018-03-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2016-01-01 2016-12-31 0000934549 us-gaap:MinimumMember 2017-01-01 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee4Member 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee2Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2017-01-01 2017-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000934549 us-gaap:PatentsMember 2016-12-31 0000934549 us-gaap:PatentsMember 2017-12-31 0000934549 us-gaap:PatentsMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000934549 us-gaap:PatentsMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000934549 2015-01-02 0000934549 actg:VeritoneMember 2017-01-01 2017-09-30 0000934549 actg:VeritoneMember 2017-09-30 0000934549 us-gaap:MinimumMember actg:MonteCarloMember 2017-01-01 2017-12-31 0000934549 actg:VeritoneMember 2017-01-01 2017-12-31 0000934549 us-gaap:MinimumMember actg:BlackScholesMember 2017-01-01 2017-12-31 0000934549 us-gaap:MinimumMember actg:MonteCarloMember 2017-01-01 2017-09-30 0000934549 us-gaap:MaximumMember actg:BlackScholesMember 2017-01-01 2017-12-31 0000934549 2016-08-15 0000934549 2017-03-14 0000934549 2017-05-17 0000934549 actg:VeritoneLoansMember actg:VeritoneMember 2017-05-17 0000934549 us-gaap:CommonStockMember 2017-12-31 0000934549 us-gaap:WarrantMember 2017-12-31 0000934549 us-gaap:BridgeLoanMember actg:VeritoneMember 2017-05-17 0000934549 actg:PrimarywarrantMember actg:VeritoneMember 2017-05-17 0000934549 actg:BlackScholesMember 2017-01-01 2017-12-31 0000934549 actg:FinnertyCommonStockMember 2017-01-01 2017-12-31 0000934549 actg:FinnertyCommonStockMember 2017-05-17 2017-05-17 0000934549 actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 us-gaap:MaximumMember actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 us-gaap:MinimumMember actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 actg:FinnertyWarrantsMember 2017-05-17 2017-05-17 0000934549 us-gaap:ShareRepurchaseProgramDomain 2017-12-31 0000934549 us-gaap:InternalRevenueServiceIRSMember actg:CapitalLossCarryforwardRelatedToBusinessAcquisitionMember 2017-12-31 0000934549 us-gaap:DomesticCountryMember 2017-12-31 0000934549 us-gaap:RestrictedStockMember 2015-01-01 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0000934549 actg:StockIssuanceProgramMember 2017-01-01 2017-12-31 0000934549 actg:A2016PlanMember 2017-12-31 0000934549 us-gaap:MinimumMember actg:GeometricBrownianMotionMember 2017-01-01 2017-12-31 0000934549 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0000934549 actg:VeritoneMember us-gaap:MinimumMember 2017-12-31 0000934549 actg:FinnertyProfitsInterestsMember 2017-01-01 2017-12-31 0000934549 us-gaap:MaximumMember actg:GeometricBrownianMotionMember 2017-01-01 2017-09-30 0000934549 us-gaap:RestrictedStockMember 2017-01-01 2017-12-31 0000934549 us-gaap:RestrictedStockMember 2016-01-01 2016-12-31 0000934549 us-gaap:EmployeeStockOptionMember 2017-12-31 0000934549 actg:NonstatutoryOptionsMember actg:DiscretionaryOptionGrantProgramMember 2017-01-01 2017-12-31 0000934549 actg:GeometricBrownianMotionMember 2017-01-01 2017-12-31 0000934549 actg:A2013StockPlanMember 2016-04-26 0000934549 us-gaap:MinimumMember actg:GeometricBrownianMotionMember 2017-01-01 2017-09-30 0000934549 2017-02-16 0000934549 us-gaap:MaximumMember actg:GeometricBrownianMotionMember 2017-01-01 2017-12-31 0000934549 actg:A2013PlanMember 2016-04-26 0000934549 actg:A2016PlanMember 2016-04-26 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0000934549 us-gaap:RestrictedStockMember 2017-12-31 0000934549 actg:LessThan10Member actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2017-01-01 2017-12-31 0000934549 actg:A10OrMoreMember actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2017-01-01 2017-12-31 0000934549 actg:A2013PlanMember 2017-12-31 0000934549 actg:PerformanceBasedVestingConditionsMember 2017-01-01 2017-12-31 0000934549 actg:MarketBasedVestingConditionsMember 2017-01-01 2017-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 us-gaap:DeferredProfitSharingMember 2017-01-01 2017-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 us-gaap:DeferredProfitSharingMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 us-gaap:DeferredProfitSharingMember 2015-01-01 2015-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2017-01-01 2017-12-31 0000934549 actg:TimeBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 actg:MarketBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 actg:PerformanceBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 actg:TimeBasedVestingConditionsMember 2017-01-01 2017-12-31 0000934549 actg:A2007PlanMember 2017-12-31 0000934549 us-gaap:MaximumMember 2017-12-31 0000934549 us-gaap:MinimumMember 2017-12-31 0000934549 2017-07-01 2017-09-30 0000934549 2016-04-01 2016-06-30 0000934549 2016-10-01 2016-12-31 0000934549 2016-01-01 2016-03-31 0000934549 2016-07-01 2016-09-30 0000934549 2017-01-01 2017-03-31 0000934549 2017-04-01 2017-06-30 0000934549 2017-10-01 2017-12-31 0000934549 2018-01-01 2018-03-31 iso4217:USD xbrli:shares actg:patents xbrli:shares xbrli:pure iso4217:USD 809400 2394000 2567000 6564000 5479000 P7Y P2Y 0.049 0.60 4000000 10000000 90000 157000 0.08 1118000 986000 211000 223000 181000 2250000 29300000 0 0 42239000 33922000 8317000 0.125 16169000 4109000 10418000 7709000 4238000 26474000 627000 3236000 12173000 646000 16682000 83323000 90871000 25261000 0 10587000 0 0 14343000 6197000 24740000 0 0 0.01 0.00 0.00 0.07 0.00 0.00 -0.28 -0.33 0.47 0 0 344300000 252000000 3041000 722000 1.00 21350000 14100000 700000 51126000 4421000 14776000 2865000 3150000 15000 0 0 2671000 2671000 0 0 0 4616000 0 -4616000 5844000 556000 390000 -1569000 -1333000 -1013000 -943000 -572000 -390000 527000 -970000 -12307000 55228000 54202000 1026000 1000000 9000000 6000000 2933000 1905000 0 104754000 19443000 0 0 90795000 13959000 1960000 0 P3M 39373000 7723000 7324000 7348000 5463000 27858000 6386000 4134000 4073000 3626000 18219000 49526000 10.00 7.00 50000000 1657000 324000 6 3 2 1 180621000 17850000 0.10 1000000 0 0 358043000 382220000 444362000 444137000 86319000 86319000 61917000 61917000 0.30 0.23 0.20 P45D P30D 3391000 522000 1334000 666000 557000 3079000 320000 433000 241000 195000 1189000 -16000 0 13908000 1601000 20000000 10000000 60000 14000 2000 12152000 2930000 102000 351000 431000 0 16.72 0.00 16.27 16.72 -12000 480000 324000 200000 16.18 15.38 6022000000 1368000000 5530000 487000 5704000 2930000 0 0 2930000 1559000 0.85 4051000 2891000 79682000 1700000 1687500 60000 1000000 2000000 50000000 30000000 false --12-31 FY 2017 2017-12-31 10-K 0000934549 50637882 Yes Accelerated Filer 202307000 ACACIA RESEARCH CORP No No 2017-12-31

14283000

7956000

26750000

153000

630000

1967000

1364000

533000

294000

-76000

-88000

P4Y

642453000

648996000

53067000

10760000

10759000

6467000

6222000

34208000

5515000

5571000

5625000

5443000

22154000

71468

3682532

4425187

296003000

79682000

308768000

188490000

78509000

139695000

1173000

19443000

19403000

617000

40000

4000000

134466000

135223000

127540000

136604000

757000

-7683000

9064000

2.50

7279000

0.500

0.000

0.50

0.001

100000000

50476042

50639926

50065382

50651239

50476042

50639926

2150335

1523746

295440

50000

51000

-159898000

-53928000

22168000

-157340000

-54660000

21672000

0.24

0.20

0.16

0.49

0.39

0.22

0.16

0.15

0.26

0.23

0.11

0.79

1.00

0.54

0.21

0.10

0.39

3000000

4421000

17926000

2865000

4800000

18188000

2955000

379000

262000

90000

13.6088

162000

10611000

102789000

100889000

2195000

984000

162000

10611000

2804000

90000

35000

2416000

2635000

422000

167000

102627000

90278000

162000

24000

10587000

53289000

34355000

22243000

-5940

-3.25

-0.20

-0.81

0.14

-0.21

-1.08

-0.24

-0.28

3.13

-2.18

0.44

0.03

0.50

0.12

-0.35

0.35

0.31

0.83

-1.37

0.00

-1.02

-0.01

0.01

0.00

0.03

0.50

0.08

-0.03

-0.49

0.00

1593000

465000

3654000

53000

1000

P2Y

P2M

P1M

0.23

2195000

P6M

P10Y

P1Y

P9Y

P3Y

P2M

P5M

P4Y5M

0.35

0.40

0.50

0.55

0.87

0.45

0.72

0.37

0.50

0.0237

0.02

0.0194

0.02

0.06

0.07

0.05

0.30

0.10

0.75

0.25

104754000

90795000

13959000

P6Y

P1Y

P6Y

P1Y

6197000

20542000

5256000

5261000

6134000

18527000

-123000

99000

28000

38176000

7994000

7535000

8334000

9056000

32919000

6916000

6734000

12715000

-335000

26030000

30100000

30149000

10090000

74731000

40165000

2175000

42340000

2248000

-152678000

-9705000

-34994000

16551000

-8463000

-36611000

-10880000

-12786000

158585000

-110280000

24639000

-220000

4800000

192000

5927000

9655000

2414000

18188000

1241000

1478000

216000

20000

2955000

0.21

2570000

-3006000

-6349000

-13332000

6750000

26597000

-619000

1593000

-135000

-10725000

-787000

11512000

-56000

798000

1605000

1100000

4119521

1120432

1926000

1795000

1392000

28560000

31850000

13109000

296003000

308768000

28191000

31836000

9557000

14000

125037000

152699000

65402000

18616000

20700000

3000000

1200000

1854000

1358000

-4105000

-1358000

-28601000

-1114000

700000

39307000

-40630000

-16114000

-9949000

34061000

24478000

-160036000

-9965000

-40573000

7082000

-10611000

-54067000

-11830000

-14252000

158465000

-110203000

22180000

2558000

68000

-348000

-186000

-266000

-732000

-291000

-12000

-96000

-97000

-496000

-160730000

-54067000

22147000

-51281000

277659000

34423000

76293000

48368000

31024000

190108000

20430000

24381000

37075000

10788000

92674000

44024000

-152622000

-9702000

-34942000

16290000

-9055000

-37409000

-11576000

-7924000

-442000

-7330000

-27272000

2598000

1213000

16000

1369000

26326000

476000

339000

618000

207000

-123000

77000

58000

-617000

-22000

30000

-356000

40000

-40000

4141000

1742000

-1242000

500000

1200000

1000000

369000

3552000

-56000

-3000

-52000

261000

592000

798000

696000

-4862000

159027000

-102950000

51911000

-109000

-477000

-374000

-12872000

82000

45000

25434000

23296000

62633000

448388000

19504000

1225000

20000000

4000000

31514000

8000

4000

2000

4105000

1358000

-1358000

0.001

10000000

0.001

3245000

2938000

82115000

43232000

82115000

43232000

938000

326000

745000

744000

1000

-157478000

-9897000

-40921000

6896000

-10877000

-54799000

-12121000

-14264000

158369000

-110300000

21684000

0.53

0.09

11512000

-342198000

-320018000

24721000

41351000

64658000

21969000

8854000

16457000

36633000

10914000

3458000

18462000

1573000

17844000

3313000

22730000

666000

4273000

13000

4952000

11048000

10575000

473000

11047000

1000

9062000

4071000

197000

320000

3158000

1316000

9063000

-1000

8885000

1025000

121000

161000

2372000

2165000

3041000

90000

9.10

138000000

12.83

3.12

0.00

333000

123000

8.90

4.77

120000

11494000

5243000

1560000

12.95

0.01

0.02

0.53

0.51

4750000

4500000

660000

727000

625390

1959000

4.84

751000

344000

296000

-926000

4.90

2250000000

200000000

3434000000

1368000

1368000000

856000

5596000

5830000

4.93

5.13

434000

1959000

4.84

3.57

5.52

5.75

4.29

23.20

15.00

16.72

0.25

P3Y22D

P4Y135D

434000

P5Y9M

2342000

2009000

1.10

1.00

0.85

1.00

19443000

104754000

450857

-262660

-35310

135000

100992

208000

207863

938000

326000

745000

20000000

-13529

-8669

265589000

47832000

294301000

489048000

-353000

646595000

50000

5491000

-128095000

-34640000

314155000

-215000

633146000

51000

3944000

-288131000

-34640000

267443000

-76000

642453000

50000

1854000

-342198000

-34640000

295659000

-88000

648996000

51000

1358000

-320018000

-34640000

0.06

1729408

34640000

33000

261000

40000

-40000

808000

196893

49505817

49925550

50015869

50618757

50237784

50075847

50333056

50499948

50599974

50590460

50692012

49925550

50015869

50124302

50237784

50333056

50499948

50554234

50590460

49505817

50075847

50495119

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Liabilities. </font><font style="font-family:inherit;font-size:10pt;">The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia reviews its equity method investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017 and 2016</font><font style="font-family:inherit;font-size:10pt;">, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments - noncurrent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,905</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,891</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,051</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,567</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">324</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">390</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss in equity method investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(943</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,569</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> years. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amounts and accumulated amortization related to investments in intangible assets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017 and 2016</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross carrying amount - patents                                                        </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization - patents</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">                                                                         </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(382,220</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(358,043</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,917</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,319</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:44%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:top;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 to 5 years (Lesser of lease term or useful life of improvement)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements - Recently Adopted. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based award grant activity for the periods presented was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,434,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total incentive awards granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,930</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,022,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks.  </font><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">54%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">79%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">49%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INVESTMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investment at Fair Value</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Veritone Investment Agreement. </font><font style="font-family:inherit;font-size:10pt;">On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provided for Acacia to invest up to </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;"> in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permitted Veritone to borrow up to </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> through two </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> advances, each bearing interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">6.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum (included in Other Income (Expense) in the consolidated statements of operations). On August 15, 2016, Acacia funded the initial </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the “First Loan”). On November 25, 2016, Acacia funded the second </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the “Second Loan”). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;"> warrants to purchase shares of Veritone’s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share. Veritone’s initial public offering date was May 12, 2017. Upon Veritone’s consummation of its public offering of its common stock on May 17, 2017 (“IPO”), all outstanding principal and accrued interest under the Veritone Loans, totaling </font><font style="font-family:inherit;font-size:10pt;">$20.7 million</font><font style="font-family:inherit;font-size:10pt;">, automatically converted into </font><font style="font-family:inherit;font-size:10pt;">1,523,746</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone’s common stock based on a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;">, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone’s IPO, resulting in the purchase by Acacia of an additional </font><font style="font-family:inherit;font-size:10pt;">2,150,335</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock, at an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;">$29.3 million</font><font style="font-family:inherit;font-size:10pt;">. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional </font><font style="font-family:inherit;font-size:10pt;">809,400</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Veritone Bridge Loan</font><font style="font-family:inherit;font-size:10pt;">. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the “Veritone Bridge Loan”), which permitted Veritone to borrow up to an additional </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, bearing interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">8.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum. On March 17, 2017, Acacia funded the initial </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> advance (the “First Bridge Loan”). On April 14, 2017, Acacia funded the second </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> advance (the “Second Bridge Loan”). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$21,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, automatically converted into </font><font style="font-family:inherit;font-size:10pt;">295,440</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone’s common stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) </font><font style="font-family:inherit;font-size:10pt;">60,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock (“Upfront Shares”), (ii) </font><font style="font-family:inherit;font-size:10pt;">90,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock (the “Bridge Installment Shares”), and (iii) 10-year warrants to purchase up to </font><font style="font-family:inherit;font-size:10pt;">157,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock with other terms and conditions similar to the warrants described above.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017. The Veritone common shares are subject to a lock-up agreement that expires on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of December 31, 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Prior to Veritone IPO</font><font style="font-family:inherit;font-size:10pt;">. Prior to conversion, Acacia’s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the “Loans”) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (“Veritone Shares”) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone’s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (2) financing probabilities ranging from </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">75%</font><font style="font-family:inherit;font-size:10pt;">, (3) marketability discount of </font><font style="font-family:inherit;font-size:10pt;">7%</font><font style="font-family:inherit;font-size:10pt;"> and (4) </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the consolidated statements of operations. As of May 2017, the unamortized loan discount totaled </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">. Interest income for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">, including accretion of the loan discount of </font><font style="font-family:inherit;font-size:10pt;">$630,000</font><font style="font-family:inherit;font-size:10pt;">. The effective yield on the Loans for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> ranged from </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">53%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Subsequent to Veritone IPO</font><font style="font-family:inherit;font-size:10pt;">. Upon Veritone’s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Veritone (excluding warrants). Based on Acacia’s representation on the Veritone board of directors and Acacia’s </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, Acacia’s ownership interest in Veritone, on a fully-diluted basis, was approximately </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone’s common stock on The NASDAQ Global Market (the “NASDAQ”) on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (“DLOM”) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia’s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">: risk-free interest rates ranging from </font><font style="font-family:inherit;font-size:10pt;">1.94%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.37%</font><font style="font-family:inherit;font-size:10pt;">; expected terms ranging from </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">nine years</font><font style="font-family:inherit;font-size:10pt;">; volatilities ranging from </font><font style="font-family:inherit;font-size:10pt;">45%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;">; and a dividend yield of </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.6484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Warrants</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated DLOM applied</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility assumptions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term assumptions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 months</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the </font><font style="font-family:inherit;font-size:10pt;">4,119,521</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock owned by Acacia totaled </font><font style="font-family:inherit;font-size:10pt;">$90,795,000</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the </font><font style="font-family:inherit;font-size:10pt;">1,120,432</font><font style="font-family:inherit;font-size:10pt;"> common stock purchase warrants held by Acacia totaled </font><font style="font-family:inherit;font-size:10pt;">$13,959,000</font><font style="font-family:inherit;font-size:10pt;">. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 10% decrease in the fair value of our investment in Veritone at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and a corresponding decrease in the net investment gain reflected in the consolidated statements of operations for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in the fair value of Acacia’s investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the period from the IPO on May 17, 2017 to </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the accompanying consolidated statements of operations reflected the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.3515625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:83%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on conversion of loans and accrued interest</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on exercise of warrant</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net unrealized gain on investment at fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;">__________________________</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;"> Pre-conversion difference between carrying value of Loan and accrued interest and the estimated fair value of common stock discounted for lack of marketability.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) </sup></font><font style="font-family:inherit;font-size:8pt;">Pre-conversion difference between carrying value of Primary Warrant and the estimated fair value of common stock and 10% Warrant discounted for lack of marketability.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,914</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,024</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51,281</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share attributable to common stockholders - basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,173</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,682</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders’ equity (deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,832</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities, preferred stock and stockholders’ equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,682</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Method Investment </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, Acacia made an investment in Miso Robotics, Inc. (“Miso Robotics”), an innovative leader in robotics and artificial intelligence solutions, totaling </font><font style="font-family:inherit;font-size:10pt;">$2,250,000</font><font style="font-family:inherit;font-size:10pt;">, acquiring a </font><font style="font-family:inherit;font-size:10pt;">22.6%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Miso Robotics, and one board seat. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry. In addition, Acacia also entered into an intellectual property services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the entire restaurant industry. Based on Acacia’s representation on the Miso Robotics board of directors, and greater than 20% ownership interest in Miso Robotics, the equity method of accounting was applied. The fair value option was not elected for Acacia’s investment in Miso Robotics due to the lack of a readily determinable fair market value. For the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, equity in losses of investee related to Miso Robotics totaled </font><font style="font-family:inherit;font-size:10pt;">$220,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EQUITY-BASED INCENTIVE PLANS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock-Based Incentive Plans</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plans provide for the following separate programs:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discretionary Option Grant Program</font><font style="font-family:inherit;font-size:10pt;">. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of those shares on the grant date (not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">110%</font><font style="font-family:inherit;font-size:10pt;"> of fair market value if such employee actually or constructively owns more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of Acacia’s voting stock or the voting stock of any of its subsidiaries).</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:60px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Issuance Program</font><font style="font-family:inherit;font-size:10pt;">. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:60px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Automatic Option Grant Program</font><font style="font-family:inherit;font-size:10pt;">. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was </font><font style="font-family:inherit;font-size:10pt;">4,750,000</font><font style="font-family:inherit;font-size:10pt;"> shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, </font><font style="font-family:inherit;font-size:10pt;">625,390</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">660,000</font><font style="font-family:inherit;font-size:10pt;"> shares available for grant under the 2013 Plan.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was </font><font style="font-family:inherit;font-size:10pt;">4,500,000</font><font style="font-family:inherit;font-size:10pt;"> shares plus </font><font style="font-family:inherit;font-size:10pt;">625,390</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">727,000</font><font style="font-family:inherit;font-size:10pt;"> shares available for grant under the 2016 Plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, there are </font><font style="font-family:inherit;font-size:10pt;">7,279,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock reserved for issuance under the Plans.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based award grant activity for the periods presented was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,434,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total incentive awards granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,930</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,022,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> the Company granted restricted stock awards and stock options (with weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.75</font><font style="font-family:inherit;font-size:10pt;"> per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">102,000</font><font style="font-family:inherit;font-size:10pt;"> (net of forfeitures) shares of restricted stock with performance-based vesting conditions were outstanding and unvested. During the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, all stock options with performance-based vesting conditions expired unvested. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> unrecognized expense for awards with performance-based vesting conditions.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.75</font><font style="font-family:inherit;font-size:10pt;"> per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> upon the Company’s achievement of 30-day average share prices ranging from </font><font style="font-family:inherit;font-size:10pt;">$7.00</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,687,500</font><font style="font-family:inherit;font-size:10pt;"> options with market-based vesting conditions remain unvested. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> unrecognized expense for options with market-based vesting conditions.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the Plans for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Contractual Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,596,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(208,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.57</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired/forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(926,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,830,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate intrinsic value of options exercised during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$296,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$344,000</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$751,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2017 was </font><font style="font-family:inherit;font-size:10pt;">$351,000</font><font style="font-family:inherit;font-size:10pt;">. The aggregate fair value of options granted during the year ended December 31, 2017 was </font><font style="font-family:inherit;font-size:10pt;">$2,930,000</font><font style="font-family:inherit;font-size:10pt;">. The aggregate fair value of options vested during the year ended December 31, 2017 and 2016 was </font><font style="font-family:inherit;font-size:10pt;">$2,009,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,342,000</font><font style="font-family:inherit;font-size:10pt;">, respectively.  No options were granted or vested during the year ended December 31, 2015. As of December 31, 2017, the total unrecognized compensation expense related to nonvested stock option awards was </font><font style="font-family:inherit;font-size:10pt;">$3,654,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average term of approximately </font><font style="font-family:inherit;font-size:10pt;">2 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes nonvested restricted share activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonvested</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(120,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.95</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(90,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2016 and 2015 was </font><font style="font-family:inherit;font-size:10pt;">$3.12</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.83</font><font style="font-family:inherit;font-size:10pt;">, respectively. The aggregate fair value of restricted stock that vested during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,560,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5,243,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11,494,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the total unrecognized compensation expense related to nonvested restricted stock awards was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$53,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average period of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2 months</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.72</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested restricted stock units outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant date fair value of restricted stock units granted during the year ended December 31, 2015 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16.72</font><font style="font-family:inherit;font-size:10pt;">.  There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> restricted units granted during the years ended December 31, 2017 and 2016. The aggregate fair value of restricted stock units that vested during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$200,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$324,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$480,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the total unrecognized compensation expense related to restricted stock unit awards was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average period of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1 month</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Profits Interest Plan </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia’s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia owns </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;"> of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, AIP holds the Veritone 10% Warrant described at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$722,000</font><font style="font-family:inherit;font-size:10pt;">. The fair value of the Units totaled </font><font style="font-family:inherit;font-size:10pt;">$3,041,000</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (“GBM”) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, assumptions utilized in the GBM included a term of </font><font style="font-family:inherit;font-size:10pt;">4.4 years</font><font style="font-family:inherit;font-size:10pt;">, stock price of </font><font style="font-family:inherit;font-size:10pt;">$23.20</font><font style="font-family:inherit;font-size:10pt;">, volatility of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, and risk free interest rates ranging from </font><font style="font-family:inherit;font-size:10pt;">1.76%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.40%</font><font style="font-family:inherit;font-size:10pt;"> for terms ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">10 years</font><font style="font-family:inherit;font-size:10pt;">. The estimated DLOM utilized was </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, based on assumptions including a term of approximately </font><font style="font-family:inherit;font-size:10pt;">4.4 years</font><font style="font-family:inherit;font-size:10pt;"> and a volatility of </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately </font><font style="font-family:inherit;font-size:10pt;">4.4 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense for the periods presented was comprised of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.60975609756098%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,071</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits interests units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,885</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,062</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income (Loss) Per Share.  </font><font style="font-family:inherit;font-size:10pt;">The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Undistributed earnings allocated to participating securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,495,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potentially dilutive securities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock options and restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,692,012</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,425,187</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,682,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,914</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,024</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51,281</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share attributable to common stockholders - basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,173</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,682</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders’ equity (deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,832</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities, preferred stock and stockholders’ equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,682</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on conversion of loans and accrued interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on exercise of Primary Warrant</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, issues, sales and settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases and issues</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements.</font><font style="font-family:inherit;font-size:10pt;"> U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(i)</font></div></td><td style="vertical-align:top;padding-left:42px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-42px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Quoted prices in active markets for identical investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(ii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pricing Models with Significant Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(iii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 </font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unobservable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, all of the Company’s investments recorded at fair value were valued utilizing Level 3 - unobservable inputs. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 7)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2016:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">There were no transfers between fair value hierarchy categories for the period presented.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on conversion of loans and accrued interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on exercise of Primary Warrant</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, issues, sales and settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases and issues</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">All gains and losses included in earnings for the period presented relate to assets and liabilities held as of December 31, 2017.</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;"> Refer to Note 7 for information regarding purchase and issues activity for the years ended December 31, 2017 and 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments at Fair Value</font><font style="font-family:inherit;font-size:10pt;">. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Method Investments</font><font style="font-family:inherit;font-size:10pt;">. Equity investments without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting, and classified within “Equity Method Investments” in the consolidated balance sheet. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the consolidated statements of operations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL IMPAIRMENT CHARGE (Fiscal Year 2015)</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill Impairment Testing - December 31, 2015. </font><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;">. Goodwill is tested for impairment at the Company’s single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant consistent gradual decline in the Company’s stock price for a sustained period;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant underperformance relative to expected historical or projected future operating results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant changes in the manner of use of assets or the strategy for the Company’s overall business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant negative industry or economic trends; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     In connection with Acacia’s annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adverse legal outcomes and changes in legal factors. </font><font style="font-family:inherit;font-size:10pt;">In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Significant consistent gradual decline in the Company’s stock price. </font><font style="font-family:inherit;font-size:10pt;">Historically, the Company’s stock price had been volatile, and the volatility continued during fiscal 2015, declining from </font><font style="font-family:inherit;font-size:10pt;">$16.72</font><font style="font-family:inherit;font-size:10pt;"> as of January 2, 2015, to </font><font style="font-family:inherit;font-size:10pt;">$4.29</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company’s stock price volatility has continued, trending downward. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company’s stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Changes in Company Management and Resource Allocations. </font><font style="font-family:inherit;font-size:10pt;">In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company’s stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company’s assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company’s stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company’s single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of </font><font style="font-family:inherit;font-size:10pt;">$252 million</font><font style="font-family:inherit;font-size:10pt;"> was below its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company’s reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company’s single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2015.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-lived Assets.</font><font style="font-family:inherit;font-size:10pt;"> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State                                                    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,865</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,926</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State                                             </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2017 and 2016</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">984</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,889</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(90,278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,611</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gain on investments held at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,587</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,611</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statements of operations in the period the determination is made. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately </font><font style="font-family:inherit;font-size:10pt;">$180,621,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$17,850,000</font><font style="font-family:inherit;font-size:10pt;">, expiring between 2026 and 2037, and 2028 and 2037, respectively. Capital loss carryovers totaled </font><font style="font-family:inherit;font-size:10pt;">$2,804,000</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2017, expiring in 2019 and 2020.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$26,326,000</font><font style="font-family:inherit;font-size:10pt;"> of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately </font><font style="font-family:inherit;font-size:10pt;">$14,100,000</font><font style="font-family:inherit;font-size:10pt;">, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, Acacia had approximately </font><font style="font-family:inherit;font-size:10pt;">$51,126,000</font><font style="font-family:inherit;font-size:10pt;"> of foreign tax credits, expiring between 2018 and 2026. In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense for the periods presented primarily reflects foreign taxes withheld on revenue agreements executed with licensees in foreign jurisdictions and other state taxes. Excluding the impact of the change in valuation allowance and the impact of the federal tax rate change under the change in tax law described below, annual effective tax rates were </font><font style="font-family:inherit;font-size:10pt;">47%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">(33)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">(28)%</font><font style="font-family:inherit;font-size:10pt;">, for fiscal years 2017, 2016 and 2015, respectively. Results for fiscal year 2017 included an unrealized gain on Acacia’s investment in Veritone which created a deferred tax liability totaling approximately </font><font style="font-family:inherit;font-size:10pt;">$10,587,000</font><font style="font-family:inherit;font-size:10pt;">. The future anticipated reversal of this deferred tax liability provides for a source of taxable income that allows for the realizability of existing deferred tax assets that have been reduced by a valuation allowance for the periods presented. The effective tax rate reflects both the recognition of the deferred tax liability and the reversal of valuation allowance </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective January 1, 2017, the Company adopted a new standard that requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. The adoption of this standard resulted in the Company recognizing gross federal and state deferred tax assets of </font><font style="font-family:inherit;font-size:10pt;">$21,350,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,559,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the impact of share-based payments to employees in prior periods. These deferred tax assets are fully offset by a valuation allowance and were impacted by the change in tax rate described below.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2011. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and 2016, the Company had total unrecognized tax benefits of approximately </font><font style="font-family:inherit;font-size:10pt;">$808,000</font><font style="font-family:inherit;font-size:10pt;">. No interest and penalties have been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2017, if recognized, approximately </font><font style="font-family:inherit;font-size:10pt;">$808,000</font><font style="font-family:inherit;font-size:10pt;"> of tax benefits, net of valuation allowance, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2017 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of these changes are effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we have reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately </font><font style="font-family:inherit;font-size:10pt;">$25,261,000</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets as of December 31, 2017, the change in tax law did not have a material impact on our consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Investments.  </font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Short-term Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.   </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,403</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,443</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Not Yet Adopted. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company may be required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under existing guidance. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales or usage based royalties. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its intellectual property is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amendments for this new accounting standard update are effective for interim and annual reporting periods beginning after December 15, 2017, and are to be applied retrospectively or via the cumulative effect as of the date of adoption, with early application not permitted. The Company expects to use the modified retrospective method of adoption and will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings in the period of initial application (first quarter of 2018 for Acacia). Comparative prior year periods would not be adjusted. The preliminary estimate of the cumulative effect of initially applying the new revenue standard is an decrease to beginning accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods. Management continues to assess the impact of this new standard on the Company’s consolidated financial statements and related disclosures, including ongoing contract reviews. Preliminary estimates of the adjustment upon initial adoption may change in connection with completion of the Company’s adoption procedures in the first quarter of 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017, with early adoption</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Retirement Savings Plan.</font><font style="font-family:inherit;font-size:10pt;">  Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Executive Severance Policy.</font><font style="font-family:inherit;font-size:10pt;">  Under Acacia’s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUARTERLY FINANCIAL DATA (unaudited)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,854</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,386</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,134</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,073</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,626</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,723</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,571</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,443</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">General and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,715</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(335</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,056</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,248</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,200</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,742</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,242</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,430</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,381</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,075</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,788</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,423</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,368</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,024</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">696</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,862</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">159,027</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(102,950</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,478</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(216</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(192</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,927</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,655</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,414</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,896</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,877</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">291</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">348</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11,830</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,252</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,465</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,203</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,965</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,573</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,082</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,611</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.24</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,333,056</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,499,948</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,554,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,590,460</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,124,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, diluted </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,333,056</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,499,948</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,599,974</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,590,460</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,618,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State                                                    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,865</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,926</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State                                             </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2017 and 2016</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">984</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,889</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(90,278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,611</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gain on investments held at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,587</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,611</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Undistributed earnings allocated to participating securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,495,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potentially dilutive securities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock options and restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,692,012</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,425,187</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,682,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 7)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2016:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:70.703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,213</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,598</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes nonvested restricted share activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonvested</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(120,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.95</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(90,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense for the periods presented was comprised of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.60975609756098%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,071</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits interests units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,885</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,062</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,854</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,386</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,134</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,073</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,626</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,723</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,571</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,443</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">General and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,715</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(335</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,056</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,248</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,200</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,742</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,242</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,430</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,381</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,075</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,788</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,423</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,368</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,024</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">696</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,862</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">159,027</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(102,950</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,478</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(216</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(192</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,927</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,655</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,414</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,896</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,877</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">291</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">348</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11,830</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,252</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">158,465</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110,203</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,965</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,573</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,082</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,611</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.24</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,333,056</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,499,948</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,554,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,590,460</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,124,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, diluted </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,333,056</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,499,948</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,599,974</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,590,460</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,618,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.72</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested restricted stock units outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the Plans for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Contractual Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,596,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,368,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(208,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.57</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired/forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(926,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,830,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:79.8828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Years Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.77%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.06</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Principles and Fiscal Year End.  </font><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation.  </font><font style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition.  </font><font style="font-family:inherit;font-size:10pt;">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology owned by Acacia’s operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30 days</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">45 days</font><font style="font-family:inherit;font-size:10pt;"> after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements.</font><font style="font-family:inherit;font-size:10pt;"> U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(i)</font></div></td><td style="vertical-align:top;padding-left:42px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-42px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Quoted prices in active markets for identical investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(ii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pricing Models with Significant Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(iii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 </font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unobservable Inputs</font><font style="font-family:inherit;font-size:10pt;">:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, all of the Company’s investments recorded at fair value were valued utilizing Level 3 - unobservable inputs. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 7)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December 31, 2016:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">There were no transfers between fair value hierarchy categories for the period presented.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on conversion of loans and accrued interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on exercise of Primary Warrant</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, issues, sales and settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases and issues</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">All gains and losses included in earnings for the period presented relate to assets and liabilities held as of December 31, 2017.</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;"> Refer to Note 7 for information regarding purchase and issues activity for the years ended December 31, 2017 and 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash and Cash Equivalents</font><font style="font-family:inherit;font-size:10pt;">.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Investments.  </font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Short-term Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks.  </font><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">54%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">79%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">49%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Financial Instruments.  </font><font style="font-family:inherit;font-size:10pt;">The carrying value of cash and cash equivalents, accounts receivables, and current liabilities approximates their fair values due to their short-term maturities.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Property and Equipment.  </font><font style="font-family:inherit;font-size:10pt;">Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:44%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:top;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 to 5 years (Lesser of lease term or useful life of improvement)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> years. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments at Fair Value</font><font style="font-family:inherit;font-size:10pt;">. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Method Investments</font><font style="font-family:inherit;font-size:10pt;">. Equity investments without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting, and classified within “Equity Method Investments” in the consolidated balance sheet. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia reviews its equity method investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-lived Assets.</font><font style="font-family:inherit;font-size:10pt;"> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Liabilities. </font><font style="font-family:inherit;font-size:10pt;">The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock-Based Compensation.</font><font style="font-family:inherit;font-size:10pt;"> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FASB issued a new standard, effective January 1, 2017, that allows entities to make a policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. Effective January 1, 2017, the Company elected to account for forfeitures of awards as they occur. The prior standard required the Company to estimate the number of awards for which the requisite service period is expected to be rendered and base the accruals of compensation cost on the estimated number of awards that will vest. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:79.8828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Years Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.77%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.06</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the periods presented.  Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes.  </font><font style="font-family:inherit;font-size:10pt;">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting.</font><font style="font-family:inherit;font-size:10pt;">  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income (Loss) Per Share.  </font><font style="font-family:inherit;font-size:10pt;">The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Undistributed earnings allocated to participating securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,495,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potentially dilutive securities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock options and restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,692,012</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,425,187</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,682,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Not Yet Adopted. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company may be required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under existing guidance. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales or usage based royalties. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its intellectual property is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amendments for this new accounting standard update are effective for interim and annual reporting periods beginning after December 15, 2017, and are to be applied retrospectively or via the cumulative effect as of the date of adoption, with early application not permitted. The Company expects to use the modified retrospective method of adoption and will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings in the period of initial application (first quarter of 2018 for Acacia). Comparative prior year periods would not be adjusted. The preliminary estimate of the cumulative effect of initially applying the new revenue standard is an decrease to beginning accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods. Management continues to assess the impact of this new standard on the Company’s consolidated financial statements and related disclosures, including ongoing contract reviews. Preliminary estimates of the adjustment upon initial adoption may change in connection with completion of the Company’s adoption procedures in the first quarter of 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017, with early adoption</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements - Recently Adopted. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, Acacia entered into a Joint Venture and Services Agreement (“Joint Venture Agreement”) with Bitzumi, Inc., a company developing macro opportunities in the cryptocurrency and blockchain industries, including a next generation decentralized exchange. Bitzumi recently filed a Regulation A Offering Statement with the Securities and Exchange Commission and a listing application with NASDAQ. Acacia made an initial </font><font style="font-family:inherit;font-size:10pt;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> equity investment in Bitzumi in January 2018. Under the Joint Venture Agreement, Acacia will provide various patent-related services to Bitzumi and has the option to invest up to an additional </font><font style="font-family:inherit;font-size:10pt;">$9,000,000</font><font style="font-family:inherit;font-size:10pt;"> to acquire Bitzumi common stock. In connection with Acacia’s initial investment, Acacia received a short-term warrant to purchase </font><font style="font-family:inherit;font-size:10pt;">$4,000,000</font><font style="font-family:inherit;font-size:10pt;"> of Bitzumi common shares. Under the Joint Venture Agreement, Acacia has a right to acquire up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> of Bitzumi common shares (inclusive of Acacia’s initial </font><font style="font-family:inherit;font-size:10pt;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> equity investment and exercise of Acacia’s short-term warrant) at a price, except as paid by Acacia for the initial investment and the exercise price of Acacia’s short-term warrant, of </font><font style="font-family:inherit;font-size:10pt;">$2.50</font><font style="font-family:inherit;font-size:10pt;"> per share. Upon meeting certain conditions set forth in the Joint Venture Agreement, Bitzumi will also issue Acacia a warrant for </font><font style="font-family:inherit;font-size:10pt;">30,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Bitzumi’s common stock. Acacia’s investment in Bitzumi represents its first venture in the cryptocurrency and blockchain marketplaces.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, Acacia made an additional equity investment in Miso Robotics totaling </font><font style="font-family:inherit;font-size:10pt;">$6,000,000</font><font style="font-family:inherit;font-size:10pt;">, increasing its ownership interest in Miso Robotics to approximately </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">. In addition, Acacia acquired an additional board seat.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Repurchase Program. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, Acacia’s Board of Directors authorized the repurchase of up to </font><font style="font-family:inherit;font-size:10pt;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors will consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. The Stock Repurchase Program is set to expire on February 28, 2019.</font></div></div>

EX-101.SCH 9 actg-20171231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Accounts Payable and Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Commitments and Contingencies Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1002001 - Statement - Consolidated Statements of Operations Parentheticals link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - Consolidated Statements of Stockholders' Equity Parentheticals link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Goodwill Impairment Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Goodwill Impairment Charges Details (Details) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Goodwill Impairment Charges (Notes) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Goodwill Impairment Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Income Taxes Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Income Taxes Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Income Taxes Provision for Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Investments (Notes) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Patents Cost and Accumulated Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Patents Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Quarterly Financial Data link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Quarterly Financial Data (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Quarterly Financial Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Retirement Savings Plan and Executive Severance Policy link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Short-term Investments link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Short-term Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Short-term Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Stock-Based Incentive Plans link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Stock-Based Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2416404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2416405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2416406 - Disclosure - Stock-Based Incentive Plans Schedule of Grants by Type (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Stock-Based Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Subsequent Events (Notes) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Subsequent Events (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Summary of Significant Accounting Policies Impact of revision (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 actg-20171231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 actg-20171231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 actg-20171231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounting Policies [Abstract] Net income (loss) attributable to Acacia Research Corporation Net Income (Loss) Attributable to Parent Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Payments of Dividends Payments of Dividends Dividends attributable to common stockholders under the two class method Dividends attributable to common stockholders under the two class method Add Back of Dividends attributable to common stockholders under the two class method Net Loss Available to Common Stockholders, Basic and Diluted Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number Diluted Shares Outstanding Adjustment Weighted Average Number Diluted Shares Outstanding Adjustment Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic and Diluted Earnings Per Share, Basic and Diluted Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Stockholders' Equity Note [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Accounts Payable and Accrued Liabilities, Current [Abstract] Payroll and other employee benefits Employee-related Liabilities, Current Accrued vacation Accrued Vacation Accrued legal expenses - patent Accrued Legal Expenses - Patent Accrued Legal Expenses - Patent Accrual for court ordered attorneys fees Accrual for court ordered attorneys fees Accrual for court ordered attorneys fees Foreign taxes payable Foreign taxes payable Amounts due to foreign jurisdictions for income taxes. Accrued consulting and other professional fees Accrued Professional Fees, Current Other accrued liabilities Other Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Statement of Comprehensive Income [Abstract] Net income (loss) including noncontrolling interests in operating subsidiaries Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrealized loss on short-term investments Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Unrealized gain on foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Add: reclassification adjustment for losses included in net income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Net (income) loss attributable to noncontrolling interests in subsidiaries Net Income (Loss) Attributable to Noncontrolling Interest Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Share-based Compensation [Abstract] Stock-based Incentive Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Commitments and Contingencies Disclosure [Abstract] Year: Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2018 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2019 Operating Leases, Future Minimum Payments, Due in Two Years 2020 Operating Leases, Future Minimum Payments, Due in Three Years 2021 Operating Leases, Future Minimum Payments, Due in Four Years 2022 Operating Leases, Future Minimum Payments, Due in Five Years Total minimum lease payments Operating Leases, Future Minimum Payments Due Disclosure of Grants in Period by Type [Abstract] Disclosure of Grants in Period by Type [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Time Based Vesting Conditions [Member] Time Based Vesting Conditions [Member] Time Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Performance Based Vesting Conditions [Member] Performance Based Vesting Conditions [Member] Performance Based Vesting Conditions Restricted Stock [Member] Restricted Stock [Member] Equity Option [Member] Equity Option [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Market Based Vesting Conditions, price Market Based Vesting Conditions, price Market Based Vesting Conditions, price Unvested Shares with Market Based Vesting Conditions Unvested Shares with Market Based Vesting Conditions Unvested Shares with Market Based Vesting Conditions Employee Service Share-based Compensation, Awards with market Cond, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Schedule of Property and Equipment [Table] Property, Plant and Equipment [Table] Property and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Furniture and Fixtures [Member] Furniture and Fixtures [Member] Computer Hardware and Software [Member] Computer Hardware and Software [Member] Computer Hardware and Software [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Property and Equipment [Line Items] Property, Plant and Equipment [Line Items] Estimated useful lives, years Property, Plant and Equipment, Estimated Useful Lives Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Treasury Stock [Member] Treasury Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] AOCI Attributable to Parent [Member] Accumulated Deficit [Member] Retained Earnings [Member] Noncontrolling Interests [Member] Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Common stock, shares outstanding Common Stock, Shares, Outstanding Net income (loss) attributable to Acacia Research Corporation Payments of Dividends Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Treasury stock, shares acquired Treasury Stock, Shares, Acquired Stock Repurchased During Period, Shares Stock Repurchased During Period, Shares Treasury stock, cost of shares acquired Treasury Stock, Value, Acquired, Cost Method Stock options exercised, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Proceeds from Stock Options Exercised Proceeds from Stock Options Exercised Stock options exercised, value Stock Issued During Period, Value, Stock Options Exercised Stock issued during period, shares, share-based compensation, net of forfeitures Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Non-cash stock compensation Share-based Compensation General and administrative expenses excluding share-based compensation General and administrative expenses excluding share-based compensation General and administrative expenses excluding share-based compensation Excess tax benefits from stock-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Payments to Noncontrolling Interests Payments to Noncontrolling Interests Contributions from noncontrolling interests in operating subsidiary, net Proceeds from (Payments to) Noncontrolling Interests Foreign Currency Transaction Gain (Loss), Unrealized Foreign Currency Transaction Gain (Loss), Unrealized Unrealized Gain (Loss) on Investments Unrealized Gain (Loss) on Investments Distributions to noncontrolling interests in operating subsidiary Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Balance Common stock, shares outstanding Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Goodwill [Line Items] Goodwill [Line Items] Goodwill, Impairment Loss Goodwill, Impairment Loss Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Short-term Investments [Abstract] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] US Treasury Securities [Member] US Treasury Securities [Member] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Gross Unrealized Gain Available-for-sale Securities, Gross Unrealized Gain Available-for-sale Securities, Gross Unrealized Loss Available-for-sale Securities, Gross Unrealized Loss Available-for-sale Securities Available-for-sale Securities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Details [Abstract] Details [Abstract] Patents [Abstract] Patents [Abstract] Patents Intangible Assets Disclosure [Text Block] Schedule of Treasury Stock by Class Class of Treasury Stock [Table Text Block] Employee Stock Option [Member] Employee Stock Option [Member] Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Outstanding at December 31, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Exercised Outstanding at December 31, 2016 Vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Exercisable at December 31, 2016 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Outstanding at December 31, 2015, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Exercised, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Outstanding at December 31, 2016, weighted average exercise price Vested, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Exercisable, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Outstanding at December 31, 2016, aggregate, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Vested, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested During the Period Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested During the Period Aggregate Intrinsic Value Exercisable, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized Compensation Expense Options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Income Statement [Abstract] Revenues Licenses Revenue Operating costs and expenses: Operating Costs and Expenses [Abstract] Cost of revenues: Cost of Revenue [Abstract] Inventor royalties Royalty Expense Contingent legal fees Contingent legal fees Contingent legal fees paid or payable to external counsel. Litigation and licensing expenses - patents Litigation and licensing expenses - patents Expenses incurred directly related to litigation and licensing of patents. Amortization of patents Amortization of Intangible Assets General and administrative expenses (including non-cash stock compensation expense of $8,885 in 2017, $9,062 in 2016 and $11,048 in 2015) General and Administrative Expense Other expenses - business development Research, consulting and other expenses - business development Expenses incurred directly related to business development research, consulting and other expenses. Impairment of Patent-Related Intangible Assets Impairment of Intangible Assets, Finite-lived Impairment of Goodwill Other Other Cost and Expense, Operating Total operating costs and expenses Operating Costs and Expenses Operating loss Operating Income (Loss) Gain on Conversion of Loan and Accrued Interest Gain on Conversion of Loan and Accrued Interest Gain on Conversion of Loan and Accrued Interest Gain on exercise of Primary Warrant Gain on exercise of Primary Warrant Gain on exercise of Primary Warrant Change in fair value of investment Change in fair value of investment Change in fair value of investment Income (Loss) from Equity Method Investments Income (Loss) from Equity Method Investments Other Income Other Income Investment Income, Interest Investment Income, Interest Total other income (expense) Other Nonoperating Income (Expense) Income (loss) from operations before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision for income taxes Income Tax Expense (Benefit) Net income (loss) including noncontrolling interests in subsidiaries Net (income) loss attributable to noncontrolling interests in subsidiaries Net income (loss) attributable to Acacia Research Corporation Common Stock, Dividends, Per Share, Cash Paid Common Stock, Dividends, Per Share, Cash Paid EX-101.PRE 13 actg-20171231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 acaciaresearchcorp05.jpg begin 644 acaciaresearchcorp05.jpg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businessmodeloptionsv4a05.jpg begin 644 businessmodeloptionsv4a05.jpg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�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end GRAPHIC 16 stockperfgrapha01.jpg begin 644 stockperfgrapha01.jpg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end XML 17 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1

Document and Entity Information Document - USD ($)
12 Months Ended

Dec. 31, 2017

Mar. 01, 2018

Jun. 30, 2017

Entity Information [Line Items]

Entity Registrant Name ACACIA RESEARCH CORP

Entity Central Index Key 0000934549

Current Fiscal Year End Date --12-31

Entity Filer Category Accelerated Filer

Document Type 10-K

Document Period End Date Dec. 31, 2017

Document Fiscal Year Focus 2017

Document Fiscal Period Focus FY

Amendment Flag false

Entity Common Stock, Shares Outstanding 50,637,882

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Public Float $ 202,307,000

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_EntityInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 18 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Current assets:

Cash and cash equivalents $ 136,604 $ 127,540

Restricted cash 0 11,512

Short-term investments 0 19,443

Accounts receivable 153 26,750

Prepaid expenses and other current assets 2,938 3,245

Total current assets 139,695 188,490

Investments at fair value 104,754 0

Equity Method Investments 2,195 0

Loan receivable and accrued interest 0 18,616

Investment warrants 0 1,960

Patents, net of accumulated amortization 61,917 86,319

Other assets 207 618

Total assets 308,768 296,003

Current liabilities:

Accounts payable and accrued expenses 7,956 14,283

Royalties and contingent legal fees payable 1,601 13,908

Total current liabilities 9,557 28,191

Other liabilities 3,552 369

Total liabilities 13,109 28,560

Commitments and contingencies (Note 11)

Stockholders' equity:

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding 0 0

Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,639,926 shares issued and outstanding as of December 31, 2017 and 50,476,042 shares issued and outstanding as of December 31, 2016 51 50

Treasury stock, at cost, 1,729,408 shares as of December 31, 2017 and 2016 (34,640) (34,640)

Additional paid-in capital 648,996 642,453

Accumulated comprehensive loss (88) (76)

Accumulated deficit (320,018) (342,198)

Total Acacia Research Corporation stockholders’ equity 294,301 265,589

Noncontrolling interests in operating subsidiaries 1,358 1,854

Total stockholders’ equity 295,659 267,443

Total liabilities and stockholders' equity $ 308,768 $ 296,003

X

- Definition
Investments at fair value
+ References
No definition available.
+ Details

Name: actg_Investmentsatfairvalue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investment warrants and shares
+ References
No definition available.
+ Details

Name: actg_Investmentwarrants

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_RoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestmentsAndReceivablesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_OtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(g))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 19 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Balance Sheets Parentheticals - $ / shares

Dec. 31, 2017

Dec. 31, 2016

Preferred stock, shares authorized 10,000,000 10,000,000

Preferred stock, par value per share $ 0.001 $ 0.001

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value per share $ 0.001 $ 0.001

Common stock, shares authorized 100,000,000 100,000,000

Common stock, shares issued 50,639,926 50,476,042

Common stock, shares outstanding 50,639,926 50,476,042

Treasury stock, shares 1,729,408 1,729,408

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 20 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Income Statement [Abstract]

Revenues $ 65,402 $ 152,699 $ 125,037

Cost of revenues:

Inventor royalties 4,952 22,730 18,462

Contingent legal fees 16,682 26,474 16,169

Litigation and licensing expenses - patents 18,219 27,858 39,373

Amortization of patents 22,154 34,208 53,067

General and administrative expenses (including non-cash stock compensation expense of $8,885 in 2017, $9,062 in 2016 and $11,048 in 2015) 26,030 32,919 38,176

Other expenses - business development 1,189 3,079 3,391

Impairment of Patent-Related Intangible Assets 2,248 42,340 74,731

Impairment of Goodwill 0 0 30,149

Other 1,200 500 4,141

Total operating costs and expenses 92,674 190,108 277,659

Operating loss (27,272) (37,409) (152,622)

Gain on Conversion of Loan and Accrued Interest 2,671 0 0

Gain on exercise of Primary Warrant 4,616 0 0

Change in fair value of investment 42,239 0 0

Income (Loss) from Equity Method Investments (220) 0 0

Other Income 1,000 0 0

Investment Income, Interest 1,605 798 (56)

Total other income (expense) 51,911 798 (56)

Income (loss) from operations before provision for income taxes 24,639 (36,611) (152,678)

Provision for income taxes (2,955) (18,188) (4,800)

Net income (loss) including noncontrolling interests in subsidiaries 21,684 (54,799) (157,478)

Net (income) loss attributable to noncontrolling interests in subsidiaries 496 732 (2,558)

Net income (loss) attributable to Acacia Research Corporation 22,180 (54,067) (160,036)

Net Loss Available to Common Stockholders, Basic and Diluted $ 22,147 $ (54,067) $ (160,730)

Earnings Per Share, Basic and Diluted $ 0.44 $ (1.08) $ (3.25)

Weighted Average Number of Shares Outstanding, Basic 50,495,119 50,075,847 49,505,817

Weighted Average Number of Shares Outstanding, Diluted 50,692,012 50,075,847 49,505,817

Common Stock, Dividends, Per Share, Cash Paid $ 0.000 $ 0.000 $ 0.500

X

- Definition
Change in fair value of investment
+ References
No definition available.
+ Details

Name: actg_Changeinfairvalueofinvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gain on Conversion of Loan and Accrued Interest
+ References
No definition available.
+ Details

Name: actg_GainonConversionofLoanandAccruedInterest

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gain on exercise of Primary Warrant
+ References
No definition available.
+ Details

Name: actg_GainonexerciseofPrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate dividends paid during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareCashPaid

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfRevenueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(13)(f))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(b))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue and income classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.4)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 21 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Operations Parentheticals - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Non-cash stock compensation $ 8,885 $ 9,062 $ 11,048

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 22 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Statement of Comprehensive Income [Abstract]

Net income (loss) including noncontrolling interests in operating subsidiaries $ 21,684 $ (54,799) $ (157,478)

Other comprehensive income (loss):

Unrealized loss on short-term investments (40) 40 (356)

Unrealized gain on foreign currency translation 58 77 (123)

Add: reclassification adjustment for losses included in net income (30) 22 617

Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 21,672 (54,660) (157,340)

Net (income) loss attributable to noncontrolling interests in subsidiaries (496) (732) 2,558

Comprehensive income $ 22,168 $ (53,928) $ (159,898)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32157-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands

Total

Common Stock [Member]

Treasury Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Accumulated Deficit [Member]

Noncontrolling Interests [Member]

Balance at Dec. 31, 2014 $ 489,048 $ 50 $ (34,640) $ 646,595 $ (353) $ (128,095) $ 5,491

Common stock, shares outstanding at Dec. 31, 2014 50,065,382

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (160,036) (160,036)

Payments of Dividends (25,434) (25,434)

Stock options exercised, shares 135,000

Proceeds from Stock Options Exercised 938

Stock options exercised, value 938 938

Stock issued during period, shares, share-based compensation, net of forfeitures 450,857

Non-cash stock compensation 11,048 $ 1 11,047

Net (income) loss attributable to noncontrolling interests in subsidiaries 2,558 2,558

Payments to Noncontrolling Interests 4,105

Foreign Currency Transaction Gain (Loss), Unrealized (123) (123)

Unrealized Gain (Loss) on Investments 261 261

Distributions to noncontrolling interests in operating subsidiary (4,105) (4,105)

Payments for Repurchase of Common Stock 0

Balance at Dec. 31, 2015 314,155 $ 51 (34,640) 633,146 (215) (288,131) 3,944

Common stock, shares outstanding at Dec. 31, 2015 50,651,239

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (54,067) (54,067)

Payments of Dividends $ 0

Stock Repurchased During Period, Shares (13,529)

Stock options exercised, shares 100,992

Proceeds from Stock Options Exercised $ 326

Stock options exercised, value 326

Stock issued during period, shares, share-based compensation, net of forfeitures (262,660)

Non-cash stock compensation 9,062 $ (1) 9,063

Net (income) loss attributable to noncontrolling interests in subsidiaries (732) (732)

Payments to Noncontrolling Interests 1,358 (1,358)

Foreign Currency Transaction Gain (Loss), Unrealized 99

Unrealized Gain (Loss) on Investments 40

Distributions to noncontrolling interests in operating subsidiary (1,358)

Payments for Repurchase of Common Stock (82)

Balance at Dec. 31, 2016 $ 267,443 $ 50 (34,640) 642,453 (76) (342,198) 1,854

Common stock, shares outstanding at Dec. 31, 2016 50,476,042 50,476,042

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation $ 22,180 22,180

Payments of Dividends $ 0

Stock Repurchased During Period, Shares (8,669)

Stock options exercised, shares 208,000 207,863

Proceeds from Stock Options Exercised $ 745 $ 1 744

Stock options exercised, value 745

Stock issued during period, shares, share-based compensation, net of forfeitures (35,310)

Non-cash stock compensation 8,885 $ 0

General and administrative expenses excluding share-based compensation 5,844

Net (income) loss attributable to noncontrolling interests in subsidiaries (496) (496)

Payments to Noncontrolling Interests 0

Foreign Currency Transaction Gain (Loss), Unrealized 28

Unrealized Gain (Loss) on Investments (40)

Payments for Repurchase of Common Stock (45)

Balance at Dec. 31, 2017 $ 295,659 $ 51 $ (34,640) $ 648,996 $ (88) $ (320,018) $ 1,358

Common stock, shares outstanding at Dec. 31, 2017 50,639,926 50,639,926

X

- Definition
General and administrative expenses excluding share-based compensation
+ References
No definition available.
+ Details

Name: actg_Generalandadministrativeexpensesexcludingsharebasedcompensation

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64836518&loc=d3e30690-110894

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64836518&loc=d3e30700-110894

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossUnrealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 24 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Cash Flows - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Cash flows from operating activities:

Net income (loss) including noncontrolling interests in operating subsidiaries $ 21,684,000 $ (54,799,000) $ (157,478,000)

Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:

Gain on Conversion of Loan and Accrued Interest (2,671,000) 0 0

Gain on exercise of Primary Warrant (4,616,000) 0 0

Change in fair value of investment (42,239,000) 0 0

Depreciation and amortization 22,243,000 34,355,000 53,289,000

Non-cash stock compensation 8,885,000 9,062,000 11,048,000

Impairment of Patent-Related Intangible Assets 2,248,000 42,340,000 74,731,000

Impairment of Goodwill 0 0 30,149,000

Other (374,000) (477,000) (109,000)

Changes in assets and liabilities:

Increase (Decrease) in Restricted Cash 11,512,000 (787,000) (10,725,000)

Accounts receivable 26,597,000 6,750,000 (13,332,000)

Prepaid expenses and other assets (135,000) 1,593,000 (619,000)

Accounts payable and accrued expenses / costs (6,349,000) (3,006,000) 2,570,000

Royalties and contingent legal fees payable (12,307,000) (970,000) 527,000

Net cash provided by (used in) operating activities 24,478,000 34,061,000 (9,949,000)

Cash flows from investing activities:

Payments to Acquire Other Investments (31,514,000) 0 0

Payments to Acquire Notes Receivable (4,000,000) (20,000,000) 0

Purchase of property and equipment (2,000) (4,000) (8,000)

Purchase of available-for-sale investments (448,388,000) (62,633,000) (23,296,000)

Sale of available-for-sale investments 43,232,000 82,115,000

Proceeds from Sale and Maturity of Marketable Securities 43,232,000 82,115,000

Patent acquisition costs 0 (1,225,000) (19,504,000)

Net cash provided by (used in) investing activities (16,114,000) (40,630,000) 39,307,000

Cash flows from financing activities:

Payments of Dividends 0 0 (25,434,000)

Distributions to noncontrolling interests in operating subsidiary 0 (1,358,000) (4,105,000)

Proceeds from the exercise of stock options 745,000 326,000 938,000

Repurchases of common stock (45,000) (82,000) 0

Net cash provided by (used in) financing activities 700,000 (1,114,000) (28,601,000)

Increase in cash and cash equivalents 9,064,000 (7,683,000) 757,000

Cash and cash equivalents, beginning 127,540,000 135,223,000 134,466,000

Cash and cash equivalents, ending 136,604,000 127,540,000 135,223,000

Patent acquisition costs included in accrued expenses $ 0 $ 0 $ 1,000,000

X

- Definition
Change in fair value of investment
+ References
No definition available.
+ Details

Name: actg_Changeinfairvalueofinvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gain on Conversion of Loan and Accrued Interest
+ References
No definition available.
+ Details

Name: actg_GainonConversionofLoanandAccruedInterest

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gain on exercise of Primary Warrant
+ References
No definition available.
+ Details

Name: actg_GainonexerciseofPrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Increase (decrease) in royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Patent Acquisition Costs Included in Accrued Expenses
+ References
No definition available.
+ Details

Name: actg_PatentAcquisitionCostsIncludedInAccruedExpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_IncreaseDecreaseInRestrictedCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingActivitiesCashFlowStatement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562
+ Details

Name: us-gaap_PaymentsToAcquireAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireNotesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to acquire investments classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireOtherInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1

Description of Business
12 Months Ended

Dec. 31, 2017

DESCRIPTION OF BUSINESS [Abstract]

Description of Business
DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into IP related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the intellectual property (“IP”) industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia’s primary licensing and enforcement business.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia’s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.

During fiscal year 2017 Acacia obtained control of one new patent portfolio. In fiscal year 2016, Acacia obtained control of two new patent portfolios, compared to three new patent portfolios, and six new patent portfolios in fiscal years 2015 and 2014, respectively.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

X

- Definition
DESCRIPTION OF BUSINESS [Abstract]
+ References
No definition available.
+ Details

Name: actg_DescriptionOfBusinessAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP).

Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund.

Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology owned by Acacia’s operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

(i)
Level 1 - Observable Inputs:  Quoted prices in active markets for identical investments;
(ii)
Level 2 - Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
(iii)
Level 3 - Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. At December 31, 2017, all of the Company’s investments recorded at fair value were valued utilizing Level 3 - unobservable inputs. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1

Level 2

Level 3
Assets as of December 31, 2017:

Investment at fair value (Note 7)⁽¹⁾
$
—

$
—

$
104,754

Assets as of December 31, 2016:

Short-term investments⁽¹⁾
$
19,443

$
—

$
—

____________________
⁽¹⁾There were no transfers between fair value hierarchy categories for the period presented.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended December 31, 2017 is as follows (in thousands):

Investment at Fair Value

Common Stock

Warrants

Total
Opening balance as of January 1, 2017
$
—

$
—

$
—

Total gains and losses included in earnings for the period⁽¹⁾

Gain on conversion of loans and accrued interest
2,671

—

2,671

Gain on exercise of Primary Warrant
—

4,616

4,616

Change in fair value of investment, net
33,922

8,317

42,239

Purchases, issues, sales and settlements

Purchases and issues⁽²⁾
54,202

1,026

55,228

Total recurring fair value measurements⁽¹⁾
$
90,795

$
13,959

$
104,754

____________________
⁽¹⁾All gains and losses included in earnings for the period presented relate to assets and liabilities held as of December 31, 2017.
⁽²⁾ Refer to Note 7 for information regarding purchase and issues activity for the years ended December 31, 2017 and 2016.

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Short-term Investments.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Impairment of Short-term Investments. Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 54%, 21% and 10%, respectively, of revenues recognized during the year ended December 31, 2017. Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. One licensee individually represented 100% of accounts receivable at December 31, 2017. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016.

For 2017, 2016 and 2015, 39%, 79% and 49%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, accounts receivables, and current liabilities approximates their fair values due to their short-term maturities.

Property and Equipment.  Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).

Equity Method Investments. Equity investments without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting, and classified within “Equity Method Investments” in the consolidated balance sheet. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the consolidated statements of operations.

Impairment of Investments. Acacia reviews its equity method investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.
Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position.
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate.

The FASB issued a new standard, effective January 1, 2017, that allows entities to make a policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. Effective January 1, 2017, the Company elected to account for forfeitures of awards as they occur. The prior standard required the Company to estimate the number of awards for which the requisite service period is expected to be rendered and base the accruals of compensation cost on the estimated number of awards that will vest.

The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

For the Years Ended

December 31, 2017

December 31, 2016

Risk-free interest rate
1.77%

1.1%
Term
4.37

3.06
Volatility
51%

53%
Dividend yield
—%

—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the periods presented.  Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 10, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying consolidated statements of operations.

Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note 7, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2017

2016

2015
Numerator (in thousands):

Basic and Diluted

Net income (loss) attributable to Acacia Research Corporation

$
22,180

$
(54,067
)

$
(160,036
)
Undistributed earnings allocated to participating securities

(33
)

—

—

Total dividends declared / paid

—

—

(25,434
)
Dividends attributable to common stockholders

—

—

24,740

Net income (loss) attributable to common stockholders – basic and diluted

$
22,147

$
(54,067
)

$
(160,730
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic

50,495,119

50,075,847

49,505,817

Effect of potentially dilutive securities:

Common stock options and restricted stock units

196,893

—

—

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted

50,692,012

50,075,847

49,505,817

Basic and diluted net loss per common share

$
0.44

$
(1.08
)

$
(3.25
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

4,425,187

3,682,532

71,468


Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company may be required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under existing guidance. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales or usage based royalties. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its intellectual property is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The amendments for this new accounting standard update are effective for interim and annual reporting periods beginning after December 15, 2017, and are to be applied retrospectively or via the cumulative effect as of the date of adoption, with early application not permitted. The Company expects to use the modified retrospective method of adoption and will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings in the period of initial application (first quarter of 2018 for Acacia). Comparative prior year periods would not be adjusted. The preliminary estimate of the cumulative effect of initially applying the new revenue standard is an decrease to beginning accumulated deficit of $3.0 million, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods. Management continues to assess the impact of this new standard on the Company’s consolidated financial statements and related disclosures, including ongoing contract reviews. Preliminary estimates of the adjustment upon initial adoption may change in connection with completion of the Company’s adoption procedures in the first quarter of 2018.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017, with early adoption
permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Recently Adopted.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18854-107790
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1

Short-term Investments
12 Months Ended

Dec. 31, 2017

Short-term Investments [Abstract]

Short-Term Investments
SHORT-TERM INVESTMENTS

Short-term investments for the periods presented were comprised of the following (in thousands):

December 31, 2016
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
19,403

$
40

$
—

$
19,443

There were no short-term investments at December 31, 2017. Short-term investments at December 31, 2016 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2017.

For the years ended December 31, 2017 and 2016, proceeds from the sale of short-term investments classified as available-for-sale were $467,790,000 and $43,232,000, respectively. Gross unrealized gains and losses were not material for the years ended December 31, 2017 and 2016. For the year ended December 31, 2015, proceeds from the sale of short-term investments were $82,115,000 and gross realized losses were $617,000.

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Debt Security
-URI http://asc.fasb.org/extlink&oid=6509901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27290-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Equity Security
-URI http://asc.fasb.org/extlink&oid=6511694

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27405-111563
+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accounts Payable and Accrued Expenses
12 Months Ended

Dec. 31, 2017

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2017 and 2016 (in thousands):

2017

2016

Payroll and other employee benefits

$
465

$
1,593

Accrued vacation

294

533

Accrued legal expenses - patent

5,479

6,564

Foreign taxes payable

15

3,150

Accrued consulting and other professional fees

1,364

1,967

Other accrued liabilities

339

476

$
7,956

$
14,283

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1

Patents
12 Months Ended

Dec. 31, 2017

Patents [Abstract]

Patents

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to six years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2017 and 2016 are as follows (in thousands):

2017

2016

Gross carrying amount - patents

$
444,137

$
444,362

Accumulated amortization - patents⁽¹⁾

(382,220
)

(358,043
)
Patents, net

$
61,917

$
86,319

⁽¹⁾ Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 4 years. Scheduled annual aggregate amortization expense is estimated to be $20,542,000 in 2018, $18,527,000 in 2019, $6,134,000 in 2020, $5,261,000 in 2021, $5,256,000 in 2022 and $6,197,000 thereafter.

For the years ended December 31, 2017, 2016 and 2015, Acacia paid patent investment costs totaling $0, $1,225,000 and $19,504,000, respectively. The patents have initial estimated economic useful lives ranging from two to seven years.

Acacia recorded impairment of patent-related intangible asset charges totaling $2,248,000, $42,340,000 and $74,731,000 for the years ended December 31, 2017, 2016 and 2015, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment charges for the periods presented consisted of the excess of the asset’s carrying value over its estimated fair value.

In December 2015, Acacia’s subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to partial impairment charges on the portfolio in the fourth quarter of 2015. Fiscal year 2016 patent impairment charges included the impairment of the remaining carrying value for the Adapitx portfolio. In addition, for the year ended December 31, 2015 analysis, management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company’s assessment of probabilities of realization given the recent adverse trial outcomes. Additionally, patent impairment charges include the carrying value of other patent portfolios for which, in 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1

Goodwill Impairment Charges (Notes)
12 Months Ended

Dec. 31, 2017

Goodwill and Patent Impairment Charges [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]
GOODWILL IMPAIRMENT CHARGE (Fiscal Year 2015)
Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company’s single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:
•
significant consistent gradual decline in the Company’s stock price for a sustained period;
•
significant underperformance relative to expected historical or projected future operating results;
•
significant changes in the manner of use of assets or the strategy for the Company’s overall business;
•
significant negative industry or economic trends; and
•
significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

     In connection with Acacia’s annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:
•
Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.
•
Significant consistent gradual decline in the Company’s stock price. Historically, the Company’s stock price had been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company’s stock price volatility has continued, trending downward. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company’s stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.
•
Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.
At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:
•
At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company’s stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company’s assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.
•
The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company’s stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company’s single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.
•
Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.
•
The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company’s reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company’s single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

X

- Definition
Goodwill and Patent Impairment Charges [Abstract]
+ References
No definition available.
+ Details

Name: actg_GoodwillandPatentImpairmentChargesAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1

Investments (Notes)
12 Months Ended

Dec. 31, 2017

Investments, All Other Investments [Abstract]

Investments and Other Noncurrent Assets [Text Block]
INVESTMENTS

Investment at Fair Value
Veritone Investment Agreement. On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provided for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permitted Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the consolidated statements of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”). On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year $700,000 warrants to purchase shares of Veritone’s common stock at an exercise price of $13.6088 per share. Veritone’s initial public offering date was May 12, 2017. Upon Veritone’s consummation of its public offering of its common stock on May 17, 2017 (“IPO”), all outstanding principal and accrued interest under the Veritone Loans, totaling $20.7 million, automatically converted into 1,523,746 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.
In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of $13.6088 per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone’s IPO, resulting in the purchase by Acacia of an additional 2,150,335 shares of Veritone common stock, at an aggregate purchase price of $29.3 million. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional 809,400 shares of Veritone common stock at an exercise price of $13.6088 per share, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.
Veritone Bridge Loan. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the “Veritone Bridge Loan”), which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, Acacia funded the initial $1.0 million advance (the “First Bridge Loan”). On April 14, 2017, Acacia funded the second $1.0 million advance (the “Second Bridge Loan”). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of $4.0 million and $21,000, respectively, automatically converted into 295,440 shares of Veritone’s common stock at a conversion price of $13.6088 per share.
In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) 60,000 shares of Veritone common stock (“Upfront Shares”), (ii) 90,000 shares of Veritone common stock (the “Bridge Installment Shares”), and (iii) 10-year warrants to purchase up to 157,000 shares of Veritone common stock with other terms and conditions similar to the warrants described above.

All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017. The Veritone common shares are subject to a lock-up agreement that expires on February 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of December 31, 2017.

Accounting Prior to Veritone IPO. Prior to conversion, Acacia’s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the “Loans”) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (“Veritone Shares”) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO.

Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone’s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from 40% to 50%, (2) financing probabilities ranging from 25% to 75%, (3) marketability discount of 7% and (4) 100% investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the consolidated statements of operations. As of May 2017, the unamortized loan discount totaled $1.7 million. Interest income for the year ended December 31, 2017 was $1.1 million, including accretion of the loan discount of $630,000. The effective yield on the Loans for the year ended December 31, 2017 ranged from 9% to 53%.
Accounting Subsequent to Veritone IPO. Upon Veritone’s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a 20% ownership interest in Veritone (excluding warrants). Based on Acacia’s representation on the Veritone board of directors and Acacia’s 20% ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of December 31, 2017, Acacia’s ownership interest in Veritone, on a fully-diluted basis, was approximately 23%.
Acacia’s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone’s common stock on The NASDAQ Global Market (the “NASDAQ”) on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (“DLOM”) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia’s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at December 31, 2017: risk-free interest rates ranging from 1.94% to 2.37%; expected terms ranging from three to nine years; volatilities ranging from 45% to 55%; and a dividend yield of zero. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:

Veritone Common Stock

Veritone Warrants

IPO Date

December 31, 2017

IPO Date

December 31, 2017
Estimated DLOM applied

5.7%

5%

5.7%

10%
Volatility assumptions

35%

37%

35%

72
%
-
87%
Term assumptions

6 months

2 months

6 months

5 months
At December 31, 2017, the fair value of the 4,119,521 shares of Veritone common stock owned by Acacia totaled $90,795,000. At December 31, 2017, the fair value of the 1,120,432 common stock purchase warrants held by Acacia totaled $13,959,000. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 10% decrease in the fair value of our investment in Veritone at December 31, 2017, and a corresponding decrease in the net investment gain reflected in the consolidated statements of operations for the year ended December 31, 2017.
Changes in the fair value of Acacia’s investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the period from the IPO on May 17, 2017 to December 31, 2017, the accompanying consolidated statements of operations reflected the following (in thousands):

2017
Gain on conversion of loans and accrued interest⁽¹⁾

$
2,671

Gain on exercise of warrant⁽²⁾

4,616

Change in fair value of investment, warrants

8,317

Change in fair value of investment, common stock

33,922

Net unrealized gain on investment at fair value

$
49,526

__________________________
⁽¹⁾ Pre-conversion difference between carrying value of Loan and accrued interest and the estimated fair value of common stock discounted for lack of marketability.
⁽²⁾Pre-conversion difference between carrying value of Primary Warrant and the estimated fair value of common stock and 10% Warrant discounted for lack of marketability.
Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):

Nine Months Ended
September 30, 2017

(Unaudited)
Revenues

$
10,914

Gross profit

10,090

Operating expenses

44,024

Other income (expense), net

(12,872
)
Net loss attributable to common stockholders

(51,281
)
Net loss per share attributable to common stockholders - basic and diluted

$
(5.94
)

September 30,
2017
Current assets

$
78,509

Noncurrent assets

1,173

Total Assets

$
79,682

Current liabilities

$
31,836

Noncurrent liabilities

14

Total liabilities

31,850

Preferred stock

—

Total stockholders’ equity (deficit)

47,832

Total liabilities, preferred stock and stockholders’ equity

$
79,682

Equity Method Investment

In June 2017, Acacia made an investment in Miso Robotics, Inc. (“Miso Robotics”), an innovative leader in robotics and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Miso Robotics, and one board seat. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry. In addition, Acacia also entered into an intellectual property services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the entire restaurant industry. Based on Acacia’s representation on the Miso Robotics board of directors, and greater than 20% ownership interest in Miso Robotics, the equity method of accounting was applied. The fair value option was not elected for Acacia’s investment in Miso Robotics due to the lack of a readily determinable fair market value. For the year ended December 31, 2017, equity in losses of investee related to Miso Robotics totaled $220,000.

X

- Definition
The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).
+ References
No definition available.
+ Details

Name: us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stockholders' Equity
12 Months Ended

Dec. 31, 2017

Stockholders' Equity Note [Abstract]

Stockholders' Equity
STOCKHOLDERS’ EQUITY

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 in 2015. On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

Tax Benefits Preservation Plan. On March 15, 2016, Acacia’s Board of Directors announced that it unanimously approved the adoption of a Tax Benefits Preservation Plan (the “Plan”). The purpose of the Plan is to protect the Company’s ability to utilize potential tax assets, such as net operating loss carryforwards (“NOLs”) and tax credits to offset potential future taxable income.

The Plan is designed to reduce the likelihood that the Company will experience an ownership change by discouraging any (i) person or group from acquiring beneficial ownership of 4.9% or more of the Company’s outstanding common stock and (ii) any existing shareholders who, as of the time of the first public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company’s then-outstanding shares of the Company’s common stock from acquiring additional shares of the Company’s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.

In connection with the adoption of the Plan, Acacia’s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company’s common stock to shareholders of record at the close of business on March 16, 2016. On or after the distribution date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company’s Series A Junior Participating Preferred Stock, $0.001 par value for a purchase price of $15.00.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes
12 Months Ended

Dec. 31, 2017

Income Tax Disclosure [Abstract]

Income Taxes
INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2017

2016

2015

Current:

Federal

$
—

$
—

$
—

State

90

262

379

Foreign

2,865

17,926

4,421

Total current

2,955

18,188

4,800

Deferred:

Federal

—

—

—

State

—

—

—

Total deferred

—

—

—

Provision for income taxes

$
2,955

$
18,188

$
4,800

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2017 and 2016 (in thousands):

2017

2016

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
90,871

$
83,323

Stock compensation

2,635

2,416

Fixed assets and intangibles

6,197

14,343

Basis of investments in affiliates

984

2,195

Accrued liabilities and other

167

422

State taxes

35

90

Total deferred tax assets

100,889

102,789

Valuation allowance

(90,278
)

(102,627
)
Total deferred tax assets, net of valuation allowance

10,611

162

Deferred tax liabilities:

Unrealized gain on investments held at fair value

(10,587
)

—

Other

(24
)

(162
)
Total deferred tax liabilities

(10,611
)

(162
)
Net deferred tax assets (liabilities)

$
—

$
—

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2017

2016

2015

Statutory federal tax rate - (benefit) expense

35
%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

8
%

50
%

3
%
Foreign tax credit

—
%

(49
)%

(3
)%
Noncontrolling interests in operating subsidiaries

1
%

1
%

(1
)%
Goodwill

—
%

—
%

7
%
Nondeductible permanent items

3
%

—
%

—
%
Expired capital loss carryforwards

—
%

—
%

1
%
Change in tax rate

102
%

—
%

—
%
Valuation allowance

(137
)%

83
%

31
%

12
%

50
%

3
%

For the periods presented, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statements of operations in the period the determination is made.

At December 31, 2017, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $180,621,000 and $17,850,000, expiring between 2026 and 2037, and 2028 and 2037, respectively. Capital loss carryovers totaled $2,804,000 at December 31, 2017, expiring in 2019 and 2020.

At December 31, 2017, approximately $26,326,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2017, Acacia had approximately $51,126,000 of foreign tax credits, expiring between 2018 and 2026. In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

Tax expense for the periods presented primarily reflects foreign taxes withheld on revenue agreements executed with licensees in foreign jurisdictions and other state taxes. Excluding the impact of the change in valuation allowance and the impact of the federal tax rate change under the change in tax law described below, annual effective tax rates were 47%, (33)% and (28)%, for fiscal years 2017, 2016 and 2015, respectively. Results for fiscal year 2017 included an unrealized gain on Acacia’s investment in Veritone which created a deferred tax liability totaling approximately $10,587,000. The future anticipated reversal of this deferred tax liability provides for a source of taxable income that allows for the realizability of existing deferred tax assets that have been reduced by a valuation allowance for the periods presented. The effective tax rate reflects both the recognition of the deferred tax liability and the reversal of valuation allowance

Effective January 1, 2017, the Company adopted a new standard that requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. The adoption of this standard resulted in the Company recognizing gross federal and state deferred tax assets of $21,350,000 and $1,559,000, respectively, related to the impact of share-based payments to employees in prior periods. These deferred tax assets are fully offset by a valuation allowance and were impacted by the change in tax rate described below.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2011. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2017 and 2016, the Company had total unrecognized tax benefits of approximately $808,000. No interest and penalties have been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2017, if recognized, approximately $808,000 of tax benefits, net of valuation allowance, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2017 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to 21%, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of these changes are effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.
While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we have reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately $25,261,000 in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets as of December 31, 2017, the change in tax law did not have a material impact on our consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans
12 Months Ended

Dec. 31, 2017

Share-based Compensation [Abstract]

Stock-based Incentive Plans
EQUITY-BASED INCENTIVE PLANS

Stock-Based Incentive Plans

The 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•
Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•
Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•
Automatic Option Grant Program. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan. At December 31, 2017, there were 660,000 shares available for grant under the 2013 Plan.

The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At December 31, 2017, there were 727,000 shares available for grant under the 2016 Plan.

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval. As of December 31, 2017, there are 7,279,000 shares of common stock reserved for issuance under the Plans.

Stock-based award grant activity for the periods presented was as follows:

2017

2016

Shares

Aggregate fair value (in thousands)

Shares

Aggregate fair value (in thousands)
Restricted stock awards with performance-based vesting conditions

—

$
—

138,000

$
431

Stock options with time-based service vesting conditions

1,368,000

2,930

3,434,000

5,704

Stock options with market-based vesting conditions

—

—

2,250,000

5,530

Stock options with performance-based vesting conditions

—

—

200,000

487

Total incentive awards granted

1,368,000

$
2,930

6,022,000

$
12,152

During the year ended December 31, 2016 the Company granted restricted stock awards and stock options (with weighted-average exercise price of $5.75 per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of December 31, 2017, 102,000 (net of forfeitures) shares of restricted stock with performance-based vesting conditions were outstanding and unvested. During the year ended December 31, 2017, all stock options with performance-based vesting conditions expired unvested. As of December 31, 2017, there was no unrecognized expense for awards with performance-based vesting conditions.

During the year ended December 31, 2016, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of $5.75 per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of 25% upon the Company’s achievement of 30-day average share prices ranging from $7.00 to $10.00. As of December 31, 2017, 1,687,500 options with market-based vesting conditions remain unvested. As of December 31, 2017, there was no unrecognized expense for options with market-based vesting conditions.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2017:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value
Outstanding at December 31, 2016

5,596,000

$
4.93

Granted

1,368,000

$
5.52

Exercised

(208,000
)

$
3.57

Expired/forfeited

(926,000
)

$
4.90

Outstanding at December 31, 2017

5,830,000

$
5.13

5.8 years

$
856,000

Vested

1,959,000

$
4.84

5.8 years

$
434,000

Exercisable at December 31, 2017

1,959,000

$
4.84

5.8 years

$
434,000

The aggregate intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 was $296,000, $344,000, and $751,000, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2017 was $351,000. The aggregate fair value of options granted during the year ended December 31, 2017 was $2,930,000. The aggregate fair value of options vested during the year ended December 31, 2017 and 2016 was $2,009,000 and $2,342,000, respectively.  No options were granted or vested during the year ended December 31, 2015. As of December 31, 2017, the total unrecognized compensation expense related to nonvested stock option awards was $3,654,000, which is expected to be recognized over a weighted-average term of approximately 2 years.

The following table summarizes nonvested restricted share activity for the year ended December 31, 2017:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value
Nonvested restricted stock at December 31, 2016

333,000

$
8.9

Granted

—

$
—

Vested

(120,000
)

$
12.95

Canceled

(90,000
)

$
9.10

Nonvested restricted stock at December 31, 2017

123,000

$
4.77

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2016 and 2015 was $3.12 and $12.83, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2017, 2016 and 2015 was $1,560,000, $5,243,000 and $11,494,000, respectively. As of December 31, 2017, the total unrecognized compensation expense related to nonvested restricted stock awards was $53,000, which is expected to be recognized over a weighted-average period of approximately 2 months.

The following table summarizes restricted stock unit activity for the year ended December 31, 2017:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value
Nonvested restricted stock units outstanding at December 31, 2016

14,000

$
16.27

Vested

(12,000
)

$
16.18

Nonvested restricted stock units outstanding at December 31, 2017

2,000

$
16.72

Vested restricted stock units outstanding at December 31, 2017

60,000

$
15.38

The weighted-average grant date fair value of restricted stock units granted during the year ended December 31, 2015 was $16.72. There were no restricted units granted during the years ended December 31, 2017 and 2016. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2017, 2016 and 2015 was $200,000, $324,000 and $480,000, respectively. As of December 31, 2017, the total unrecognized compensation expense related to restricted stock unit awards was $1,000, which is expected to be recognized over a weighted-average period of approximately 1 month.

Profits Interest Plan

On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia’s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of December 31, 2017.

Acacia owns 60% of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As of December 31, 2017, AIP holds the Veritone 10% Warrant described at Note 7.

Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of $722,000. The fair value of the Units totaled $3,041,000 as of December 31, 2017. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.

The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (“GBM”) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note 7) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the year ended December 31, 2017, assumptions utilized in the GBM included a term of 4.4 years, stock price of $23.20, volatility of 50%, and risk free interest rates ranging from 1.76% to 2.40% for terms ranging from one to 10 years. The estimated DLOM utilized was 30%, based on assumptions including a term of approximately 4.4 years and a volatility of 85% for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately 4.4 years.

Compensation expense for the periods presented was comprised of the following:

2017

2016

2015

Restricted stock awards with time-based service conditions

$
1,025

$
4,071

$
10,575

Restricted stock unit awards with time-based service conditions

161

320

473

Restricted stock awards with performance-based vesting conditions

121

197

—

Stock options with time-based service vesting conditions

2,165

1,316

—

Stock options with market-based vesting conditions

2,372

3,158

—

Stock options with performance-based vesting conditions

—

—

—

Profits interests units

3,041

—

—

Total compensation expense

$
8,885

$
9,062

$
11,048

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1

Commitments and Contingencies
12 Months Ended

Dec. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2019 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2018
$
1,213

2019
1,369

2020
16

Total minimum lease payments
$
2,598

Rent expense for the years ended December 31, 2017, 2016 and 2015 approximated $1,392,000, $1,795,000 and $1,926,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows. Fiscal year 2017 includes estimated contingency accruals totaling $1,200,000. The estimated range of potential expenses related to these matters is $1,200,000 to $3,000,000. Fiscal year 2016 and 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $500,000 and $4,141,000, respectively.

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2017.

Bank Guarantee
In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. The Guarantee was secured by a cash deposit at the contracting bank, which was classified as restricted cash in the accompanying December 31, 2016 consolidated balance sheets, totaling $11,512,000. Upon resolution of all related matters in June 2017, the Guarantee was extinguished resulting in release of the cash collateral (and related restrictions on the cash balance) by the contracting bank. As a result, currently no amounts of Acacia’s cash and investments are restricted as to use.
Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. The Acacia IP Fund was terminated as of December 31, 2017. At December 31, 2017 and 2016, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):

2017

2016
Cash and other assets

$
986

$
1,118

Investments - noncurrent

1,905

2,933

Total assets

$
2,891

$
4,051

Accrued expenses and contributions

$
2,567

$
2,394

Net assets

$
324

$
1,657

2017

2016
Revenues

$
—

$
16

Operating expenses

390

572

Loss from operations

(390
)

(556
)
Net loss in equity method investments

(943
)

(1,013
)
Net loss

$
(1,333
)

$
(1,569
)

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73718637&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1

Retirement Savings Plan and Executive Severance Policy
12 Months Ended

Dec. 31, 2017

RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]

Retirement Savings Plan and Executive Severance Policy
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

Retirement Savings Plan.  Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy.  Under Acacia’s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

X

- Definition
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
+ References
No definition available.
+ Details

Name: actg_RetirementSavingsPlanAndExecutiveSeverancePolicyAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 80
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e2410-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39675-114964

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963
+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1

Supplemental Cash Flow Information
12 Months Ended

Dec. 31, 2016

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information
SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for state income taxes totaled $181,000, $223,000 and $211,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Foreign taxes withheld totaled $2,865,000, $14,776,000 and $4,421,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Refer to Note 4 for accrued foreign taxes payable.

Refer to Note 5 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 7 for information regarding noncash investing activity related to the investment in Veritone for the periods presented.

X

- Definition
The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586
+ Details

Name: us-gaap_CashFlowSupplementalDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1

Quarterly Financial Data
12 Months Ended

Dec. 31, 2017

Quarterly Financial Data [Abstract]

Quarterly Financial Data
QUARTERLY FINANCIAL DATA (unaudited)
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2017. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2017

2017

2017

2017

2016

2016

2016

2016

(Unaudited, in thousands, except share and per share information)
Revenues

$
8,854

$
16,457

$
36,633

$
3,458

$
24,721

$
41,351

$
64,658

$
21,969

Operating costs and expenses:

Cost of revenues:

Inventor royalties

666

4,273

—

13

1,573

—

17,844

3,313

Contingent legal fees

627

3,236

12,173

646

4,109

10,418

7,709

4,238

Litigation and licensing expenses - patents

6,386

4,134

4,073

3,626

7,723

7,324

7,348

5,463

Amortization of patents

5,515

5,571

5,625

5,443

10,760

10,759

6,467

6,222

General and administrative expenses (including non-cash stock compensation expense)

6,916

6,734

12,715

(335
)

7,994

7,535

8,334

9,056

Other expenses - business development

320

433

241

195

522

1,334

666

557

Impairment of patent-related intangible assets

—

—

2,248

—

—

40,165

—

2,175

Other

—

—

—

1,200

1,742

(1,242
)

—

—

Total operating costs and expenses

20,430

24,381

37,075

10,788

34,423

76,293

48,368

31,024

Operating income (loss)

(11,576
)

(7,924
)

(442
)

(7,330
)

(9,702
)

(34,942
)

16,290

(9,055
)
Total other income (expense)

696

(4,862
)

159,027

(102,950
)

(3
)

(52
)

261

592

Income (loss) before (provision for) benefit from income taxes

(10,880
)

(12,786
)

158,585

(110,280
)

(9,705
)

(34,994
)

16,551

(8,463
)
Provision for income taxes

(1,241
)

(1,478
)

(216
)

(20
)

(192
)

(5,927
)

(9,655
)

(2,414
)
Net income (loss) including noncontrolling interests

(12,121
)

(14,264
)

158,369

(110,300
)

(9,897
)

(40,921
)

6,896

(10,877
)
Net (income) loss attributable to noncontrolling interests in subsidiaries

291

12

96

97

(68
)

348

186

266

Net income (loss) attributable to Acacia Research Corporation

$
(11,830
)

$
(14,252
)

$
158,465

$
(110,203
)

$
(9,965
)

$
(40,573
)

$
7,082

$
(10,611
)
Net income (loss) per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.24
)

$
(0.28
)

$
3.13

$
(2.18
)

$
(0.20
)

$
(0.81
)

$
0.14

$
(0.21
)
Weighted-average number of shares outstanding, basic

50,333,056

50,499,948

50,554,234

50,590,460

49,925,550

50,015,869

50,124,302

50,237,784

Weighted-average number of shares outstanding, diluted

50,333,056

50,499,948

50,599,974

50,590,460

49,925,550

50,015,869

50,618,757

50,237,784

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialDataAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305
+ Details

Name: us-gaap_QuarterlyFinancialInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Subsequent Events (Notes)
12 Months Ended

Dec. 31, 2017

Subsequent Events [Abstract]

Subsequent Events [Text Block]
SUBSEQUENT EVENTS

Investments

In January 2018, Acacia entered into a Joint Venture and Services Agreement (“Joint Venture Agreement”) with Bitzumi, Inc., a company developing macro opportunities in the cryptocurrency and blockchain industries, including a next generation decentralized exchange. Bitzumi recently filed a Regulation A Offering Statement with the Securities and Exchange Commission and a listing application with NASDAQ. Acacia made an initial $1,000,000 equity investment in Bitzumi in January 2018. Under the Joint Venture Agreement, Acacia will provide various patent-related services to Bitzumi and has the option to invest up to an additional $9,000,000 to acquire Bitzumi common stock. In connection with Acacia’s initial investment, Acacia received a short-term warrant to purchase $4,000,000 of Bitzumi common shares. Under the Joint Venture Agreement, Acacia has a right to acquire up to an aggregate of $10.0 million of Bitzumi common shares (inclusive of Acacia’s initial $1,000,000 equity investment and exercise of Acacia’s short-term warrant) at a price, except as paid by Acacia for the initial investment and the exercise price of Acacia’s short-term warrant, of $2.50 per share. Upon meeting certain conditions set forth in the Joint Venture Agreement, Bitzumi will also issue Acacia a warrant for 30,000,000 shares of Bitzumi’s common stock. Acacia’s investment in Bitzumi represents its first venture in the cryptocurrency and blockchain marketplaces.

In February 2018, Acacia made an additional equity investment in Miso Robotics totaling $6,000,000, increasing its ownership interest in Miso Robotics to approximately 30%. In addition, Acacia acquired an additional board seat.

Stock Repurchase Program.

In February 2018, Acacia’s Board of Directors authorized the repurchase of up to $20,000,000 of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors will consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. The Stock Repurchase Program is set to expire on February 28, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Fiscal Period
Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP).

Consolidation, Subsidiaries or Other Investments, Consolidated Entities
Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Net income (loss) attributable to noncontrolling interest
Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund.

Revenue Recognition
Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology owned by Acacia’s operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses
Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Cash and Cash Equivalents

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Marketable Securities
Short-term Investments.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Impairment of Short-term Investments. Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentrations of Credit Risk

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable. Acacia places its cash equivalents and short-term investments primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 54%, 21% and 10%, respectively, of revenues recognized during the year ended December 31, 2017. Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. One licensee individually represented 100% of accounts receivable at December 31, 2017. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016.

For 2017, 2016 and 2015, 39%, 79% and 49%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Fair Value of Financial Instruments
Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, accounts receivables, and current liabilities approximates their fair values due to their short-term maturities.

Furniture and Equipment
Property and Equipment.  Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents
Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

Fair Value Measurements
Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

(i)
Level 1 - Observable Inputs:  Quoted prices in active markets for identical investments;
(ii)
Level 2 - Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
(iii)
Level 3 - Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. At December 31, 2017, all of the Company’s investments recorded at fair value were valued utilizing Level 3 - unobservable inputs. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1

Level 2

Level 3
Assets as of December 31, 2017:

Investment at fair value (Note 7)⁽¹⁾
$
—

$
—

$
104,754

Assets as of December 31, 2016:

Short-term investments⁽¹⁾
$
19,443

$
—

$
—

____________________
⁽¹⁾There were no transfers between fair value hierarchy categories for the period presented.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended December 31, 2017 is as follows (in thousands):

Investment at Fair Value

Common Stock

Warrants

Total
Opening balance as of January 1, 2017
$
—

$
—

$
—

Total gains and losses included in earnings for the period⁽¹⁾

Gain on conversion of loans and accrued interest
2,671

—

2,671

Gain on exercise of Primary Warrant
—

4,616

4,616

Change in fair value of investment, net
33,922

8,317

42,239

Purchases, issues, sales and settlements

Purchases and issues⁽²⁾
54,202

1,026

55,228

Total recurring fair value measurements⁽¹⁾
$
90,795

$
13,959

$
104,754

____________________
⁽¹⁾All gains and losses included in earnings for the period presented relate to assets and liabilities held as of December 31, 2017.
⁽²⁾ Refer to Note 7 for information regarding purchase and issues activity for the years ended December 31, 2017 and 2016.

Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).

Equity Method Investments. Equity investments without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting, and classified within “Equity Method Investments” in the consolidated balance sheet. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the consolidated statements of operations.

Impairment of investments [Policy Text Block]
Impairment of Investments. Acacia reviews its equity method investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.

Impairment of Long-Lived Assets
Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Contingent liabilities [Policy Text Block]
Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.
Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position.

Stock-based Compensation
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate.

The FASB issued a new standard, effective January 1, 2017, that allows entities to make a policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. Effective January 1, 2017, the Company elected to account for forfeitures of awards as they occur. The prior standard required the Company to estimate the number of awards for which the requisite service period is expected to be rendered and base the accruals of compensation cost on the estimated number of awards that will vest.

The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

For the Years Ended

December 31, 2017

December 31, 2016

Risk-free interest rate
1.77%

1.1%
Term
4.37

3.06
Volatility
51%

53%
Dividend yield
—%

—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the periods presented.  Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 10, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying consolidated statements of operations.

Income Taxes
Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

Segment Reporting
Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates
Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note 7, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.

Earnings Per Share
Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2017

2016

2015
Numerator (in thousands):

Basic and Diluted

Net income (loss) attributable to Acacia Research Corporation

$
22,180

$
(54,067
)

$
(160,036
)
Undistributed earnings allocated to participating securities

(33
)

—

—

Total dividends declared / paid

—

—

(25,434
)
Dividends attributable to common stockholders

—

—

24,740

Net income (loss) attributable to common stockholders – basic and diluted

$
22,147

$
(54,067
)

$
(160,730
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic

50,495,119

50,075,847

49,505,817

Effect of potentially dilutive securities:

Common stock options and restricted stock units

196,893

—

—

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted

50,692,012

50,075,847

49,505,817

Basic and diluted net loss per common share

$
0.44

$
(1.08
)

$
(3.25
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

4,425,187

3,682,532

71,468



Treasury Stock [Policy Text Block]
Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.


Recently Adopted Accounting Policies
Recent Accounting Pronouncements - Not Yet Adopted.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company may be required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under existing guidance. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales or usage based royalties. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its intellectual property is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The amendments for this new accounting standard update are effective for interim and annual reporting periods beginning after December 15, 2017, and are to be applied retrospectively or via the cumulative effect as of the date of adoption, with early application not permitted. The Company expects to use the modified retrospective method of adoption and will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings in the period of initial application (first quarter of 2018 for Acacia). Comparative prior year periods would not be adjusted. The preliminary estimate of the cumulative effect of initially applying the new revenue standard is an decrease to beginning accumulated deficit of $3.0 million, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods. Management continues to assess the impact of this new standard on the Company’s consolidated financial statements and related disclosures, including ongoing contract reviews. Preliminary estimates of the adjustment upon initial adoption may change in connection with completion of the Company’s adoption procedures in the first quarter of 2018.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017, with early adoption
permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently adopted accounting policies [Policy Text Block]
Recently Adopted Accounting Pronouncements - Recently Adopted.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

X

- Definition
Contingent liabilities [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_ContingentliabilitiesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs of revenues recognized during the period.
+ References
No definition available.
+ Details

Name: actg_CostOfRevenuesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Impairment of investments [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_ImpairmentofinvestmentsPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Inventor royalties and contingent legal expenses [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Net income (loss) attributable to noncontrolling interest
+ References
No definition available.
+ Details

Name: actg_NetincomelossattributabletononcontrollinginterestPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Recently adopted accounting policies [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_RecentlyAdoptedAccountingPoliciesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Treasury Stock [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_TreasuryStockPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 55
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68064133&loc=d3e61082-112788

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68064133&loc=d3e61044-112788
+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64809438&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.3A-04)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355119-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68079674&loc=d3e5291-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828
+ Details

Name: us-gaap_FiscalPeriod

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-URI http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64802544&loc=d3e202-110218
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.M)
-URI http://asc.fasb.org/extlink&oid=65877573&loc=d3e87990-122713

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Readily Determinable Fair Value
-URI http://asc.fasb.org/extlink&oid=65888395

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section S50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6381980&loc=d3e87707-122711

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62652-112803

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_MarketableSecuritiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.B.Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for segment reporting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1

Level 2

Level 3
Assets as of December 31, 2017:

Investment at fair value (Note 7)⁽¹⁾
$
—

$
—

$
104,754

Assets as of December 31, 2016:

Short-term investments⁽¹⁾
$
19,443

$
—

$
—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The fair values of stock options granted during the periods presented were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

For the Years Ended

December 31, 2017

December 31, 2016

Risk-free interest rate
1.77%

1.1%
Term
4.37

3.06
Volatility
51%

53%
Dividend yield
—%

—%

Property and Equipment, Useful Lives
Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Schedule of Earnings Per Share, Basic and Diluted
The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2017

2016

2015
Numerator (in thousands):

Basic and Diluted

Net income (loss) attributable to Acacia Research Corporation

$
22,180

$
(54,067
)

$
(160,036
)
Undistributed earnings allocated to participating securities

(33
)

—

—

Total dividends declared / paid

—

—

(25,434
)
Dividends attributable to common stockholders

—

—

24,740

Net income (loss) attributable to common stockholders – basic and diluted

$
22,147

$
(54,067
)

$
(160,730
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic

50,495,119

50,075,847

49,505,817

Effect of potentially dilutive securities:

Common stock options and restricted stock units

196,893

—

—

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders – diluted

50,692,012

50,075,847

49,505,817

Basic and diluted net loss per common share

$
0.44

$
(1.08
)

$
(3.25
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

4,425,187

3,682,532

71,468



X

- Definition
Property and Equipment, Useful Lives [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PropertyAndEquipmentUsefulLivesTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1311-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258
+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1

Short-term Investments (Tables)
12 Months Ended

Dec. 31, 2017

Short-term Investments [Abstract]

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
A reconciliation of the activity for fair value measurements categorized within Level 3 for the year ended December 31, 2017 is as follows (in thousands):

Investment at Fair Value

Common Stock

Warrants

Total
Opening balance as of January 1, 2017
$
—

$
—

$
—

Total gains and losses included in earnings for the period⁽¹⁾

Gain on conversion of loans and accrued interest
2,671

—

2,671

Gain on exercise of Primary Warrant
—

4,616

4,616

Change in fair value of investment, net
33,922

8,317

42,239

Purchases, issues, sales and settlements

Purchases and issues⁽²⁾
54,202

1,026

55,228

Total recurring fair value measurements⁽¹⁾
$
90,795

$
13,959

$
104,754

Short-term Investments
Short-term investments for the periods presented were comprised of the following (in thousands):

December 31, 2016
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
19,403

$
40

$
—

$
19,443

X

- Definition
Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258
+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26626-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.4)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2,12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accounts Payable and Accrued Expenses (Tables)
12 Months Ended

Dec. 31, 2017

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
Accounts payable and accrued expenses consist of the following at December 31, 2017 and 2016 (in thousands):

2017

2016

Payroll and other employee benefits

$
465

$
1,593

Accrued vacation

294

533

Accrued legal expenses - patent

5,479

6,564

Foreign taxes payable

15

3,150

Accrued consulting and other professional fees

1,364

1,967

Other accrued liabilities

339

476

$
7,956

$
14,283

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1

Patents (Tables)
12 Months Ended

Dec. 31, 2017

Patents [Abstract]

Patents
The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2017 and 2016 are as follows (in thousands):

2017

2016

Gross carrying amount - patents

$
444,137

$
444,362

Accumulated amortization - patents⁽¹⁾

(382,220
)

(358,043
)
Patents, net

$
61,917

$
86,319

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1

Investments (Tables)
12 Months Ended

Dec. 31, 2017

Investments, All Other Investments [Abstract]

Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]
For the period from the IPO on May 17, 2017 to December 31, 2017, the accompanying consolidated statements of operations reflected the following (in thousands):

2017
Gain on conversion of loans and accrued interest⁽¹⁾

$
2,671

Gain on exercise of warrant⁽²⁾

4,616

Change in fair value of investment, warrants

8,317

Change in fair value of investment, common stock

33,922

Net unrealized gain on investment at fair value

$
49,526

Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):

Nine Months Ended
September 30, 2017

(Unaudited)
Revenues

$
10,914

Gross profit

10,090

Operating expenses

44,024

Other income (expense), net

(12,872
)
Net loss attributable to common stockholders

(51,281
)
Net loss per share attributable to common stockholders - basic and diluted

$
(5.94
)

September 30,
2017
Current assets

$
78,509

Noncurrent assets

1,173

Total Assets

$
79,682

Current liabilities

$
31,836

Noncurrent liabilities

14

Total liabilities

31,850

Preferred stock

—

Total stockholders’ equity (deficit)

47,832

Total liabilities, preferred stock and stockholders’ equity

$
79,682

Schedule of Assumptions Used [Table Text Block]
he DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:

Veritone Common Stock

Veritone Warrants

IPO Date

December 31, 2017

IPO Date

December 31, 2017
Estimated DLOM applied

5.7%

5%

5.7%

10%
Volatility assumptions

35%

37%

35%

72
%
-
87%
Term assumptions

6 months

2 months

6 months

5 months

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

X

- Definition
Tabular disclosure of the amount of gains or losses for the period included in earnings or resulted in a change to net assets, have arisen from the use of significant unobservable inputs (level 3) to measure the fair value of assets, liabilities, and financial instruments classified in shareholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarningsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_ScheduleOfAssumptionsUsedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes (Tables)
12 Months Ended

Dec. 31, 2017

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)
Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2017

2016

2015

Current:

Federal

$
—

$
—

$
—

State

90

262

379

Foreign

2,865

17,926

4,421

Total current

2,955

18,188

4,800

Deferred:

Federal

—

—

—

State

—

—

—

Total deferred

—

—

—

Provision for income taxes

$
2,955

$
18,188

$
4,800

Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2017 and 2016 (in thousands):

2017

2016

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
90,871

$
83,323

Stock compensation

2,635

2,416

Fixed assets and intangibles

6,197

14,343

Basis of investments in affiliates

984

2,195

Accrued liabilities and other

167

422

State taxes

35

90

Total deferred tax assets

100,889

102,789

Valuation allowance

(90,278
)

(102,627
)
Total deferred tax assets, net of valuation allowance

10,611

162

Deferred tax liabilities:

Unrealized gain on investments held at fair value

(10,587
)

—

Other

(24
)

(162
)
Total deferred tax liabilities

(10,611
)

(162
)
Net deferred tax assets (liabilities)

$
—

$
—

Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2017

2016

2015

Statutory federal tax rate - (benefit) expense

35
%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

8
%

50
%

3
%
Foreign tax credit

—
%

(49
)%

(3
)%
Noncontrolling interests in operating subsidiaries

1
%

1
%

(1
)%
Goodwill

—
%

—
%

7
%
Nondeductible permanent items

3
%

—
%

—
%
Expired capital loss carryforwards

—
%

—
%

1
%
Change in tax rate

102
%

—
%

—
%
Valuation allowance

(137
)%

83
%

31
%

12
%

50
%

3
%

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans (Tables)
12 Months Ended

Dec. 31, 2017

Share-based Compensation [Abstract]

Schedule of Other Share-based Compensation, Activity [Table Text Block]
Compensation expense for the periods presented was comprised of the following:

2017

2016

2015

Restricted stock awards with time-based service conditions

$
1,025

$
4,071

$
10,575

Restricted stock unit awards with time-based service conditions

161

320

473

Restricted stock awards with performance-based vesting conditions

121

197

—

Stock options with time-based service vesting conditions

2,165

1,316

—

Stock options with market-based vesting conditions

2,372

3,158

—

Stock options with performance-based vesting conditions

—

—

—

Profits interests units

3,041

—

—

Total compensation expense

$
8,885

$
9,062

$
11,048

Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period [Text Block]
Stock-based award grant activity for the periods presented was as follows:

2017

2016

Shares

Aggregate fair value (in thousands)

Shares

Aggregate fair value (in thousands)
Restricted stock awards with performance-based vesting conditions

—

$
—

138,000

$
431

Stock options with time-based service vesting conditions

1,368,000

2,930

3,434,000

5,704

Stock options with market-based vesting conditions

—

—

2,250,000

5,530

Stock options with performance-based vesting conditions

—

—

200,000

487

Total incentive awards granted

1,368,000

$
2,930

6,022,000

$
12,152

Stock Options Activity
The following table summarizes stock option activity for the Plans for the year ended December 31, 2017:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value
Outstanding at December 31, 2016

5,596,000

$
4.93

Granted

1,368,000

$
5.52

Exercised

(208,000
)

$
3.57

Expired/forfeited

(926,000
)

$
4.90

Outstanding at December 31, 2017

5,830,000

$
5.13

5.8 years

$
856,000

Vested

1,959,000

$
4.84

5.8 years

$
434,000

Exercisable at December 31, 2017

1,959,000

$
4.84

5.8 years

$
434,000

Nonvested Restricted Stock Activity
The following table summarizes nonvested restricted share activity for the year ended December 31, 2017:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value
Nonvested restricted stock at December 31, 2016

333,000

$
8.9

Granted

—

$
—

Vested

(120,000
)

$
12.95

Canceled

(90,000
)

$
9.10

Nonvested restricted stock at December 31, 2017

123,000

$
4.77

Restricted Stock Units Activity
The following table summarizes restricted stock unit activity for the year ended December 31, 2017:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value
Nonvested restricted stock units outstanding at December 31, 2016

14,000

$
16.27

Vested

(12,000
)

$
16.18

Nonvested restricted stock units outstanding at December 31, 2017

2,000

$
16.72

Vested restricted stock units outstanding at December 31, 2017

60,000

$
15.38

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period [Text Block]
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardGrantsinPeriodTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in outstanding nonvested shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in other outstanding share-based compensation awards other than stock options or nonvested awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1

Commitments and Contingencies (Tables)
12 Months Ended

Dec. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases
Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2018
$
1,213

2019
1,369

2020
16

Total minimum lease payments
$
2,598

Net assets of IP Fund [Table Text Block]
At December 31, 2017 and 2016, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):

2017

2016
Cash and other assets

$
986

$
1,118

Investments - noncurrent

1,905

2,933

Total assets

$
2,891

$
4,051

Accrued expenses and contributions

$
2,567

$
2,394

Net assets

$
324

$
1,657

2017

2016
Revenues

$
—

$
16

Operating expenses

390

572

Loss from operations

(390
)

(556
)
Net loss in equity method investments

(943
)

(1,013
)
Net loss

$
(1,333
)

$
(1,569
)

X

- Definition
Financial statements of IP Fund [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_NetAssetsOfIpFundTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1

Quarterly Financial Data (Tables)
12 Months Ended

Dec. 31, 2017

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Quarterly Financial Data
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2017. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2017

2017

2017

2017

2016

2016

2016

2016

(Unaudited, in thousands, except share and per share information)
Revenues

$
8,854

$
16,457

$
36,633

$
3,458

$
24,721

$
41,351

$
64,658

$
21,969

Operating costs and expenses:

Cost of revenues:

Inventor royalties

666

4,273

—

13

1,573

—

17,844

3,313

Contingent legal fees

627

3,236

12,173

646

4,109

10,418

7,709

4,238

Litigation and licensing expenses - patents

6,386

4,134

4,073

3,626

7,723

7,324

7,348

5,463

Amortization of patents

5,515

5,571

5,625

5,443

10,760

10,759

6,467

6,222

General and administrative expenses (including non-cash stock compensation expense)

6,916

6,734

12,715

(335
)

7,994

7,535

8,334

9,056

Other expenses - business development

320

433

241

195

522

1,334

666

557

Impairment of patent-related intangible assets

—

—

2,248

—

—

40,165

—

2,175

Other

—

—

—

1,200

1,742

(1,242
)

—

—

Total operating costs and expenses

20,430

24,381

37,075

10,788

34,423

76,293

48,368

31,024

Operating income (loss)

(11,576
)

(7,924
)

(442
)

(7,330
)

(9,702
)

(34,942
)

16,290

(9,055
)
Total other income (expense)

696

(4,862
)

159,027

(102,950
)

(3
)

(52
)

261

592

Income (loss) before (provision for) benefit from income taxes

(10,880
)

(12,786
)

158,585

(110,280
)

(9,705
)

(34,994
)

16,551

(8,463
)
Provision for income taxes

(1,241
)

(1,478
)

(216
)

(20
)

(192
)

(5,927
)

(9,655
)

(2,414
)
Net income (loss) including noncontrolling interests

(12,121
)

(14,264
)

158,369

(110,300
)

(9,897
)

(40,921
)

6,896

(10,877
)
Net (income) loss attributable to noncontrolling interests in subsidiaries

291

12

96

97

(68
)

348

186

266

Net income (loss) attributable to Acacia Research Corporation

$
(11,830
)

$
(14,252
)

$
158,465

$
(110,203
)

$
(9,965
)

$
(40,573
)

$
7,082

$
(10,611
)
Net income (loss) per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.24
)

$
(0.28
)

$
3.13

$
(2.18
)

$
(0.20
)

$
(0.81
)

$
0.14

$
(0.21
)
Weighted-average number of shares outstanding, basic

50,333,056

50,499,948

50,554,234

50,590,460

49,925,550

50,015,869

50,124,302

50,237,784

Weighted-average number of shares outstanding, diluted

50,333,056

50,499,948

50,599,974

50,590,460

49,925,550

50,015,869

50,618,757

50,237,784

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1280-108306
+ Details

Name: us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1

Description of Business (Details) - patents
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Description of Business [Line Items]

Number of patent portfolios acquired 1 2 3 6

X

- Definition
[Line Items] for Description of Business [Table]
+ References
No definition available.
+ Details

Name: actg_DescriptionOfBusinessLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of patent portfolios acquired
+ References
No definition available.
+ Details

Name: actg_Numberofpatentportfoliosacquired

Namespace Prefix: actg_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

XML 51 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Mar. 31, 2018

Cumulative Effect of New Accounting Principle in Period of Adoption $ 3,000,000

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $ 104,754,000 $ 0

Investments at fair value 104,754,000 0

Short-term investments $ 0 $ 19,443,000

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 2.00% 1.00%

Fair Value Assumptions, Expected Term 4 years 135 days 3 years 22 days

Lag time in recognizing revenues from licensee's quarter 3 months

Fair Value Assumptions, Weighted Average Volatility Rate 51.00% 53.00%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend $ 0 $ 0

Gain on Conversion of Loan and Accrued Interest 2,671,000 0 $ 0

Gain on exercise of Primary Warrant 4,616,000 0 0

Change in fair value of investment 42,239,000 0 $ 0

Investment at Fair Value Purchases and Issues $ 55,228,000

Minimum [Member]

Period after quarter end licensees report activity 30 days

Patents, useful life 1 year

Maximum [Member]

Period after quarter end licensees report activity 45 days

Patents, useful life 6 years

Fair Value, Inputs, Level 2 [Member]

Investments at fair value $ 0

Short-term investments 0

Fair Value, Inputs, Level 3 [Member]

Investments at fair value 0

Short-term investments 104,754,000

Fair Value, Inputs, Level 1 [Member]

Investments at fair value 19,443,000

Short-term investments 0

Warrant [Member]

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value 13,959,000 0

Gain on Conversion of Loan and Accrued Interest 0

Gain on exercise of Primary Warrant (4,616,000)

Change in fair value of investment 8,317,000

Investment at Fair Value Purchases and Issues 1,026,000

Common Stock [Member]

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value 90,795,000 $ 0

Gain on Conversion of Loan and Accrued Interest 2,671,000

Gain on exercise of Primary Warrant 0

Change in fair value of investment 33,922,000

Investment at Fair Value Purchases and Issues $ 54,202,000

X

- Definition
Change in fair value of investment
+ References
No definition available.
+ Details

Name: actg_Changeinfairvalueofinvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gain on Conversion of Loan and Accrued Interest
+ References
No definition available.
+ Details

Name: actg_GainonConversionofLoanandAccruedInterest

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gain on exercise of Primary Warrant
+ References
No definition available.
+ Details

Name: actg_GainonexerciseofPrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investment at Fair Value Purchases and Issues
+ References
No definition available.
+ Details

Name: actg_InvestmentatFairValuePurchasesandIssues

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investments at fair value
+ References
No definition available.
+ Details

Name: actg_Investmentsatfairvalue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Lag time in recognizing revenues from licensees' quarter
+ References
No definition available.
+ Details

Name: actg_LagTimeInRecognizingRevenuesFromLicenseesQuarter

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period after quarter end licensees report activity
+ References
No definition available.
+ Details

Name: actg_PeriodAfterQuarterEndLicenseesReportActivity

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Weighted average expected volatility rate of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(g))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies Concentrations (Details)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Licensee 1 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 54.00% 26.00% 24.00%

Licensee 1 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 100.00% 39.00%

Licensee 2 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 21.00% 23.00% 20.00%

Licensee 2 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 22.00%

Licensee 3 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 10.00% 11.00% 16.00%

Licensee 3 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 16.00%

Licensee 4 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 15.00%

Licensees in foreign jurisdictions [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 39.00% 79.00% 49.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConcentrationRiskLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueRightsGrantedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_LicenseesInForeignJurisdictionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies Property and Equipment (Details)
12 Months Ended

Dec. 31, 2017

Furniture and Fixtures [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Furniture and Fixtures [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Computer Hardware and Software [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Computer Hardware and Software [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Leasehold Improvements [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 2

Leasehold Improvements [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

X

- Definition
Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 35
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223
+ Details

Name: us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=actg_ComputerHardwareAndSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Accounting Policies [Abstract]

Net income (loss) attributable to Acacia Research Corporation $ (110,203) $ 158,465 $ (14,252) $ (11,830) $ (10,611) $ 7,082 $ (40,573) $ (9,965) $ 22,180 $ (54,067) $ (160,036)

Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 33 0 0

Payments of Dividends 0 0 (25,434)

Dividends attributable to common stockholders under the two class method 0 0 24,740

Net Loss Available to Common Stockholders, Basic and Diluted $ 22,147 $ (54,067) $ (160,730)

Weighted Average Number of Shares Outstanding, Basic 50,495,119 50,075,847 49,505,817

Weighted Average Number Diluted Shares Outstanding Adjustment 196,893 0 0

Weighted Average Number of Shares Outstanding, Diluted 50,590,460 50,599,974 50,499,948 50,333,056 50,237,784 50,618,757 50,015,869 49,925,550 50,692,012 50,075,847 49,505,817

Earnings Per Share, Basic and Diluted $ (2.18) $ 3.13 $ (0.28) $ (0.24) $ (0.21) $ 0.14 $ (0.81) $ (0.20) $ 0.44 $ (1.08) $ (3.25)

Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share 4,425,187 3,682,532 71,468

X

- Definition
Add Back of Dividends attributable to common stockholders under the two class method
+ References
No definition available.
+ Details

Name: actg_Dividendsattributabletocommonstockholdersunderthetwoclassmethod

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64863997&loc=SL5780133-109256
+ Details

Name: us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 55 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1

Short-term Investments (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale securities, amortized cost $ 19,403,000

Available-for-sale securities, gross unrealized gains 40,000

Available-for-sale securities, gross unrealized losses 0

Available-for-sale securities, fair value $ 19,443,000

Investment Maturity Date Dec. 31, 2017

Available-for-sale Securities, Gross Realized Losses $ 617,000

Proceeds from Sale and Maturity of Marketable Securities $ 43,232,000 $ 82,115,000

X

- Definition
The maturity date of the investment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 12
-Sentence Column A
+ Details

Name: invest_InvestmentMaturityDate1

Namespace Prefix: invest_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65884222&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1

Short-term Investments Marketable Securities (Details)
$ in Thousands
12 Months Ended

Dec. 31, 2016

USD ($)

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale Securities, Amortized Cost Basis $ 19,403

Available-for-sale Securities, Gross Unrealized Gain 40

Available-for-sale Securities, Gross Unrealized Loss 0

Available-for-sale Securities $ 19,443

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65884222&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 57 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Accounts Payable and Accrued Liabilities, Current [Abstract]

Payroll and other employee benefits $ 465 $ 1,593

Accrued vacation 294 533

Accrued legal expenses - patent 5,479 6,564

Foreign taxes payable 15 3,150

Accrued consulting and other professional fees 1,364 1,967

Other accrued liabilities 339 476

Accounts payable and accrued expenses $ 7,956 $ 14,283

X

- Definition
Accrued Legal Expenses - Patent
+ References
No definition available.
+ Details

Name: actg_AccruedLegalExpensesPatent

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amounts due to foreign jurisdictions for income taxes.
+ References
No definition available.
+ Details

Name: actg_Foreigntaxespayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 25
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361
+ Details

Name: us-gaap_AccruedVacationCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 58 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1

Patents (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Patents [Line Items]

Patents, net $ 61,917 $ 86,319 $ 61,917 $ 86,319

Patents, weighted average useful life 4 years

Payments to acquire intangible assets $ 0 1,225 $ 19,504

Impairment of Patent-Related Intangible Assets 0 $ 2,248 $ 0 $ 0 2,175 $ 0 $ 40,165 $ 0 $ 2,248 42,340 $ 74,731

Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Acquired Finite Lived Intangible Asset, Useful Life 2 years

Maximum [Member]

Patents [Line Items]

Patents, useful life 6 years

Acquired Finite Lived Intangible Asset, Useful Life 7 years

Patents [Member]

Patents [Line Items]

Gross carrying amount - patents 444,137 444,362 $ 444,137 444,362

Accumulated amortization - patents 382,220 358,043 382,220 358,043

Patents, net $ 61,917 $ 86,319 $ 61,917 $ 86,319

Patents [Member] | Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Patents [Member] | Maximum [Member]

Patents [Line Items]

Patents, useful life 6 years

X

- Definition
Acquired Finite Lived Intangible Asset, Useful Life
+ References
No definition available.
+ Details

Name: actg_AcquiredFiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: actg_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents, Accumulated Amortization
+ References
No definition available.
+ Details

Name: actg_PatentsAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Patents, Gross
+ References
No definition available.
+ Details

Name: actg_PatentsGross

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1

Patents Future Amortization Expense (Details)

Dec. 31, 2017

USD ($)

Patents [Abstract]

2018 $ 20,542,000

2019 18,527,000

2020 6,134,000

2021 5,261,000

2022 5,256,000

After Year Five $ 6,197,000

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 60 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1

Goodwill Impairment Charges (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Jan. 02, 2015

Goodwill and Patent Impairment Charges [Abstract]

Goodwill $ 30,100

Share Price $ 4.29 $ 16.72

Estimated Fair Value of the Reporting Unit $ 252,000

Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach 344,300

Assets $ 308,768 $ 296,003

Impairment of Goodwill $ 0 $ 0 $ 30,149

X

- Definition
Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedCarryingValueofReportingUnitMarketCapitalizationPlusCostSynergiesApproach

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Estimated Fair Value of the Reporting Unit, Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedFairValueoftheReportingUnit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Goodwill and Patent Impairment Charges [Abstract]
+ References
No definition available.
+ Details

Name: actg_GoodwillandPatentImpairmentChargesAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

XML 61 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1

Goodwill Impairment Charges Details (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Goodwill [Line Items]

Goodwill, Impairment Loss $ 0 $ 0 $ 30,149

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 62 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1

Investments (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended

May 17, 2017

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Sep. 30, 2017

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Mar. 14, 2017

Aug. 15, 2016

Accounts, Notes, Loans and Financing Receivable [Line Items]

Income (Loss) from Equity Method Investments $ (220,000) $ 0 $ 0

Cash Paid for Investment 2,250,000

Assets, Current $ 139,695,000 $ 188,490,000 139,695,000 188,490,000

Revenues $ 3,458,000 $ 36,633,000 $ 16,457,000 $ 8,854,000 21,969,000 $ 64,658,000 $ 41,351,000 $ 24,721,000

Gain on Conversion of Loan and Accrued Interest 2,671,000 0 0

Gain on exercise of Primary Warrant 4,616,000 0 0

Change in fair value of investment $ 42,239,000 0 0

Percentage of ownership, Veritone 20.00% 23.00% 23.00%

First Loan Warrant $ 700,000

Time-sharing Transactions, Stated Interest Rate for Notes Receivable 6.00%

Maximum Investment in Veritone $ 50,000,000

Secured Promissory Note Advance 10,000,000

Veritone Primary Warrant 50,000,000

Secured Convertible Promissory Note $ 20,000,000

Unamortized loan discount $ 1,700,000

Investment Income, Interest $ 1,605,000 798,000 $ (56,000)

Loan receivable and accrued interest $ 20,700,000 $ 0 18,616,000 0 18,616,000

Investment warrants 0 1,960,000 0 1,960,000

Accretion (Amortization) of Discounts and Premiums, Investments 630,000

Loss on fair value investment net 49,526,000

Assets 308,768,000 296,003,000 308,768,000 296,003,000

Liabilities, Current 9,557,000 28,191,000 9,557,000 28,191,000

Liabilities 13,109,000 28,560,000 13,109,000 28,560,000

Stockholders' Equity Attributable to Parent $ 294,301,000 $ 265,589,000 $ 294,301,000 $ 265,589,000

Common stock, shares outstanding 50,639,926 50,476,042 50,639,926 50,476,042

Debt Instrument, Convertible, Conversion Price $ 13.6088

Cash paid for primary warrant exercise $ 29,300,000

10% Warrant 809,400

Bridge Loan $ 4,000,000 $ 4,000,000

Bridge loan stated interest rate 8.00%

Veritone Bridge Loan Advance 1 $ 1,000,000

Veritone Bridge Loan Advance 3 and 4 $ 2,000,000

Upfront Shares 60,000

Bridge Installment Shares 90,000

Bridge Warrant Share 157,000

Investments at fair value $ 104,754,000 $ 0 $ 104,754,000 $ 0

Equity Method Investment, Ownership Percentage 23.00% 23.00%

Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Receivable with Imputed Interest, Effective Yield (Interest Rate) 53.00%

Fair Value Assumptions, Expected Volatility Rate 50.00%

Fair Value Inputs, Probability of Default 75.00%

Fair value inputs recovery 100.00%

Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Receivable with Imputed Interest, Effective Yield (Interest Rate) 9.00%

Monte Carlo [Member] | Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 40.00%

Fair Value Inputs, Discount for Lack of Marketability 7.00%

Fair Value Inputs, Probability of Default 25.00%

Finnerty - Common Stock [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 35.00% 37.00%

Fair Value Inputs, Discount for Lack of Marketability 6.00% 5.00%

Fair Value Assumptions, Expected Term 6 months 2 months

Finnerty - Warrants [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 35.00%

Fair Value Inputs, Discount for Lack of Marketability 6.00% 10.00%

Fair Value Assumptions, Expected Term 6 months 5 months

Finnerty - Warrants [Member] | Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 87.00%

Finnerty - Warrants [Member] | Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 72.00%

Black Scholes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Dividend Payments $ 0

Black Scholes [Member] | Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Risk Free Interest Rate 2.37%

Fair Value Assumptions, Expected Volatility Rate 55.00%

Fair Value Assumptions, Expected Term 9 years

Black Scholes [Member] | Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Risk Free Interest Rate 1.94%

Fair Value Assumptions, Expected Volatility Rate 45.00%

Fair Value Assumptions, Expected Term 3 years

Veritone [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Assets, Current 78,509,000 $ 78,509,000

Revenues 10,914,000

Investment Income, Interest $ 1,100,000

Gross Profit 10,090,000

Operating Expenses 44,024,000

Other Operating Income (Expense), Net (12,872,000)

Net Income (Loss) Available to Common Stockholders, Diluted $ (51,281,000)

Basic and diluted loss per common share $ (5,940)

Assets, Noncurrent 1,173,000 $ 1,173,000

Assets 79,682,000 79,682,000

Liabilities, Current 31,836,000 31,836,000

Liabilities, Noncurrent 14,000 14,000

Liabilities 31,850,000 31,850,000

Preferred Stock, Value, Outstanding 0 0

Stockholders' Equity Attributable to Parent 47,832,000 47,832,000

Total liabilities, preferred stock and stockholders' equity $ 79,682,000 $ 79,682,000

Common Stock [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Investment Owned, Balance, Shares 4,119,521 4,119,521

Investments at fair value $ 90,795,000 $ 90,795,000

Warrant [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Investment Owned, Balance, Shares 1,120,432 1,120,432

Investments at fair value $ 13,959,000 $ 13,959,000

Veritone Loans [Member] | Veritone [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Common stock, shares outstanding 1,523,746

Primary warrant [Member] | Veritone [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Common stock, shares outstanding 2,150,335

Bridge Loan [Member] | Veritone [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Common stock, shares outstanding 295,440

Warrant [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Gain on Conversion of Loan and Accrued Interest 0

Gain on exercise of Primary Warrant (4,616,000)

Change in fair value of investment 8,317,000

Common Stock [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Gain on Conversion of Loan and Accrued Interest 2,671,000

Gain on exercise of Primary Warrant 0

Change in fair value of investment $ 33,922,000

X

- Definition
10% Warrant
+ References
No definition available.
+ Details

Name: actg_A10Warrant

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Bridge Installment Shares
+ References
No definition available.
+ Details

Name: actg_BridgeInstallmentShares

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Bridge Warrant Share
+ References
No definition available.
+ Details

Name: actg_BridgeWarrantShare

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Bridge loan stated interest rate
+ References
No definition available.
+ Details

Name: actg_Bridgeloanstatedinterestrate

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Cash Paid for Investment
+ References
No definition available.
+ Details

Name: actg_CashPaidforInvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Cash paid for primary warrant exercise
+ References
No definition available.
+ Details

Name: actg_Cashpaidforprimarywarrantexercise

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Change in fair value of investment
+ References
No definition available.
+ Details

Name: actg_Changeinfairvalueofinvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Fair value inputs recovery
+ References
No definition available.
+ Details

Name: actg_Fairvalueinputsrecovery

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
First Loan Warrant
+ References
No definition available.
+ Details

Name: actg_FirstLoanWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gain on Conversion of Loan and Accrued Interest
+ References
No definition available.
+ Details

Name: actg_GainonConversionofLoanandAccruedInterest

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gain on exercise of Primary Warrant
+ References
No definition available.
+ Details

Name: actg_GainonexerciseofPrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investments at fair value
+ References
No definition available.
+ Details

Name: actg_Investmentsatfairvalue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investment warrants and shares
+ References
No definition available.
+ Details

Name: actg_Investmentwarrants

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Loss on fair value investment net
+ References
No definition available.
+ Details

Name: actg_Lossonfairvalueinvestmentnet

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Maximum Investment in Veritone
+ References
No definition available.
+ Details

Name: actg_MaximumInvestmentinVeritone

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of ownership, Veritone
+ References
No definition available.
+ Details

Name: actg_PercentageofownershipVeritone

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Secured Convertible Promissory Note
+ References
No definition available.
+ Details

Name: actg_SecuredConvertiblePromissoryNote

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Secured Promissory Note Advance
+ References
No definition available.
+ Details

Name: actg_SecuredPromissoryNoteAdvance

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total liabilities, preferred stock and stockholders' equity
+ References
No definition available.
+ Details

Name: actg_Totalliabilitiespreferredstockandstockholdersequity

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Unamortized loan discount
+ References
No definition available.
+ Details

Name: actg_Unamortizedloandiscount

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Upfront Shares
+ References
No definition available.
+ Details

Name: actg_UpfrontShares

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Veritone Bridge Loan Advance 1
+ References
No definition available.
+ Details

Name: actg_VeritoneBridgeLoanAdvance1

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Veritone Bridge Loan Advance 3 and 4
+ References
No definition available.
+ Details

Name: actg_VeritoneBridgeLoanAdvance3and4

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Veritone Primary Warrant
+ References
No definition available.
+ Details

Name: actg_VeritonePrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsNotesAndLoansReceivableLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(10))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(16))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_BridgeLoan

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031898-161870
+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of dividends expected to be paid to holders of the underlying shares or contracted instruments over the term of the instruments life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedDividendPayments

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Risk-free interest rate assumption used in valuing an instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustment to the discount rate used to measure fair value for lack of ability to convert business interests into cash quickly.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueInputsDiscountForLackOfMarketability

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of likelihood a loan will not be repaid and instead default, used as an input to measure fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueInputsProbabilityOfDefault

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(13)(f))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(b))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Balance held at close of period in number of shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-12C.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010
+ Details

Name: us-gaap_InvestmentOwnedBalanceShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(26))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(23))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(25))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(24))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestmentsAndReceivablesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Net Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValueOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Stated interest rate of notes receivable from time-sharing transactions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 978
-SubTopic 310
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68077313&loc=d3e27327-108691
+ Details

Name: us-gaap_TimesharingTransactionsStatedInterestRateForNotesReceivable

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_MonteCarloMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_FinnertyCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_FinnertyWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_BlackScholesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=actg_VeritoneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_ContributingsharesAxis=actg_VeritoneLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_ContributingsharesAxis=actg_PrimarywarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_ContributingsharesAxis=us-gaap_BridgeLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stockholders' Equity (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Feb. 16, 2017

Jan. 02, 2015

Stockholders Equity [Line Items]

Dividends declared, per share $ 0.50

Common stock dividends declared, quarterly $ 0.125

Payments of Dividends $ 0 $ 0 $ 25,434,000

Beneficial Ownership Percentage Limit 4.90% 60.00%

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding $ 0 $ 0

Share Price $ 4.29 $ 16.72

Share Repurchase Program [Domain]

Stockholders Equity [Line Items]

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding $ 0.001

Share Price $ 15.00

X

- Definition
Beneficial Ownership Percentage Limit
+ References
No definition available.
+ Details

Name: actg_BeneficialOwnershipPercentageLimit

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Common stock dividends declared, quarterly
+ References
No definition available.
+ Details

Name: actg_Commonstockdividendsdeclaredquarterly

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
[Line Items] for Stockholders' Equity [Table]
+ References
No definition available.
+ Details

Name: actg_StockholdersEquityLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ShareRepurchaseProgramDomain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Income Taxes [Line Items]

Operating loss carryforwards, federal $ 180,621,000

Operating loss carryforwards, state 17,850,000

Deferred tax assets, valuation allowance 90,278,000 $ 102,627,000

Federal NOL annual utilization limit 14,100,000

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits 90,871,000 $ 83,323,000

Foreign tax credits, additional paid in capital benefit $ 51,126,000

Effective Income Tax Rate Reconciliation, Percent 12.00% 50.00% 3.00%

Effective tax rate excluding valuation allowance 47.00% (33.00%) (28.00%)

Deferred Tax Liabilities, Other $ 10,587,000

Federal Deferred Tax Asset, Impact of ASU 2016-09 21,350,000

Deferred Tax Assets, Gross 100,889,000 $ 102,789,000

Deferred Tax Assets, State Taxes 1,559,000

Unrecognized tax benefits 808,000

Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 0.21

Deferred Tax Asset, Revaluation 25,261,000

Domestic Tax Authority [Member]

Income Taxes [Line Items]

Net operating losses included in deferred tax assets 2,804,000

Capital Loss Carryforward Related to Business Acquisition [Member] | Internal Revenue Service (IRS) [Member]

Income Taxes [Line Items]

Operating Loss Carryforwards $ 26,326,000

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Deferred Tax Asset, Revaluation
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetRevaluation

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Effective tax rate excluding valuation allowance
+ References
No definition available.
+ Details

Name: actg_Effectivetaxrateexcludingvaluationallowance

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Federal Deferred Tax Asset, Impact of ASU 2016-09
+ References
No definition available.
+ Details

Name: actg_FederalDeferredTaxAssetImpactofASU201609

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Federal NOL Annual Utilization Limit
+ References
No definition available.
+ Details

Name: actg_FederalNolAnnualUtilizationLimit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Foreign tax credits that have not been recorded as a deferred tax asset as the benefit will be credited to additional paid in capital when realized as a reduction of tax payable on the tax return.
+ References
No definition available.
+ Details

Name: actg_ForeignTaxCreditsAdditionalPaidInCapitalBenefit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
[Line Items] for Income Taxes [Table]
+ References
No definition available.
+ Details

Name: actg_IncomeTaxesLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating loss carryforwards, federal
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsFederal

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Operating loss carryforwards, state
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsState

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
State Deferred Tax Asset, Impact of ASU 2016-09
+ References
No definition available.
+ Details

Name: actg_StateDeferredTaxAssetImpactofASU201609

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Asset
-URI http://asc.fasb.org/extlink&oid=6510090
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=SL6600010-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Unrecognized Tax Benefit
-URI http://asc.fasb.org/extlink&oid=6527854
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxCreditCarryforwardAxis=actg_CapitalLossCarryforwardRelatedToBusinessAcquisitionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes Provision for Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Current:

Federal $ 0 $ 0 $ 0

State taxes 90 262 379

Foreign taxes 2,865 17,926 4,421

Total current 2,955 18,188 4,800

Deferred:

Federal 0 0 0

State taxes 0 0 0

Total deferred 0 0 0

(Provision) benefit for income taxes $ 20 $ 216 $ 1,478 $ 1,241 $ 2,414 $ 9,655 $ 5,927 $ 192 $ 2,955 $ 18,188 $ 4,800

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentForeignTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 66 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes Deferred Taxes (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Deferred tax assets:

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits $ 90,871 $ 83,323

Stock compensation 2,635 2,416

Deferred tax assets intangibles and fixed assets 6,197 14,343

Basis of investments in affiliates 984 2,195

Accrued liabilities and other 167 422

Deferred Tax Assets, State Taxes 35 90

Total deferred tax assets 100,889 102,789

Deferred tax liabilities:

Fixed assets and intangibles (10,587) 0

Other (24) (162)

Deferred Tax Liabilities, Gross (10,611) (162)

Net deferred tax liabilities 0 0

Less: valuation allowance (90,278) (102,627)

Net deferred taxes $ 10,611 $ 162

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from tangible and intangible assets.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesFixedAssetsAndIntangibles

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesNetOfDeferredTaxAssets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Deferred tax assets intangibles and fixed assets
+ References
No definition available.
+ Details

Name: actg_Deferredtaxassetsintangiblesandfixedassets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(15)(b)(2))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(2))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Liability
-URI http://asc.fasb.org/extlink&oid=6510232

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Asset
-URI http://asc.fasb.org/extlink&oid=6510090
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsGrossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the entity's investment in its wholly-owned subsidiaries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsInvestmentInSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsStateTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 67 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1

Income Taxes Income Tax Rate (Details)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Effective income tax rate reconciliation goodwill 0.00% 0.00% 7.00%

Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]

Statutory federal tax rate 35.00% (35.00%) (35.00%)

State income and foreign taxes, net of federal tax effect 8.00% 50.00% 3.00%

Foreign tax credit 0.00% (49.00%) (3.00%)

Noncontrolling interests in operating subsidiaries 1.00% 1.00% (1.00%)

Non deductible permanent items 3.00% 0.00% 0.00%

Expired net operating loss carryforwards 0.00% 0.00% 1.00%

Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 102.00% (0.00%) (0.00%)

Valuation allowance (137.00%) 83.00% 31.00%

Total 12.00% 50.00% 3.00%

X

- Definition
Effective income tax rate reconcilation, expired net operating losses
+ References
No definition available.
+ Details

Name: actg_EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Effective income tax rate reconciliation goodwill
+ References
No definition available.
+ Details

Name: actg_Effectiveincometaxratereconciliationgoodwill

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 68 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans (Details) - USD ($)
9 Months Ended 12 Months Ended

Sep. 30, 2017

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Feb. 16, 2017

Apr. 26, 2016

Jan. 02, 2015

Share-based Compensation Arrangement by Share-based Payment Award

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 2,009,000 $ 2,342,000

Employee Service Share-based Compensation, Awards with market Cond, Compensation Cost Not yet Recognized 0

Non-cash stock compensation $ 8,885,000 $ 9,062,000 $ 11,048,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value $ 0.00 $ 16.72

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value $ 200,000 $ 324,000 480,000

Ownership percent of voting stock 10.00%

Aggregate intrinsic value of options exercised $ 296,000 344,000 $ 751,000

Weighted average grant date fair value of restricted stock granted $ 0.00

Number of shares of common stock reserved for issuance 7,279,000

Beneficial Ownership Percentage Limit 4.90% 60.00%

Fair Value of Profits Interest $ 3,041,000 $ 722,000

Share Price $ 4.29 $ 16.72

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Total unrecognized compensation expense for nonvested awards $ 3,654,000

Weighted average period over which unrecognized compensation expense will be recognized 2 years

Restricted stock awards with time based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 1,025,000 $ 4,071,000 $ 10,575,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Weighted average grant date fair value of restricted stock granted $ 3.12 $ 12.83

Aggregate fair value of restricted stock vested 1,560,000 $ 5,243,000 $ 11,494,000

Total unrecognized compensation expense for nonvested awards $ 53,000

Weighted average period over which unrecognized compensation expense will be recognized 2 months

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Total unrecognized compensation expense for nonvested awards $ 1,000

Weighted average period over which unrecognized compensation expense will be recognized 1 month

Restricted stock unit awards with time-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 161,000 320,000 473,000

Restricted stock unit awards with performance based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 121,000 197,000 0

Stock options with time-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 2,165,000 1,316,000 0

Stock options with market-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 2,372,000 3,158,000 0

Stock options with performance-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 0 0 0

Deferred Profit Sharing [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 3,041,000 $ 0 $ 0

2007 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 0

2016 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Aggregate shares available for issuance 4,500,000

Number of shares available for grant 727,000

Discretionary Option Grant Program [Member] | Nonstatutory Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 85.00%

Stock Issuance Program [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

2013 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Aggregate shares available for issuance 4,750,000

Number of shares available for grant 660,000

2013 Stock Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 625,390

Less than 10% [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

10% or More [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 110.00%

Geometric Brownian Motion [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Fair Value Assumptions, Expected Term 4 years 5 months

Fair Value Assumptions, Expected Volatility Rate 50.00%

Finnerty - Profits Interests [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Term specific volatility 85.00%

Fair Value Inputs, Discount for Lack of Marketability 30.00%

Minimum [Member] | Geometric Brownian Motion [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Fair Value Assumptions, Expected Term 1 year

Fair Value Assumptions, Risk Free Interest Rate 2.00%

Minimum [Member] | Veritone [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Share Price $ 23.20

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Fair Value Assumptions, Expected Volatility Rate 50.00%

Maximum [Member] | Geometric Brownian Motion [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Fair Value Assumptions, Expected Term 10 years

Fair Value Assumptions, Risk Free Interest Rate 2.00%

X

- Definition
Beneficial Ownership Percentage Limit
+ References
No definition available.
+ Details

Name: actg_BeneficialOwnershipPercentageLimit

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair Value of Profits Interest
+ References
No definition available.
+ Details

Name: actg_FairValueofProfitsInterest

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Ownership Percent of Voting Stock
+ References
No definition available.
+ Details

Name: actg_OwnershipPercentOfVotingStock

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsGrantsinPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Term specific volatility
+ References
No definition available.
+ Details

Name: actg_Termspecificvolatility

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Risk-free interest rate assumption used in valuing an instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustment to the discount rate used to measure fair value for lack of ability to convert business interests into cash quickly.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueInputsDiscountForLackOfMarketability

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Purchase price of common stock expressed as a percentage of its fair value.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockawardswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockunitawardswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockunitawardswithperformancebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithmarketbasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithperformancebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_DeferredProfitSharingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2007PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2016PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_DiscretionaryOptionGrantProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_NonstatutoryOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_StockIssuanceProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013StockPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_LessThan10Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_IncentiveStockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_A10OrMoreMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_GeometricBrownianMotionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=actg_FinnertyProfitsInterestsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: invest_InvestmentAxis=actg_VeritoneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 69 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans Stock Options (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,368,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.52

Outstanding at December 31, 2015 5,596,000

Exercised (208,000)

Outstanding at December 31, 2016 5,830,000 5,596,000

Vested 1,959,000

Exercisable at December 31, 2016 1,959,000

Outstanding at December 31, 2015, weighted average exercise price $ 4.93

Exercised, weighted average exercise price 3.57

Outstanding at December 31, 2016, weighted average exercise price 5.13 $ 4.93

Vested, weighted average exercise price 4.84

Exercisable, weighted average exercise price $ 4.84

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 5 years 9 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 5 years 9 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 434,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 5 years 9 months

Outstanding at December 31, 2016, aggregate, intrinsic value $ 856,000

Vested, aggregate intrinsic value 351,000

Exercisable, aggregate intrinsic value 434,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value 2,930,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 2,009,000 $ 2,342,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period (926,000)

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 4.90

Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized $ 0

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 25.00%

Unvested Shares with Market Based Vesting Conditions 1,687,500

Employee Service Share-based Compensation, Awards with market Cond, Compensation Cost Not yet Recognized $ 0

Performance Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 200,000,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.75

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 0 $ 487,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 months

Unrecognized Compensation Expense Options $ 53,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 102,000

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years

Unrecognized Compensation Expense Options $ 3,654,000

Market Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 2,250,000,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.75

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 0 $ 5,530,000

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 7.00

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 10.00

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithPerformanceCondiditonsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Market Based Vesting Conditions, price
+ References
No definition available.
+ Details

Name: actg_MarketBasedVestingConditionsprice

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number,
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsWithPerformanceConditionsNonvestedNumber

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested During the Period Aggregate Intrinsic Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedDuringthePeriodAggregateIntrinsicValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangmentbySharebasedPaymentAwardOptionsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unvested Shares with Market Based Vesting Conditions
+ References
No definition available.
+ Details

Name: actg_UnvestedShareswithMarketBasedVestingConditions

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=actg_PerformanceBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_MarketBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans Nonvested Restriced Stock (Details) - $ / shares
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Share-based Compensation Arrangement by Share-based Payment Award

Nonvested at December 31, 2015 333,000

Granted 0

Vested (120,000)

Canceled (90,000)

Nonvested at December 31, 2016 123,000 333,000

Nonvested, weighted average grant date fair value at December 31, 2015 $ 8.90

Granted, weighted average grant date fair value 0.00

Vested, weighted average grant date fair value 12.95

Canceled, weighted average grant date fair value 9.10

Nonvested, weighted average grant date fair value at December 31, 2016 $ 4.77 $ 8.90

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Granted, weighted average grant date fair value $ 3.12 $ 12.83

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) - $ / shares
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award

Share-based Awards, Restricted Stock Units, Vested Oustanding 60,000

Share-based Compensation Arrangement Restricted Stock Units, Nonvested 2,000 14,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Nonvested, Weighted Average Grant Date Fair Value $ 16.72 $ 16.27

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period (12,000)

Granted 0

Nonvested at December 31, 2016 123,000 333,000

Granted, weighted average grant date fair value $ 0.00

Vested, weighted average grant date fair value 16.18

Nonvested, weighted average grant date fair value at December 31, 2016 4.77 $ 8.90

Vested outstanding, weighted average grant date fair value $ 15.38

X

- Definition
Share-based Awards, Restricted Stock Units, Vested Oustanding
+ References
No definition available.
+ Details

Name: actg_SharebasedAwardsRestrictedStockUnitsVestedOustanding

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement Restricted Stock Units, Nonvested
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementRestrictedStockUnitsNonvested

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Nonvested, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested During Period
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedDuringPeriod

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 72 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stock-Based Incentive Plans Schedule of Grants by Type (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0

Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period 1,368,000,000 6,022,000,000

Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value $ 2,930,000 $ 12,152,000

Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized $ 0

Unvested Shares with Market Based Vesting Conditions 1,687,500

Employee Service Share-based Compensation, Awards with market Cond, Compensation Cost Not yet Recognized $ 0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,368,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 2,930,000

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 7.00

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 10.00

Time Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,368,000,000 3,434,000,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 2,930,000 $ 5,704,000

Market Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 2,250,000,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 0 $ 5,530,000

Performance Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0 138,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value $ 0 $ 431,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 200,000,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 0 $ 487,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 102,000

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithPerformanceCondiditonsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Market Based Vesting Conditions, price
+ References
No definition available.
+ Details

Name: actg_MarketBasedVestingConditionsprice

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardAllGrantsFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number,
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsWithPerformanceConditionsNonvestedNumber

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockAwardsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardTotalGrantsDuringthePeriod

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangmentbySharebasedPaymentAwardOptionsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unvested Shares with Market Based Vesting Conditions
+ References
No definition available.
+ Details

Name: actg_UnvestedShareswithMarketBasedVestingConditions

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_TimeBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_MarketBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_PerformanceBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1

Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Restricted Cash and Cash Equivalents $ 0 $ 11,512,000 $ 0 $ 11,512,000

Rent expense 1,392,000 1,795,000 $ 1,926,000

Other 1,200,000 $ 0 $ 0 $ 0 0 $ 0 $ (1,242,000) $ 1,742,000 1,200,000 500,000 $ 4,141,000

Cash and other assets, IP Fund 986,000 1,118,000 986,000 1,118,000

Investments, IP Fund 1,905,000 2,933,000 1,905,000 2,933,000

Total assets, IP Fund 2,891,000 4,051,000 2,891,000 4,051,000

Accrued expenses and contributions, IP Fund 2,567,000 2,394,000 2,567,000 2,394,000

Net assets, IP Fund 324,000 $ 1,657,000 324,000 1,657,000

Revenues, IP Fund 0 16,000

IP Fund, Operating expenses 390,000 572,000

IP Fund, Gain from Operations (390,000) (556,000)

IP Fund, Net Loss in Equity Method Investment (943,000) (1,013,000)

IP Fund, Net Loss (1,333,000) $ (1,569,000)

Minimum [Member]

Loss Contingency, Estimate of Possible Loss 1,200,000 1,200,000

Maximum [Member]

Loss Contingency, Estimate of Possible Loss $ 3,000,000 $ 3,000,000

X

- Definition
Accrued expenses and contributions, IP Fund
+ References
No definition available.
+ Details

Name: actg_AccruedExpensesAndContributionsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Cash and other assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_CashAndOtherAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
IP Fund, Gain from Operations
+ References
No definition available.
+ Details

Name: actg_IPFundGainfromOperations

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
IP Fund, Net Loss
+ References
No definition available.
+ Details

Name: actg_IPFundNetLoss

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Net Loss in Equity Method Investment
+ References
No definition available.
+ Details

Name: actg_IPFundNetLossinEquityMethodInvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Operating expenses
+ References
No definition available.
+ Details

Name: actg_IPFundOperatingexpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investments, IP Fund
+ References
No definition available.
+ Details

Name: actg_InvestmentsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fund net assets
+ References
No definition available.
+ Details

Name: actg_NetAssetsFundRelated

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Revenues, IP Fund
+ References
No definition available.
+ Details

Name: actg_RevenuesIPFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_TotalAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349
+ Details

Name: us-gaap_LossContingencyEstimateOfPossibleLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. This element is for unclassified presentations; for classified presentations there is a separate and distinct element.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RestrictedCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R58.htm IDEA: XBRL DOCUMENT v3.8.0.1

Commitments and Contingencies Operating Leases (Details)
$ in Thousands

Dec. 31, 2017

USD ($)

Year:

2018 $ 1,213

2019 1,369

2020 16

Total minimum lease payments $ 2,598

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 75 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1

Supplemental Cash Flow Information (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Supplemental Cash Flow Information [Abstract]

Cash paid for state income taxes $ 181,000 $ 223,000 $ 211,000

Foreign withholding taxes $ 2,865,000 $ 14,776,000 $ 4,421,000

X

- Definition
Cash paid for state income taxes during the period.
+ References
No definition available.
+ Details

Name: actg_CashPaidForStateIncomeTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Foreign withholding taxes
+ References
No definition available.
+ Details

Name: actg_ForeignWithholdingTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 76 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1

Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Revenues $ 3,458 $ 36,633 $ 16,457 $ 8,854 $ 21,969 $ 64,658 $ 41,351 $ 24,721

Inventor royalties 13 0 4,273 666 3,313 17,844 0 1,573 $ 4,952 $ 22,730 $ 18,462

Contingent legal fees 646 12,173 3,236 627 4,238 7,709 10,418 4,109 16,682 26,474 16,169

Litigation and licensing expenses - patents 3,626 4,073 4,134 6,386 5,463 7,348 7,324 7,723 18,219 27,858 39,373

Amortization of patents 5,443 5,625 5,571 5,515 6,222 6,467 10,759 10,760 22,154 34,208 53,067

Marketing, general and administrative expenses (including non-cash stock compensation expense) 335 (12,715) (6,734) (6,916) (9,056) (8,334) (7,535) (7,994) (26,030) (32,919) (38,176)

Other expenses - business development 195 241 433 320 557 666 1,334 522 1,189 3,079 3,391

Impairment of Patent-Related Intangible Assets 0 2,248 0 0 2,175 0 40,165 0 2,248 42,340 74,731

Impairment of Goodwill 0 0 30,149

Other 1,200 0 0 0 0 0 (1,242) 1,742 1,200 500 4,141

Total operating costs and expenses 10,788 37,075 24,381 20,430 31,024 48,368 76,293 34,423 92,674 190,108 277,659

Operating loss (7,330) (442) (7,924) (11,576) (9,055) 16,290 (34,942) (9,702) (27,272) (37,409) (152,622)

Total other income (expense) (102,950) 159,027 (4,862) 696 592 261 (52) (3) 51,911 798 (56)

Income (loss) from operations before (provision for) benefit from income taxes (110,280) 158,585 (12,786) (10,880) (8,463) 16,551 (34,994) (9,705) 24,639 (36,611) (152,678)

(Provision) benefit for income taxes (20) (216) (1,478) (1,241) (2,414) (9,655) (5,927) (192) (2,955) (18,188) (4,800)

Net income (loss) including noncontrolling interests in subsidiaries (110,300) 158,369 (14,264) (12,121) (10,877) 6,896 (40,921) (9,897) 21,684 (54,799) (157,478)

Net (income) loss attributable to noncontrolling interests in subsidiaries (97) (96) (12) (291) (266) (186) (348) 68 (496) (732) 2,558

Net income (loss) attributable to Acacia Research Corporation $ (110,203) $ 158,465 $ (14,252) $ (11,830) $ (10,611) $ 7,082 $ (40,573) $ (9,965) $ 22,180 $ (54,067) $ (160,036)

Earnings Per Share, Basic and Diluted $ (2.18) $ 3.13 $ (0.28) $ (0.24) $ (0.21) $ 0.14 $ (0.81) $ (0.20) $ 0.44 $ (1.08) $ (3.25)

Weighted Average Number of Shares Outstanding, Basic and Diluted 50,590,460 50,554,234 50,499,948 50,333,056 50,237,784 50,124,302 50,015,869 49,925,550

Weighted Average Number of Shares Outstanding, Diluted 50,590,460 50,599,974 50,499,948 50,333,056 50,237,784 50,618,757 50,015,869 49,925,550 50,692,012 50,075,847 49,505,817

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 77 R61.htm IDEA: XBRL DOCUMENT v3.8.0.1

Subsequent Events (Details)
3 Months Ended

Mar. 31, 2018

USD ($)

$ / shares

shares

Investment in Bitzumi $ 1,000,000

Investment in Bitzumi, Remaining Amount 9,000,000

Bitzumi, Warrant to Purchase Common Shares 4,000,000

Bitzumi, total Investment $ 10,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 2.50

Warrant to purchase common share, Bitzumi | shares 30,000,000

Investment in Miso Robotics $ 6,000,000

Percentage of ownership, Miso Robotics 30.00%

Stock repurchase program, authorized amount $ 20,000,000

X

- Definition
Bitzumi, Warrant to Purchase Common Shares
+ References
No definition available.
+ Details

Name: actg_BitzumiWarranttoPurchaseCommonShares

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Bitzumi, total Investment
+ References
No definition available.
+ Details

Name: actg_BitzumitotalInvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investment in Bitzumi
+ References
No definition available.
+ Details

Name: actg_InvestmentinBitzumi

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investment in Bitzumi, Remaining Amount
+ References
No definition available.
+ Details

Name: actg_InvestmentinBitzumiRemainingAmount

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investment in Miso Robotics
+ References
No definition available.
+ Details

Name: actg_InvestmentinMisoRobotics

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of ownership, Miso Robotics
+ References
No definition available.
+ Details

Name: actg_PercentageofownershipMisoRobotics

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Warrant to purchase common share, Bitzumi
+ References
No definition available.
+ Details

Name: actg_WarranttopurchasecommonshareBitzumi

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramAuthorizedAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 78 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; EXCEL 79 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 82 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 178 396 1 false 64 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.acaciaresearch.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1002001 - Statement - Consolidated Statements of Operations Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperationsParentheticals Consolidated Statements of Operations Parentheticals Statements 5 false false R6.htm 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 2101100 - Disclosure - Description of Business Sheet http://www.acaciaresearch.com/role/DescriptionOfBusiness Description of Business Notes 9 false false R10.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2104100 - Disclosure - Short-term Investments Sheet http://www.acaciaresearch.com/role/ShortTermInvestments Short-term Investments Notes 11 false false R12.htm 2106100 - Disclosure - Accounts Payable and Accrued Expenses Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses Accounts Payable and Accrued Expenses Notes 12 false false R13.htm 2108100 - Disclosure - Patents Sheet http://www.acaciaresearch.com/role/Patents Patents Notes 13 false false R14.htm 2112100 - Disclosure - Goodwill Impairment Charges (Notes) Notes http://www.acaciaresearch.com/role/GoodwillImpairmentChargesNotes Goodwill Impairment Charges (Notes) Notes 14 false false R15.htm 2113100 - Disclosure - Investments (Notes) Notes http://www.acaciaresearch.com/role/InvestmentsNotes Investments (Notes) Notes 15 false false R16.htm 2114100 - Disclosure - Stockholders' Equity Sheet http://www.acaciaresearch.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 2115100 - Disclosure - Income Taxes Sheet http://www.acaciaresearch.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2116100 - Disclosure - Stock-Based Incentive Plans Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlans Stock-Based Incentive Plans Notes 18 false false R19.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 2118100 - Disclosure - Retirement Savings Plan and Executive Severance Policy Sheet http://www.acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy Retirement Savings Plan and Executive Severance Policy Notes 20 false false R21.htm 2119100 - Disclosure - Supplemental Cash Flow Information Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 21 false false R22.htm 2120100 - Disclosure - Quarterly Financial Data Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialData Quarterly Financial Data Notes 22 false false R23.htm 2121100 - Disclosure - Subsequent Events (Notes) Notes http://www.acaciaresearch.com/role/SubsequentEventsNotes Subsequent Events (Notes) Notes 23 false false R24.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 2304301 - Disclosure - Short-term Investments (Tables) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsTables Short-term Investments (Tables) Tables http://www.acaciaresearch.com/role/ShortTermInvestments 26 false false R27.htm 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables Accounts Payable and Accrued Expenses (Tables) Tables http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses 27 false false R28.htm 2308301 - Disclosure - Patents (Tables) Sheet http://www.acaciaresearch.com/role/PatentsTables Patents (Tables) Tables http://www.acaciaresearch.com/role/Patents 28 false false R29.htm 2313301 - Disclosure - Investments (Tables) Sheet http://www.acaciaresearch.com/role/InvestmentsTables Investments (Tables) Tables http://www.acaciaresearch.com/role/InvestmentsNotes 29 false false R30.htm 2315301 - Disclosure - Income Taxes (Tables) Sheet http://www.acaciaresearch.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.acaciaresearch.com/role/IncomeTaxes 30 false false R31.htm 2316301 - Disclosure - Stock-Based Incentive Plans (Tables) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables Stock-Based Incentive Plans (Tables) Tables http://www.acaciaresearch.com/role/StockBasedIncentivePlans 31 false false R32.htm 2317301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.acaciaresearch.com/role/CommitmentsAndContingencies 32 false false R33.htm 2320301 - Disclosure - Quarterly Financial Data (Tables) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables Quarterly Financial Data (Tables) Tables http://www.acaciaresearch.com/role/QuarterlyFinancialData 33 false false R34.htm 2401401 - Disclosure - Description of Business (Details) Sheet http://www.acaciaresearch.com/role/DescriptionOfBusinessDetails Description of Business (Details) Details http://www.acaciaresearch.com/role/DescriptionOfBusiness 34 false false R35.htm 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails Summary of Significant Accounting Policies Concentrations (Details) Details 36 false false R37.htm 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies Property and Equipment (Details) Details 37 false false R38.htm 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails Summary of Significant Accounting Policies Earnings per share (Details) Details 38 false false R39.htm 2404402 - Disclosure - Short-term Investments (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsDetails Short-term Investments (Details) Details http://www.acaciaresearch.com/role/ShortTermInvestmentsTables 39 false false R40.htm 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsMarketableSecuritiesDetails Short-term Investments Marketable Securities (Details) Details 40 false false R41.htm 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesDetails Accounts Payable and Accrued Expenses (Details) Details http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables 41 false false R42.htm 2408402 - Disclosure - Patents (Details) Sheet http://www.acaciaresearch.com/role/PatentsDetails Patents (Details) Details http://www.acaciaresearch.com/role/PatentsTables 42 false false R43.htm 2408404 - Disclosure - Patents Future Amortization Expense (Details) Sheet http://www.acaciaresearch.com/role/PatentsFutureAmortizationExpenseDetails Patents Future Amortization Expense (Details) Details 43 false false R44.htm 2412402 - Disclosure - Goodwill Impairment Charges (Details) Sheet http://www.acaciaresearch.com/role/GoodwillImpairmentChargesDetails Goodwill Impairment Charges (Details) Details http://www.acaciaresearch.com/role/GoodwillImpairmentChargesNotes 44 false false R45.htm 2412403 - Disclosure - Goodwill Impairment Charges Details (Details) Sheet http://www.acaciaresearch.com/role/GoodwillImpairmentChargesDetailsDetails Goodwill Impairment Charges Details (Details) Details 45 false false R46.htm 2413402 - Disclosure - Investments (Details) Sheet http://www.acaciaresearch.com/role/InvestmentsDetails Investments (Details) Details http://www.acaciaresearch.com/role/InvestmentsTables 46 false false R47.htm 2414402 - Disclosure - Stockholders' Equity (Details) Sheet http://www.acaciaresearch.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.acaciaresearch.com/role/StockholdersEquity 47 false false R48.htm 2415402 - Disclosure - Income Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.acaciaresearch.com/role/IncomeTaxesTables 48 false false R49.htm 2415403 - Disclosure - Income Taxes Provision for Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesProvisionForTaxesDetails Income Taxes Provision for Taxes (Details) Details 49 false false R50.htm 2415404 - Disclosure - Income Taxes Deferred Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDeferredTaxesDetails Income Taxes Deferred Taxes (Details) Details 50 false false R51.htm 2415405 - Disclosure - Income Taxes Income Tax Rate (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesIncomeTaxRateDetails Income Taxes Income Tax Rate (Details) Details 51 false false R52.htm 2416402 - Disclosure - Stock-Based Incentive Plans (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansDetails Stock-Based Incentive Plans (Details) Details http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables 52 false false R53.htm 2416403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansStockOptionsDetails Stock-Based Incentive Plans Stock Options (Details) Details 53 false false R54.htm 2416404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestricedStockDetails Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Details 54 false false R55.htm 2416405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestrictedStockUnitsDetails Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Details 55 false false R56.htm 2416406 - Disclosure - Stock-Based Incentive Plans Schedule of Grants by Type (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansScheduleOfGrantsByTypeDetails Stock-Based Incentive Plans Schedule of Grants by Type (Details) Details 56 false false R57.htm 2417402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables 57 false false R58.htm 2417403 - Disclosure - Commitments and Contingencies Operating Leases (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesOperatingLeasesDetails Commitments and Contingencies Operating Leases (Details) Details 58 false false R59.htm 2419401 - Disclosure - Supplemental Cash Flow Information (Details) Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformationDetails Supplemental Cash Flow Information (Details) Details http://www.acaciaresearch.com/role/SupplementalCashFlowInformation 59 false false R60.htm 2420402 - Disclosure - Quarterly Financial Data (Details) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataDetails Quarterly Financial Data (Details) Details http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables 60 false false R61.htm 2421402 - Disclosure - Subsequent Events (Details) Sheet http://www.acaciaresearch.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.acaciaresearch.com/role/SubsequentEventsNotes 61 false false All Reports Book All Reports actg-20171231.xml actg-20171231.xsd actg-20171231_cal.xml actg-20171231_def.xml actg-20171231_lab.xml actg-20171231_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2016-01-31 true true ZIP 84 0000934549-18-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000934549-18-000007-xbrl.zip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end

Document and Entity Information Document - USD ($)	12 Months Ended
Document and Entity Information Document - USD ($)	Dec. 31, 2017	Mar. 01, 2018	Jun. 30, 2017
Entity Information [Line Items]
Entity Registrant Name	ACACIA RESEARCH CORP
Entity Central Index Key	0000934549
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		50,637,882
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 202,307,000

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 136,604	$ 127,540
Restricted cash	0	11,512
Short-term investments	0	19,443
Accounts receivable	153	26,750
Prepaid expenses and other current assets	2,938	3,245
Total current assets	139,695	188,490
Investments at fair value	104,754	0
Equity Method Investments	2,195	0
Loan receivable and accrued interest	0	18,616
Investment warrants	0	1,960
Patents, net of accumulated amortization	61,917	86,319
Other assets	207	618
Total assets	308,768	296,003
Current liabilities:
Accounts payable and accrued expenses	7,956	14,283
Royalties and contingent legal fees payable	1,601	13,908
Total current liabilities	9,557	28,191
Other liabilities	3,552	369
Total liabilities	13,109	28,560
Commitments and contingencies (Note 11)
Stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,639,926 shares issued and outstanding as of December 31, 2017 and 50,476,042 shares issued and outstanding as of December 31, 2016	51	50
Treasury stock, at cost, 1,729,408 shares as of December 31, 2017 and 2016	(34,640)	(34,640)
Additional paid-in capital	648,996	642,453
Accumulated comprehensive loss	(88)	(76)
Accumulated deficit	(320,018)	(342,198)
Total Acacia Research Corporation stockholders’ equity	294,301	265,589
Noncontrolling interests in operating subsidiaries	1,358	1,854
Total stockholders’ equity	295,659	267,443
Total liabilities and stockholders' equity	$ 308,768	$ 296,003

Consolidated Balance Sheets Parentheticals - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	50,639,926	50,476,042
Common stock, shares outstanding	50,639,926	50,476,042
Treasury stock, shares	1,729,408	1,729,408

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Revenues	$ 65,402	$ 152,699	$ 125,037
Cost of revenues:
Inventor royalties	4,952	22,730	18,462
Contingent legal fees	16,682	26,474	16,169
Litigation and licensing expenses - patents	18,219	27,858	39,373
Amortization of patents	22,154	34,208	53,067
General and administrative expenses (including non-cash stock compensation expense of $8,885 in 2017, $9,062 in 2016 and $11,048 in 2015)	26,030	32,919	38,176
Other expenses - business development	1,189	3,079	3,391
Impairment of Patent-Related Intangible Assets	2,248	42,340	74,731
Impairment of Goodwill	0	0	30,149
Other	1,200	500	4,141
Total operating costs and expenses	92,674	190,108	277,659
Operating loss	(27,272)	(37,409)	(152,622)
Gain on Conversion of Loan and Accrued Interest	2,671	0	0
Gain on exercise of Primary Warrant	4,616	0	0
Change in fair value of investment	42,239	0	0
Income (Loss) from Equity Method Investments	(220)	0	0
Other Income	1,000	0	0
Investment Income, Interest	1,605	798	(56)
Total other income (expense)	51,911	798	(56)
Income (loss) from operations before provision for income taxes	24,639	(36,611)	(152,678)
Provision for income taxes	(2,955)	(18,188)	(4,800)
Net income (loss) including noncontrolling interests in subsidiaries	21,684	(54,799)	(157,478)
Net (income) loss attributable to noncontrolling interests in subsidiaries	496	732	(2,558)
Net income (loss) attributable to Acacia Research Corporation	22,180	(54,067)	(160,036)
Net Loss Available to Common Stockholders, Basic and Diluted	$ 22,147	$ (54,067)	$ (160,730)
Earnings Per Share, Basic and Diluted	$ 0.44	$ (1.08)	$ (3.25)
Weighted Average Number of Shares Outstanding, Basic	50,495,119	50,075,847	49,505,817
Weighted Average Number of Shares Outstanding, Diluted	50,692,012	50,075,847	49,505,817
Common Stock, Dividends, Per Share, Cash Paid	$ 0.000	$ 0.000	$ 0.500

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Noncontrolling Interests [Member]
Balance at Dec. 31, 2014	$ 489,048	$ 50	$ (34,640)	$ 646,595	$ (353)	$ (128,095)	$ 5,491
Common stock, shares outstanding at Dec. 31, 2014		50,065,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(160,036)					(160,036)
Payments of Dividends	(25,434)			(25,434)
Stock options exercised, shares		135,000
Proceeds from Stock Options Exercised	938
Stock options exercised, value	938			938
Stock issued during period, shares, share-based compensation, net of forfeitures		450,857
Non-cash stock compensation	11,048	$ 1		11,047
Net (income) loss attributable to noncontrolling interests in subsidiaries	2,558						2,558
Payments to Noncontrolling Interests	4,105
Foreign Currency Transaction Gain (Loss), Unrealized	(123)				(123)
Unrealized Gain (Loss) on Investments	261				261
Distributions to noncontrolling interests in operating subsidiary	(4,105)						(4,105)
Payments for Repurchase of Common Stock	0
Balance at Dec. 31, 2015	314,155	$ 51	(34,640)	633,146	(215)	(288,131)	3,944
Common stock, shares outstanding at Dec. 31, 2015		50,651,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(54,067)					(54,067)
Payments of Dividends	$ 0
Stock Repurchased During Period, Shares	(13,529)
Stock options exercised, shares		100,992
Proceeds from Stock Options Exercised	$ 326
Stock options exercised, value				326
Stock issued during period, shares, share-based compensation, net of forfeitures		(262,660)
Non-cash stock compensation	9,062	$ (1)		9,063
Net (income) loss attributable to noncontrolling interests in subsidiaries	(732)						(732)
Payments to Noncontrolling Interests	1,358						(1,358)
Foreign Currency Transaction Gain (Loss), Unrealized					99
Unrealized Gain (Loss) on Investments					40
Distributions to noncontrolling interests in operating subsidiary							(1,358)
Payments for Repurchase of Common Stock	(82)
Balance at Dec. 31, 2016	$ 267,443	$ 50	(34,640)	642,453	(76)	(342,198)	1,854
Common stock, shares outstanding at Dec. 31, 2016	50,476,042	50,476,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	$ 22,180					22,180
Payments of Dividends	$ 0
Stock Repurchased During Period, Shares	(8,669)
Stock options exercised, shares	208,000	207,863
Proceeds from Stock Options Exercised	$ 745	$ 1		744
Stock options exercised, value				745
Stock issued during period, shares, share-based compensation, net of forfeitures		(35,310)
Non-cash stock compensation	8,885	$ 0
General and administrative expenses excluding share-based compensation				5,844
Net (income) loss attributable to noncontrolling interests in subsidiaries	(496)						(496)
Payments to Noncontrolling Interests	0
Foreign Currency Transaction Gain (Loss), Unrealized					28
Unrealized Gain (Loss) on Investments					(40)
Payments for Repurchase of Common Stock	(45)
Balance at Dec. 31, 2017	$ 295,659	$ 51	$ (34,640)	$ 648,996	$ (88)	$ (320,018)	$ 1,358
Common stock, shares outstanding at Dec. 31, 2017	50,639,926	50,639,926

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net income (loss) including noncontrolling interests in operating subsidiaries	$ 21,684,000	$ (54,799,000)	$ (157,478,000)
Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:
Gain on Conversion of Loan and Accrued Interest	(2,671,000)	0	0
Gain on exercise of Primary Warrant	(4,616,000)	0	0
Change in fair value of investment	(42,239,000)	0	0
Depreciation and amortization	22,243,000	34,355,000	53,289,000
Non-cash stock compensation	8,885,000	9,062,000	11,048,000
Impairment of Patent-Related Intangible Assets	2,248,000	42,340,000	74,731,000
Impairment of Goodwill	0	0	30,149,000
Other	(374,000)	(477,000)	(109,000)
Changes in assets and liabilities:
Increase (Decrease) in Restricted Cash	11,512,000	(787,000)	(10,725,000)
Accounts receivable	26,597,000	6,750,000	(13,332,000)
Prepaid expenses and other assets	(135,000)	1,593,000	(619,000)
Accounts payable and accrued expenses / costs	(6,349,000)	(3,006,000)	2,570,000
Royalties and contingent legal fees payable	(12,307,000)	(970,000)	527,000
Net cash provided by (used in) operating activities	24,478,000	34,061,000	(9,949,000)
Cash flows from investing activities:
Payments to Acquire Other Investments	(31,514,000)	0	0
Payments to Acquire Notes Receivable	(4,000,000)	(20,000,000)	0
Purchase of property and equipment	(2,000)	(4,000)	(8,000)
Purchase of available-for-sale investments	(448,388,000)	(62,633,000)	(23,296,000)
Sale of available-for-sale investments		43,232,000	82,115,000
Proceeds from Sale and Maturity of Marketable Securities		43,232,000	82,115,000
Patent acquisition costs	0	(1,225,000)	(19,504,000)
Net cash provided by (used in) investing activities	(16,114,000)	(40,630,000)	39,307,000
Cash flows from financing activities:
Payments of Dividends	0	0	(25,434,000)
Distributions to noncontrolling interests in operating subsidiary	0	(1,358,000)	(4,105,000)
Proceeds from the exercise of stock options	745,000	326,000	938,000
Repurchases of common stock	(45,000)	(82,000)	0
Net cash provided by (used in) financing activities	700,000	(1,114,000)	(28,601,000)
Increase in cash and cash equivalents	9,064,000	(7,683,000)	757,000
Cash and cash equivalents, beginning	127,540,000	135,223,000	134,466,000
Cash and cash equivalents, ending	136,604,000	127,540,000	135,223,000
Patent acquisition costs included in accrued expenses	$ 0	$ 0	$ 1,000,000

Description of Business	12 Months Ended
Description of Business	Dec. 31, 2017
DESCRIPTION OF BUSINESS [Abstract]
Description of Business	DESCRIPTION OF BUSINESS Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into IP related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the intellectual property (“IP”) industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia’s primary licensing and enforcement business. Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia’s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth. During fiscal year 2017 Acacia obtained control of one new patent portfolio. In fiscal year 2016, Acacia obtained control of two new patent portfolios, compared to three new patent portfolios, and six new patent portfolios in fiscal years 2015 and 2014, respectively. Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Dec. 31, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity	STOCKHOLDERS’ EQUITY Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 in 2015. On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders. Tax Benefits Preservation Plan. On March 15, 2016, Acacia’s Board of Directors announced that it unanimously approved the adoption of a Tax Benefits Preservation Plan (the “Plan”). The purpose of the Plan is to protect the Company’s ability to utilize potential tax assets, such as net operating loss carryforwards (“NOLs”) and tax credits to offset potential future taxable income. The Plan is designed to reduce the likelihood that the Company will experience an ownership change by discouraging any (i) person or group from acquiring beneficial ownership of 4.9% or more of the Company’s outstanding common stock and (ii) any existing shareholders who, as of the time of the first public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company’s then-outstanding shares of the Company’s common stock from acquiring additional shares of the Company’s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change. In connection with the adoption of the Plan, Acacia’s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company’s common stock to shareholders of record at the close of business on March 16, 2016. On or after the distribution date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company’s Series A Junior Participating Preferred Stock, $0.001 par value for a purchase price of $15.00.

Retirement Savings Plan and Executive Severance Policy	12 Months Ended
Retirement Savings Plan and Executive Severance Policy	Dec. 31, 2017
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
Retirement Savings Plan and Executive Severance Policy	RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented. Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

Supplemental Cash Flow Information	12 Months Ended
Supplemental Cash Flow Information	Dec. 31, 2016
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	SUPPLEMENTAL CASH FLOW INFORMATION Cash paid for state income taxes totaled $181,000, $223,000 and $211,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Foreign taxes withheld totaled $2,865,000, $14,776,000 and $4,421,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Refer to Note 4 for accrued foreign taxes payable. Refer to Note 5 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 7 for information regarding noncash investing activity related to the investment in Veritone for the periods presented.

Subsequent Events (Notes)	12 Months Ended
Subsequent Events (Notes)	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	SUBSEQUENT EVENTS Investments In January 2018, Acacia entered into a Joint Venture and Services Agreement (“Joint Venture Agreement”) with Bitzumi, Inc., a company developing macro opportunities in the cryptocurrency and blockchain industries, including a next generation decentralized exchange. Bitzumi recently filed a Regulation A Offering Statement with the Securities and Exchange Commission and a listing application with NASDAQ. Acacia made an initial $1,000,000 equity investment in Bitzumi in January 2018. Under the Joint Venture Agreement, Acacia will provide various patent-related services to Bitzumi and has the option to invest up to an additional $9,000,000 to acquire Bitzumi common stock. In connection with Acacia’s initial investment, Acacia received a short-term warrant to purchase $4,000,000 of Bitzumi common shares. Under the Joint Venture Agreement, Acacia has a right to acquire up to an aggregate of $10.0 million of Bitzumi common shares (inclusive of Acacia’s initial $1,000,000 equity investment and exercise of Acacia’s short-term warrant) at a price, except as paid by Acacia for the initial investment and the exercise price of Acacia’s short-term warrant, of $2.50 per share. Upon meeting certain conditions set forth in the Joint Venture Agreement, Bitzumi will also issue Acacia a warrant for 30,000,000 shares of Bitzumi’s common stock. Acacia’s investment in Bitzumi represents its first venture in the cryptocurrency and blockchain marketplaces. In February 2018, Acacia made an additional equity investment in Miso Robotics totaling $6,000,000, increasing its ownership interest in Miso Robotics to approximately 30%. In addition, Acacia acquired an additional board seat. Stock Repurchase Program. In February 2018, Acacia’s Board of Directors authorized the repurchase of up to $20,000,000 of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors will consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. The Stock Repurchase Program is set to expire on February 28, 2019.

Description of Business (Details) - patents	12 Months Ended
Description of Business (Details) - patents	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Description of Business [Line Items]
Number of patent portfolios acquired	1	2	3	6

Summary of Significant Accounting Policies Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2017
Furniture and Fixtures [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Furniture and Fixtures [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Computer Hardware and Software [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Computer Hardware and Software [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Leasehold Improvements [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	2
Leasehold Improvements [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Accounting Policies [Abstract]
Net income (loss) attributable to Acacia Research Corporation	$ (110,203)	$ 158,465	$ (14,252)	$ (11,830)	$ (10,611)	$ 7,082	$ (40,573)	$ (9,965)	$ 22,180	$ (54,067)	$ (160,036)
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic									33	0	0
Payments of Dividends									0	0	(25,434)
Dividends attributable to common stockholders under the two class method									0	0	24,740
Net Loss Available to Common Stockholders, Basic and Diluted									$ 22,147	$ (54,067)	$ (160,730)
Weighted Average Number of Shares Outstanding, Basic									50,495,119	50,075,847	49,505,817
Weighted Average Number Diluted Shares Outstanding Adjustment									196,893	0	0
Weighted Average Number of Shares Outstanding, Diluted	50,590,460	50,599,974	50,499,948	50,333,056	50,237,784	50,618,757	50,015,869	49,925,550	50,692,012	50,075,847	49,505,817
Earnings Per Share, Basic and Diluted	$ (2.18)	$ 3.13	$ (0.28)	$ (0.24)	$ (0.21)	$ 0.14	$ (0.81)	$ (0.20)	$ 0.44	$ (1.08)	$ (3.25)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share									4,425,187	3,682,532	71,468

Short-term Investments (Details) - USD ($)	12 Months Ended
Short-term Investments (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, amortized cost	$ 19,403,000
Available-for-sale securities, gross unrealized gains	40,000
Available-for-sale securities, gross unrealized losses	0
Available-for-sale securities, fair value	$ 19,443,000
Investment Maturity Date	Dec. 31, 2017
Available-for-sale Securities, Gross Realized Losses		$ 617,000
Proceeds from Sale and Maturity of Marketable Securities	$ 43,232,000	$ 82,115,000

Short-term Investments Marketable Securities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 19,403
Available-for-sale Securities, Gross Unrealized Gain	40
Available-for-sale Securities, Gross Unrealized Loss	0
Available-for-sale Securities	$ 19,443

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Accounts Payable and Accrued Liabilities, Current [Abstract]
Payroll and other employee benefits	$ 465	$ 1,593
Accrued vacation	294	533
Accrued legal expenses - patent	5,479	6,564
Foreign taxes payable	15	3,150
Accrued consulting and other professional fees	1,364	1,967
Other accrued liabilities	339	476
Accounts payable and accrued expenses	$ 7,956	$ 14,283

Patents (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Patents (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Patents [Line Items]
Patents, net	$ 61,917				$ 86,319				$ 61,917	$ 86,319
Patents, weighted average useful life									4 years
Payments to acquire intangible assets									$ 0	1,225	$ 19,504
Impairment of Patent-Related Intangible Assets	0	$ 2,248	$ 0	$ 0	2,175	$ 0	$ 40,165	$ 0	$ 2,248	42,340	$ 74,731
Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Acquired Finite Lived Intangible Asset, Useful Life									2 years
Maximum [Member]
Patents [Line Items]
Patents, useful life									6 years
Acquired Finite Lived Intangible Asset, Useful Life									7 years
Patents [Member]
Patents [Line Items]
Gross carrying amount - patents	444,137				444,362				$ 444,137	444,362
Accumulated amortization - patents	382,220				358,043				382,220	358,043
Patents, net	$ 61,917				$ 86,319				$ 61,917	$ 86,319
Patents [Member] \| Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Patents [Member] \| Maximum [Member]
Patents [Line Items]
Patents, useful life									6 years

Patents Future Amortization Expense (Details)	Dec. 31, 2017 USD ($)
Patents [Abstract]
2018	$ 20,542,000
2019	18,527,000
2020	6,134,000
2021	5,261,000
2022	5,256,000
After Year Five	$ 6,197,000

Investments (Details) - USD ($)		3 Months Ended								9 Months Ended	12 Months Ended
Investments (Details) - USD ($)	May 17, 2017	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 14, 2017	Aug. 15, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Income (Loss) from Equity Method Investments											$ (220,000)	$ 0	$ 0
Cash Paid for Investment											2,250,000
Assets, Current		$ 139,695,000				$ 188,490,000					139,695,000	188,490,000
Revenues		$ 3,458,000	$ 36,633,000	$ 16,457,000	$ 8,854,000	21,969,000	$ 64,658,000	$ 41,351,000	$ 24,721,000
Gain on Conversion of Loan and Accrued Interest											2,671,000	0	0
Gain on exercise of Primary Warrant											4,616,000	0	0
Change in fair value of investment											$ 42,239,000	0	0
Percentage of ownership, Veritone	20.00%	23.00%									23.00%
First Loan Warrant															$ 700,000
Time-sharing Transactions, Stated Interest Rate for Notes Receivable															6.00%
Maximum Investment in Veritone															$ 50,000,000
Secured Promissory Note Advance															10,000,000
Veritone Primary Warrant															50,000,000
Secured Convertible Promissory Note															$ 20,000,000
Unamortized loan discount	$ 1,700,000
Investment Income, Interest											$ 1,605,000	798,000	$ (56,000)
Loan receivable and accrued interest	$ 20,700,000	$ 0				18,616,000					0	18,616,000
Investment warrants		0				1,960,000					0	1,960,000
Accretion (Amortization) of Discounts and Premiums, Investments											630,000
Loss on fair value investment net											49,526,000
Assets		308,768,000				296,003,000					308,768,000	296,003,000
Liabilities, Current		9,557,000				28,191,000					9,557,000	28,191,000
Liabilities		13,109,000				28,560,000					13,109,000	28,560,000
Stockholders' Equity Attributable to Parent		$ 294,301,000				$ 265,589,000					$ 294,301,000	$ 265,589,000
Common stock, shares outstanding		50,639,926				50,476,042					50,639,926	50,476,042
Debt Instrument, Convertible, Conversion Price	$ 13.6088
Cash paid for primary warrant exercise	$ 29,300,000
10% Warrant	809,400
Bridge Loan	$ 4,000,000													$ 4,000,000
Bridge loan stated interest rate														8.00%
Veritone Bridge Loan Advance 1														$ 1,000,000
Veritone Bridge Loan Advance 3 and 4														$ 2,000,000
Upfront Shares														60,000
Bridge Installment Shares														90,000
Bridge Warrant Share														157,000
Investments at fair value		$ 104,754,000				$ 0					$ 104,754,000	$ 0
Equity Method Investment, Ownership Percentage		23.00%									23.00%
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)											53.00%
Fair Value Assumptions, Expected Volatility Rate											50.00%
Fair Value Inputs, Probability of Default											75.00%
Fair value inputs recovery											100.00%
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)											9.00%
Monte Carlo [Member] \| Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate										40.00%
Fair Value Inputs, Discount for Lack of Marketability											7.00%
Fair Value Inputs, Probability of Default											25.00%
Finnerty - Common Stock [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate	35.00%										37.00%
Fair Value Inputs, Discount for Lack of Marketability	6.00%										5.00%
Fair Value Assumptions, Expected Term	6 months										2 months
Finnerty - Warrants [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate	35.00%
Fair Value Inputs, Discount for Lack of Marketability	6.00%										10.00%
Fair Value Assumptions, Expected Term	6 months										5 months
Finnerty - Warrants [Member] \| Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate											87.00%
Finnerty - Warrants [Member] \| Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate											72.00%
Black Scholes [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Dividend Payments											$ 0
Black Scholes [Member] \| Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Risk Free Interest Rate											2.37%
Fair Value Assumptions, Expected Volatility Rate											55.00%
Fair Value Assumptions, Expected Term											9 years
Black Scholes [Member] \| Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Risk Free Interest Rate											1.94%
Fair Value Assumptions, Expected Volatility Rate											45.00%
Fair Value Assumptions, Expected Term											3 years
Veritone [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Assets, Current			78,509,000							$ 78,509,000
Revenues										10,914,000
Investment Income, Interest											$ 1,100,000
Gross Profit										10,090,000
Operating Expenses										44,024,000
Other Operating Income (Expense), Net										(12,872,000)
Net Income (Loss) Available to Common Stockholders, Diluted										$ (51,281,000)
Basic and diluted loss per common share										$ (5,940)
Assets, Noncurrent			1,173,000							$ 1,173,000
Assets			79,682,000							79,682,000
Liabilities, Current			31,836,000							31,836,000
Liabilities, Noncurrent			14,000							14,000
Liabilities			31,850,000							31,850,000
Preferred Stock, Value, Outstanding			0							0
Stockholders' Equity Attributable to Parent			47,832,000							47,832,000
Total liabilities, preferred stock and stockholders' equity			$ 79,682,000							$ 79,682,000
Common Stock [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Owned, Balance, Shares		4,119,521									4,119,521
Investments at fair value		$ 90,795,000									$ 90,795,000
Warrant [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Owned, Balance, Shares		1,120,432									1,120,432
Investments at fair value		$ 13,959,000									$ 13,959,000
Veritone Loans [Member] \| Veritone [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Common stock, shares outstanding	1,523,746
Primary warrant [Member] \| Veritone [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Common stock, shares outstanding	2,150,335
Bridge Loan [Member] \| Veritone [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Common stock, shares outstanding	295,440
Warrant [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gain on Conversion of Loan and Accrued Interest											0
Gain on exercise of Primary Warrant											(4,616,000)
Change in fair value of investment											8,317,000
Common Stock [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gain on Conversion of Loan and Accrued Interest											2,671,000
Gain on exercise of Primary Warrant											0
Change in fair value of investment											$ 33,922,000

Stockholders' Equity (Details) - USD ($)	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Feb. 16, 2017	Jan. 02, 2015
Stockholders Equity [Line Items]
Dividends declared, per share			$ 0.50
Common stock dividends declared, quarterly			$ 0.125
Payments of Dividends	$ 0	$ 0	$ 25,434,000
Beneficial Ownership Percentage Limit	4.90%			60.00%
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	$ 0	$ 0
Share Price			$ 4.29		$ 16.72
Share Repurchase Program [Domain]
Stockholders Equity [Line Items]
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	$ 0.001
Share Price	$ 15.00

Income Taxes (Details) - USD ($)	12 Months Ended
Income Taxes (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Taxes [Line Items]
Operating loss carryforwards, federal	$ 180,621,000
Operating loss carryforwards, state	17,850,000
Deferred tax assets, valuation allowance	90,278,000	$ 102,627,000
Federal NOL annual utilization limit	14,100,000
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	90,871,000	$ 83,323,000
Foreign tax credits, additional paid in capital benefit	$ 51,126,000
Effective Income Tax Rate Reconciliation, Percent	12.00%	50.00%	3.00%
Effective tax rate excluding valuation allowance	47.00%	(33.00%)	(28.00%)
Deferred Tax Liabilities, Other	$ 10,587,000
Federal Deferred Tax Asset, Impact of ASU 2016-09	21,350,000
Deferred Tax Assets, Gross	100,889,000	$ 102,789,000
Deferred Tax Assets, State Taxes	1,559,000
Unrecognized tax benefits	808,000
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	0.21
Deferred Tax Asset, Revaluation	25,261,000
Domestic Tax Authority [Member]
Income Taxes [Line Items]
Net operating losses included in deferred tax assets	2,804,000
Capital Loss Carryforward Related to Business Acquisition [Member] \| Internal Revenue Service (IRS) [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards	$ 26,326,000

Income Taxes Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets:
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	$ 90,871	$ 83,323
Stock compensation	2,635	2,416
Deferred tax assets intangibles and fixed assets	6,197	14,343
Basis of investments in affiliates	984	2,195
Accrued liabilities and other	167	422
Deferred Tax Assets, State Taxes	35	90
Total deferred tax assets	100,889	102,789
Deferred tax liabilities:
Fixed assets and intangibles	(10,587)	0
Other	(24)	(162)
Deferred Tax Liabilities, Gross	(10,611)	(162)
Net deferred tax liabilities	0	0
Less: valuation allowance	(90,278)	(102,627)
Net deferred taxes	$ 10,611	$ 162

Income Taxes Income Tax Rate (Details)	12 Months Ended
Income Taxes Income Tax Rate (Details)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation goodwill	0.00%	0.00%	7.00%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Statutory federal tax rate	35.00%	(35.00%)	(35.00%)
State income and foreign taxes, net of federal tax effect	8.00%	50.00%	3.00%
Foreign tax credit	0.00%	(49.00%)	(3.00%)
Noncontrolling interests in operating subsidiaries	1.00%	1.00%	(1.00%)
Non deductible permanent items	3.00%	0.00%	0.00%
Expired net operating loss carryforwards	0.00%	0.00%	1.00%
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent	102.00%	(0.00%)	(0.00%)
Valuation allowance	(137.00%)	83.00%	31.00%
Total	12.00%	50.00%	3.00%

Stock-Based Incentive Plans (Details) - USD ($)	9 Months Ended	12 Months Ended
Stock-Based Incentive Plans (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Feb. 16, 2017	Apr. 26, 2016	Jan. 02, 2015
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value		$ 2,009,000	$ 2,342,000
Employee Service Share-based Compensation, Awards with market Cond, Compensation Cost Not yet Recognized		0
Non-cash stock compensation		$ 8,885,000	$ 9,062,000	$ 11,048,000
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value		$ 0.00	$ 16.72
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value		$ 200,000	$ 324,000	480,000
Ownership percent of voting stock		10.00%
Aggregate intrinsic value of options exercised		$ 296,000	344,000	$ 751,000
Weighted average grant date fair value of restricted stock granted		$ 0.00
Number of shares of common stock reserved for issuance		7,279,000
Beneficial Ownership Percentage Limit		4.90%			60.00%
Fair Value of Profits Interest		$ 3,041,000			$ 722,000
Share Price				$ 4.29			$ 16.72
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Total unrecognized compensation expense for nonvested awards		$ 3,654,000
Weighted average period over which unrecognized compensation expense will be recognized		2 years
Restricted stock awards with time based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		$ 1,025,000	$ 4,071,000	$ 10,575,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Weighted average grant date fair value of restricted stock granted			$ 3.12	$ 12.83
Aggregate fair value of restricted stock vested		1,560,000	$ 5,243,000	$ 11,494,000
Total unrecognized compensation expense for nonvested awards		$ 53,000
Weighted average period over which unrecognized compensation expense will be recognized		2 months
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Total unrecognized compensation expense for nonvested awards		$ 1,000
Weighted average period over which unrecognized compensation expense will be recognized		1 month
Restricted stock unit awards with time-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		$ 161,000	320,000	473,000
Restricted stock unit awards with performance based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		121,000	197,000	0
Stock options with time-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		2,165,000	1,316,000	0
Stock options with market-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		2,372,000	3,158,000	0
Stock options with performance-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		0	0	0
Deferred Profit Sharing [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation		$ 3,041,000	$ 0	$ 0
2007 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant		0
2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Aggregate shares available for issuance						4,500,000
Number of shares available for grant		727,000
Discretionary Option Grant Program [Member] \| Nonstatutory Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price		85.00%
Stock Issuance Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price		100.00%
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Aggregate shares available for issuance						4,750,000
Number of shares available for grant		660,000
2013 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant						625,390
Less than 10% [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price		100.00%
10% or More [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price		110.00%
Geometric Brownian Motion [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Fair Value Assumptions, Expected Term		4 years 5 months
Fair Value Assumptions, Expected Volatility Rate		50.00%
Finnerty - Profits Interests [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Term specific volatility		85.00%
Fair Value Inputs, Discount for Lack of Marketability		30.00%
Minimum [Member] \| Geometric Brownian Motion [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Fair Value Assumptions, Expected Term	1 year
Fair Value Assumptions, Risk Free Interest Rate		2.00%
Minimum [Member] \| Veritone [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Share Price		$ 23.20
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Fair Value Assumptions, Expected Volatility Rate		50.00%
Maximum [Member] \| Geometric Brownian Motion [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Fair Value Assumptions, Expected Term	10 years
Fair Value Assumptions, Risk Free Interest Rate		2.00%

Commitments and Contingencies (Details) - USD ($)	3 Months Ended								12 Months Ended
Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restricted Cash and Cash Equivalents	$ 0				$ 11,512,000				$ 0	$ 11,512,000
Rent expense									1,392,000	1,795,000	$ 1,926,000
Other	1,200,000	$ 0	$ 0	$ 0	0	$ 0	$ (1,242,000)	$ 1,742,000	1,200,000	500,000	$ 4,141,000
Cash and other assets, IP Fund	986,000				1,118,000				986,000	1,118,000
Investments, IP Fund	1,905,000				2,933,000				1,905,000	2,933,000
Total assets, IP Fund	2,891,000				4,051,000				2,891,000	4,051,000
Accrued expenses and contributions, IP Fund	2,567,000				2,394,000				2,567,000	2,394,000
Net assets, IP Fund	324,000				$ 1,657,000				324,000	1,657,000
Revenues, IP Fund									0	16,000
IP Fund, Operating expenses									390,000	572,000
IP Fund, Gain from Operations									(390,000)	(556,000)
IP Fund, Net Loss in Equity Method Investment									(943,000)	(1,013,000)
IP Fund, Net Loss									(1,333,000)	$ (1,569,000)
Minimum [Member]
Loss Contingency, Estimate of Possible Loss	1,200,000								1,200,000
Maximum [Member]
Loss Contingency, Estimate of Possible Loss	$ 3,000,000								$ 3,000,000

Commitments and Contingencies Operating Leases (Details) $ in Thousands	Dec. 31, 2017 USD ($)
Year:
2018	$ 1,213
2019	1,369
2020	16
Total minimum lease payments	$ 2,598

Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
Supplemental Cash Flow Information (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Supplemental Cash Flow Information [Abstract]
Cash paid for state income taxes	$ 181,000	$ 223,000	$ 211,000
Foreign withholding taxes	$ 2,865,000	$ 14,776,000	$ 4,421,000

Subsequent Events (Details)	3 Months Ended
Subsequent Events (Details)	Mar. 31, 2018 USD ($) $ / shares shares
Investment in Bitzumi	$ 1,000,000
Investment in Bitzumi, Remaining Amount	9,000,000
Bitzumi, Warrant to Purchase Common Shares	4,000,000
Bitzumi, total Investment	$ 10,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 2.50
Warrant to purchase common share, Bitzumi \| shares	30,000,000
Investment in Miso Robotics	$ 6,000,000
Percentage of ownership, Miso Robotics	30.00%
Stock repurchase program, authorized amount	$ 20,000,000